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Abbreviations: 
• 4-HNE: 4-Hydroxynonenal 
• 7-T: 7(Z)-Tricosene 
• 20-HE: 20-hydroxyecdysone 
• AA: Arachidonic Acid 
• AEA: Anandamide 
• AGP: α-acid glycoprotein 
• α-1m: α-1microglobulin 
• ApoD: Apolipoprotein D 
• ApoM: Apolipoprotein M 
• ATF3: Activating Transcription Factor 3 
• BBP: Bilin-Binding Protein 
• CALβ: Chondrogenesis-Associated Lipocalin β 
• CG: Computed Gene 
• CNS: Central Nervous System 
• CRC: Crustacyanin 
• DHA: Docosahexaenoic Acid 
• DNA: Deoxyribonucleic acid 
• Ex-FABP: Extracellular Fatty Acid Binding Protein 
• FA: Fatty Acid 
• FABP: Fatty Acid Binding Protein 
• FOXO: Forkhead Box Protein O 
• GLaz: Glial Lazarillo 
• Gp93: Glycoprotein-93 
• GPI: Glycosylphosphatidylinositol 
• HDL: High Density Lipoparticles 
• Hr39: Hormone Receptor-39 
• HSD: High Sugar Diet 
• IIS: Insulin/IGF1 Signaling 
• Ins: Insecticyanin 
• InR: Insulin Receptor 
• JNK: Jun-N-terminal Kinase 
• KO: Knock-Out 
• Kr: Krüppel 
• LA: Linoleic Acid 
• Laz: Lazarillo 
• Lcn: Lipocalin 
• Lip-4: Lipase-4 
• Lola: Longitudinals Lacking Protein 
• L-PGDS: Prostaglandin D Synthase Lipocalin 
• MPI: Metalloproteinase Inhibitors 
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• mRNA: Messenger Ribonucleic Acid 
• MUP: Major Urinary Protein 
• NAE: N-acylethanolamines 
• NGAL: Neutrophil Gelatinase-Associated Lipocalin 
• n-HETE: Hydroxyeicosatetraenoic Acid 
• n-HpETE: hydroperoxyeicosatetraenoic acid 
• NLaz: Neural Lazarillo 
• OEA: Oleoylethanolamine 
• OBP: Odorant Binding Protein 
• PDB: Protein Data Bank 
• PEA: Palmitoylethanolamine 
• pI: Isoelectric Point 
• PI3K: Phosphatidyl-Inositol 3-Kinase 
• PQ: Paraquat (1,1'-dimethyl-4,4'-bipyridinium dichloride) 
• PUFA: Poly-Unsaturated Fatty Acid 
• RBP: Retinol Binding Protein 
• ROS: Reactive Oxygen Species 
• Scn: Siderocalin 
• SCR: Structurally Conserved Region 
• SM: Sphingomyelin 
• SMase: Sphingomyelinase 
• TAG: Triacylglycerides 
• TL: Tear Lipocalinç 
• UTR: Untranslated Region 
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Introductory words 
 
This thesis will present a mechanistical experimental approach to understand a 
molecular function common to the Lipocalin protein family. As an introduction, I will 
first summarize their evolution, ligand-binding properties and functional implications. 
Following I will focus on the current knowledge about the Lipocalin Lazarillo and its 
homologs, my playmates for the past few years. 
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The Lipocalin protein family: A brief introduction and general characteristics. 
 
The definition of “protein family” varies according to different authors. In a simple 
way, a protein family can be defined as a collection of related proteins [Pfam database: 
1]. This relationship was typically based on protein function and/or primary structure. 
However, with the increasing number of protein tertiary structures resolved, protein 
families are also described according to its folding. Precisely, the Lipocalins belong to a 
set of families mainly defined by its structural homology. The Lipocalin fold is shaped 
by a β-barrel, forming a cup or calyx, with a central cavity that serves as a ligand-
binding site [2]. Together with fatty acid binding proteins (FABPs), avidins and 
metalloproteinase inhibitors (MPI), the Lipocalins assemble the Calycin superfamily 
[2]. 
Historically, the Lipocalin name was suggested by Pervaiz and Brew in 1987 [3] 
studying the structure-function correlations among several proteins. However, the 
Lipocalin protein family concept was previously proposed by Unterman et al. in 1981 
[4] by comparing the amino acid sequence homology between some Lipocalin family 
members. 
Lipocalins are typically small (160-230 amino acid residues) extracellular proteins. 
Family members are found in all five life kingdoms [5], and their numbers are growing 
quickly due to the new sequenced genomes: over six hundred Lipocalins are currently 
identified.  
Although Lipocalins are sometimes classified as mere transport proteins, it is now 
clear that they are carrying out a wide variety of really important functions. Their roles 
include regulation of the immune response, metabolism, oxidative stress defense, 
coloration and control of behavior among many others. A reflection of this 
physiological variety is that Lipocalins are being used as clinical markers in cancer, 
kidney injury and lipid disorders [6]. 
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Lipocalin Family phylogeny: Clade division. 
 
By using several conserved features of Lipocalins, a phylogeny of the family can be 
inferred. Phylogenetic trees, based on both protein sequences and gene architecture, 
have been built (fig.1A and 1B respectively) and show a similar topology [5,7-9]. The 
number of tertiary structures of Lipocalins has grown lately, and it should be now 
possible and desirable to update the Lipocalin tree considering protein folding as a 
phylogenetic signal as well. 
Focusing in the phylogenetic tree derived from protein sequence, the animal 
Lipocalins are divided into twelve monophyletic clades (defined and named in fig. 1A). 
Clade I is especially interesting because it encompasses the majority of arthropodan 
Lipocalins and ApoD (Apolipoprotein D), the most ancestral chordate Lipocalin.  
Subsequently, the family can be divided in ancestral vertebrate Lipocalins, those 
more related to ApoD (clades III, IV, V and VI) and modern vertebrate Lipocalins 
(clades VII-XII) (see fig 1A) [5]. 
Combining phylogenetic and structural information Gutierrez et al [10] conclude 
that more recently evolved Lipocalins have a more flexible protein structure (based on 
number of disulfide bonds), and  bind smaller ligands with more efficiency than the 
ancestral Lipocalins. These points are in agreement with the fact that modern Lipocalins 
show a tendency to present more gene duplications and could be more specialized. 
 
Lipocalin structure: From genes to proteins. 
 
Tertiary and secondary structure 
 
As mentioned above the Lipocalin fold comprises a right hand β-barrel (composed 
of eight antiparallel β-strands, labeled as A-H in fig.2A) that encloses an internal ligand-
binding cavity. This cavity, or pocket, is usually outlined by apolar amino acids and is 
ideal for binding small hydrophobic compounds. The β-strands are linked by loops (L1, 
L3, L5 and L7) that are located close to the opening of the binding pocket and can 
influence the ligand-binding properties [11,12]. At the other side of the molecule you 
will find loops L2, L4, L6 and L8. Loops L2-L8 are all typical short β-hairpin, whereas 
L1, which is a large Ω loop, forms a lid that can partially or completely covers the 
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Figure 1. Two sets of independent characters have produced very similar phylogenetic 
relationships between Lipocalins.  
(A) Phylogenetic tree of the Lipocalin family derived from a multiple alignment of protein sequences, 
rooted with a group of bacterial Lipocalins. (B) Lipocalin phylogeny based on exon-intron arrangement, 
rooted with a protoctist Lipocalin. Scale bars represent branch length (number of substitutions/site) 
[Adapted from 7]. 
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ligand-binding site. There is a 310 helix at the protein N-terminus, whereas at the C-
terminus there is a canonical α-helix (fig.2) [2]. Most Lipocalins contain one or more 
intramolecular disulphide bonds that help to stabilize the β-barrel and are required to get 
the proper conformation and ligand-binding properties [13,14]. Several cysteine (Cys) 
residues present a pattern that is conserved in the family [7].  
Within this general scheme, some Lipocalins show specific divergences in their 
primary and secondary structure. L-PGDS (Lipocalin-type Prostaglandin D Synthase), 
α-1m (α-1microglobulin) and the human version of ApoD show an unpaired Cys. The 
loops L5 and L7 appear elongated in RBP (Retinol Binding Protein). An unusually long 
N-terminus is present in the insect Lipocalin Karl. 
Many Lipocalins present N- and/or O-linked glycosylation, and glycosylation 
residues range from none to six. Glycosylation is known to confer different properties 
and function, as happens for instance in Glycodelin [15], TL (Tear Lipocalin or Lcn1) 
[16], AGP (α-acid glycoprotein) [17], and the glycosylation-dependent secretion of α-
1m [18]. 
 
Primary structure 
 
Lipocalins show an extreme divergence at their amino acid sequence level, and a 
pairwise identity of 20-30% is common inside the family. This fact poses difficulties 
when assigning newly discovered sequences to the family. However, three conserved 
motifs, called structurally conserved regions (SCR), are revealed by multiple alignments 
[19].  
- SCR1 is defined by the residues G-x1-W-x2 (being x2 usually Y/F/W), and it is located 
in the first β-strand (strand A). 
- SCR2 consensus sequence is T-D/N-Y-x-x-Y. Physically the SCR2 is found in the 
loop L6, connecting strands F and G. 
- SCR3 is the shortest SCR and consists of a charged residue (R/K) in the β-strand H. 
SCR1 and SCR3 appear conserved in over 90% of Lipocalins, whereas SCR2 is 
present in approximately 60% of them. Therefore, it is not unusual that entire groups of 
Lipocalins lack an individual motif. This is the case of ApoM (Apolipoprotein M) and 
AGP. Given that the Lipocalin motifs are so short, many proteins have been 
bioinformatically misclassified as Lipocalins by some protein databases. Curiously, all 
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three motifs are at the base of the calyx and seem to be important to achieve a proper 
folding. Especially essential is the SCR1 tryptophan residue [20,21]. 
Following the suggestion of Flower [19], Lipocalins were conceptually divided in 
two groups: kernel Lipocalins, where all SCR are present, and outlier Lipocalins that 
miss at least one SCR.  
 
Gene Structure 
 
Some characteristic features of Lipocalins are also extended to gene structure, 
exhibiting a similar arrangement of exons and introns in the coding sequence of their 
genes [9].  
Vertebrate Lipocalins show seven exons (1-7) and six introns (A-F), usually 
including six coding exons (e1-e6). Exons 2-5 code for the entire set of β-strands. In 
some cases, e6 appears fused with e7, as happens in human ApoM or chicken Calβ 
genes. Additionally, the intron phase pattern is well conserved (0,2,1,1,1; each number 
indicates the position within the codons where the intron is inserted) [5,9]. 
Looking at the phylum arthropoda, there is a higher variability in gene structure, 
with a lower number of exons compared to vertebrate Lipocalins. However, exon sizes 
and the pattern of intron phases are quite similar between vertebrates and arthropods, a 
further genomic support for sharing a common ancestor. The Lipocalin gene 
architecture in other organisms, including plants, has not been studied in detail yet. 
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Ligand binding and Lipocalin Function: A family overview. 
 
Several properties of the binding pocket (depth, width, polarity and loop positions) 
determine what ligands are able to bind to each Lipocalin. Biological processes often 
depend on protein-ligand binding events, and this is indeed the case for Lipocalins. 
Their functions cannot be completely understood without taking in account their 
ligands. Some examples of the close relationship between ligand and function in 
different Lipocalin clades include: 
 
 
- MrLC is a crustacyanin (clade I) from the prawn Macrobrachium rosenbergii that 
shows dual binding capacities. MrLC binds astaxanthin, which is responsible for the 
bluish prawn coloration, but MrLC also binds 20-hydroxyecdysone (20-HE) and 
regulates prawn molting [22]. 
Another example of coloration function involves Insecticyanin (Ins, also from 
clade I) and its ligand biliverdin IXγ, which confers a green color to Manduca sexta 
larvae [23-25]. 
 
- RBP belongs to clade III and has been identified from fish to mammals. RBP was the 
first crystallized Lipocalin [26] and is considered a prototypal Lipocalin. Actually, the 
RBP ligand retinol has been demonstrated to be a common ligand in vitro for most 
Lipocalins [27-29]. RBP transports retinol from the liver to peripheral target tissues, and 
plays a key role in vision and several development processes [30,31]. 
 
- Siderocalin (Scn), also known as Lipocalin-2 (Lcn2), neutrophil gelatinase-associated 
Lipocalin (NGAL) or 24p3, belongs to clade V and is a Lipocalin involved in the 
immune response. Scn binds siderophores, small secreted bacterial compounds that are 
able to chelate iron, an essential and scarce nutrient. Therefore, Scn acts as an anti-
bacterial component of the innate immune response by sequestering iron away from 
invading pathogens [32]. This mechanism of action is shared with the avian Lipocalins 
Q83 [33] and Ex-FABP [34]. 
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- Odorant binding proteins (OBP) and Major urinary proteins (MUP), clades X and IX 
respectively, are chemosensory proteins that act as peri-receptors transporting odorant 
or pheromones to the neuroepithelium, and are involved in behavior regulation [35-37]. 
In addition, bovine OBP has a protective role by binding 1-octen-3-ol, a potent biting 
insect attractant which comes from mammal breath and sweat [38]. 
 
A set of Lipocalins shows anti-oxidant binding properties. ApoM binds oxidized 
phospholipids selectively, thus serving as a scavenger of lipoprotein oxidation products 
[39]. TL and OBP bind to 4-hydroxy-2-nonenal (4-HNE), an end-product of ω-6 PUFA 
(poly-unsaturated fatty acid) peroxidation, and prevent its cytotoxicity [40,41]. Finally, 
α-1m binds heme and participates in its degradation [42]. Additionally, α-1m shows 
reductase/dehydrogenase properties and may act as and oxidation repair factor for 
important structural proteins as collagen [43]. 
 
Clade I: Arthropodan and vertebrate Lipocalin meeting point. 
 
As discussed above, the Lipocalin clade I includes most arthropodan Lipocalins and 
the most ancestral chordate Lipocalin: ApoD. Clade I can be subdivided into three 
groups: Lazarillo-related Lipocalins, Crustacyanins (CRC) and Bilin binding-related 
Lipocalins. Another group of arthropodan Lipocalins, the Nitrophorins of blood-feeding 
insects, represents a large independent expansion of very divergent Lipocalin genes, and 
the phylogeny reconstruction tools usually place them among more recent Lipocalin 
clades (fig.1A.).  
Below I will go over what is known about the ‘founding member’ of the Clade I 
group: Lazarillo. I will follow by describing the Clade I Lipocalins from the model 
organism Drosophila melanogaster, and the chordate homolog ApoD. 
 
Lazarillo 
 
Lazarillo (Laz) is a kernel Lipocalin from the grasshopper Schistocerca americana. 
The mature form of Laz has 170 residues, with a theoretical isoelectric point (pI) of 4.83 
[ProtParam tool. 44].  Laz presents four Cys residues forming two internal disulfide 
bonds [45]. The Laz gene contains three introns, being A and B extremely long [9].  
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Laz shows a unique feature in the family. It is the only Lipocalin for what a 
glycosylphosphatidylinositol (GPI) anchor to the plasma membrane has been 
demonstrated [45]. However, a potential GPI modification was also suggested in its 
plant homolog AtTIL (Arabidopsis thaliana temperature-inducible Lipocalin, [46]). 
Nevertheless, other Lipocalin - plasma membrane associations have been reported [47-
49]. 
Laz is highly glycosylated. Five N-linked oligosaccharides are predicted, and 
curiously all five are polarized to one side of the globular protein [50]. 
The natural Laz ligand or ligands are still unknown, but a set of potential candidates 
have been assayed in vitro. Recombinant Laz is able to bind retinoic acid and long chain 
fatty acids (FA), whereas biliverdin, farnesol or juvenile hormone do not bind [51].  
Looking at the spatio-temporal expression pattern, Laz shows a restricted 
expression in the developing nervous system, and it is involved in axon growth and 
guidance. Adding a monoclonal antibody against Laz to grasshopper embryo cultures 
perturbs axon extension and causes growth cone misrouting. Moreover, outside the 
nervous system Laz is associated mainly with the excretory system: Malpighian tubules 
and subesophageal body [45,52]. 
Due to its selective expression pattern, Laz has been used as a tool for 
characterizing the nervous system in economically important species as the desert locust 
Schistocerca gregaria or Locusta migratoria [53-56]. 
 
Drosophila Lipocalins 
 
Eight Lipocalin genes in the Drosophila genome: Glial Lazarillo (GLaz), Neural 
Lazarillo (NLaz), and Karl and five additional Lipocalin genes which are still identified 
only by their CG (computed gene) code number. 
The chromosomal distribution of Drosophila Lipocalins is shown schematically in 
fig.3A. It is remarkable that the Drosophila third chromosome hosts four Lipocalins in 
the right arm: CG31446, CG5399, CG44013 and CG44014, found in pairs (CG31446 - 
CG5399 and CG44013 - CG44014), and in adjacent chromosomal regions (88 and 89). 
This agglomeration of Lipocalin genes is similar to that of human chromosome 9 and 
chicken chromosome 17 [5]. Three of these fly Lipocalins have only one intron, while 
CG31446 has two introns. The data above and their situation in the Drosophila 
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- CG31446 and CG5399 (89A2 region) show 33% identity in a pairwise alignment. 
At the sequence level, the C-terminus of CG5399 shows a high degree of similarity with 
that of Laz, and a potential GPI modification site is predicted [big-PI Predictor: The GPI 
Prediction Server. 57,58]. If confirmed experimentally, this would be the only GPI-
linked Drosophila Lipocalin. 
CG5399 and CG31446 functions are unknown. However, a couple of pieces of 
information are available. CG5399 expression in S2 cells appears enhanced more than 
ten times when cells are treated with the insecticide methoxyfenozide (RH-2485) [59]. 
On the other hand, CG31446 is over-expressed in a soluble guanlyl-cyclase mutant [60], 
and it is down-regulated in flies under long-term high magnetic field exposure [61]. 
 
- CG44013 and CG44014 (88F7 region) genes are separated by only sixteen base 
pairs. Both genes are predicted to code for kernel Lipocalins, showing 45% identity and 
64% similarity between them. CG44013 and CG44014 were considered a single ORF 
called CG14872 in a previous Drosophila genome annotation.  
The current functional information about these two Lipocalins comes from 
expression data microarrays that considered the combined CG14872 annotation. Larvae 
fed with wheat germ agglutinin (an anti-insect lectin) increase CG14872 transcription as 
part of their defensive response [62]. 
 
- CG31659 is located in the left arm of the second chromosome (22A1 region), 
next to the NLaz gene. CG31659 is one of the most abundantly expressed genes in testis 
and male accessory gland [63]. Indeed, the CG31659 protein has been identified as a 
seminal fluid protein and is transferred from males to females during mating in 
Drosophila melanogaster and D. yakuba, but not in D.simulans [64]. 
 
- Karl (CG4139) is located in the X chromosome (10E3 region) and codes for an 
atypical Lipocalin. Karl N-terminal is extremely long, SCR1 is not easily identifiable 
and loop-2 appears expanded. 
  The functional information about Karl is scarce and fragmentary, coming mainly 
from gene expression microarrays. Karl is strongly expressed in lymph glands and 
circulating hemocytes [65,66]. Hemocytes are an important component of the insect 
immune system because they act as macrophages and produce antimicrobial peptides. 
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The immune role of Karl was confirmed by Hull-Thompson [67], as Karl over-
expressing flies are more resistant to Enterococcus faecalis infection than the control fly 
line.  
Furthermore, the insertion of a p-element in the Karl gene causes an extension of 
fly developing time around one hundred hours [68] and affects wing shape [69]. 
Finally, Karl is expressed in 25 Drosophila cell lines, including the popular 
Schneider’s cell lines [70], at higher level than in whole flies at any developmental 
stage [71]. 
 
GLaz: Glial Lazarillo. 
 
The right arm of the second chromosome (49F4 region) contains the GLaz gene. 
GLaz intron-exon organization is defined by 3 introns and 4 exons, as the grasshopper 
Laz gene. However, it differs from the typical insect gene arrangement: 4 introns and 5 
exons, as the equivalent GLaz exons 4 and 5 are fused.  
The GLaz mature protein has 192 residues with a theoretical pI of 8.62 [ProtParam 
tool. 44], and only one N-glycosylation is predicted at position 16th [72]. GLaz pairwise 
identities reach 26% with NLaz, 29% with Laz and 30% with ApoD. GLaz structure 
presents two of unique features: the loops 2 and 3 are elongated. 
At the moment, GLaz can be considered an ‘orphan’ protein. GLaz binding 
properties have been reported neither in vitro nor in vivo.  
In terms of expression, GLaz is found in the longitudinal glia of the developing 
ventral nerve cord of the central nervous system (CNS), and in specific glial precursors 
during late stages of embryogenesis. Subsequently, GLaz is absent in larvae, and again 
present in pupae and the adult nervous system [50,73]. Outside the nervous system 
GLaz is mainly expressed in the developing gut and salivary glands [50], and in adult 
hemocytes [73]. 
 
GLaz expression level has been experimentally altered in Drosophila using genetic 
tools. Male flies lacking GLaz exhibit multiple phenotypic defects. GLaz null-mutant 
(KO) flies show a shortened lifespan and a reduced resistance to starvation, H2O2 or 
paraquat (PQ) (1,1'-dimethyl-4,4'-bipyridinium dichloride). Paraquat is a generator of 
reactive oxygen species (ROS) that was used as herbicide, and is now broadly used in 
laboratories as a model to simulate Parkinson’s disease. The higher sensibility to PQ is 
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also reflected in a lower performance in behavioral tests (phototaxis, geotropism and 
flight tests), an increase of apoptotic cells and lipid peroxidation levels. Furthermore, 
GLaz-KO male flies show a smaller body mass and a lower amount of triacylglycerides 
(TAG) [73]. 
In contrast, GLaz over-expressing flies resulted in increased lifespan and enhanced 
resistance to starvation and hyperoxia. Alterations in O2 concentration produce a decline 
in locomotion of wild-type flies, and this deficiency is rescued by GLaz over-expression 
[74]. The protective properties of GLaz were corroborated in a cellular model, as 
Drosophila S2 cells over-expressing GLaz are protected against PQ and Aβ42 peptide 
toxicity [75]. 
Flies respond to multiple stress situations (hyperoxia, high temperatures, PQ 
exposure [75] and high sugar diet [76]) by increasing GLaz levels. This unspecific 
regulation of expression suggests that GLaz forms part of the organism first defensive 
line. 
Due to GLaz ability to deal with oxidative stress, the effect of GLaz over-
expression has been studied in the context of flies that model human neurodegenerative 
diseases. Friedreich’s ataxia is caused by a decreased expression of the mitochondrial 
protein frataxin. This deficiency provokes a dysfunction of the mithocondrial 
respiratory chain with a subsequent increase of oxidative stress, cell damage and 
degeneration [77]. GLaz was able to correct the lipid peroxidation levels and mitigate 
the dyslipidemia and shortened lifespan caused by frataxin reduction in a Drosophila 
model of Friederich’s ataxia [78]. 
Finally, it has been reported that the insertion of a p-element in the GLaz promoter 
does not alter ethanol sensitivity, place memory or olfaction memory [79]. 
 
NLaz: Neural Lazarillo. 
 
The NLaz gene is located in the 22A1region of the second chromosome. Its intron-
exon arrangement is slightly particular, because exon 1 is divided in two by a small 
intron.  
The mature NLaz protein has 199 amino acids with a theoretical pI of 4.50 
[ProtParam tool. 44], and shows four potential N-glycosylations sites (Asn46, 52, 71 
and 172) [72,NetNGlyc 1.0 Server. 80]. Indeed, two N-glycosylations (Asn52 and 
Asn71) have been confirmed in head extracts [81]. 
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Phylogenetically, NLaz is the closest Drosophila gene homolog to the grasshopper 
Laz and ApoD (fig. 3B). NLaz shows 39% identity with ApoD and 37% with Laz. The 
NLaz C-terminal sequence is extended in comparison to most Lipocalins. This ‘tail’ is 
not cleaved to GPI-anchor the protein to the plasma membrane, as it happens with 
grasshopper Laz. However, this peculiarity also appears in the neural Lipocalin Gallerin 
from the moth Galleria mellonella and in CG44014 and CG31446 fly Lipocalins. 
In terms of expression, NLaz temporal pattern is similar to that of GLaz, but the 
tissue profile is quite different. While GLaz is expressed by glial cells in the CNS, NLaz 
is expressed by a subset of neuroblasts and neurons. Outside the nervous system NLaz 
is expressed in the fat body and the developing gut [72]. 
 
A NLaz-KO fly line was generated by introducing a stop codon in the NLaz coding 
sequence [82]. This fly line has been used to study the influence of NLaz in metabolism, 
signaling and stress response. 
Energy storage (TAG, glucose and glycogen levels) are decreased in NLaz-KO 
male flies. In agreement, flies lacking NLaz show a decreased resistance to starvation, 
whereas over-expression of NLaz in the fat body results in an increment of starvation 
resistance. The same pattern, lower resistance in NLaz-KO and high in the over-
expressor, was achieved in longevity and PQ toxicity assays [67]. 
It is known that the interaction between Jun-N-terminal kinase (JNK) and 
insulin/IGF1 signaling (IIS) has to be tightly regulated to ensure proper metabolic 
adaptation to environmental challenges [83]. NLaz is transcriptionally regulated by JNK 
signaling and is up-regulated under stress conditions. NLaz inhibits the IIS and it seems 
to act at the level of the plasma membrane modulating PI3K (phosphatidyl-inositol 3-
kinase) activity. As a consequence of this IIS inhibition, FOXO (Forkhead box protein 
O) targets insulin receptor (InR), Lipase-4 (Lip4) and the heat shock protein 22 (hsp22) 
are up-regulated and contribute to promote stress tolerance and longevity. In contrast, 
when flies lacking NLaz are under stress conditions they cannot inhibit the IIS activity 
and cannot attain the appropriate protective response [67]. 
Flies fed with a high sugar diet (HSD) accumulate high levels of circulating glucose 
and show a small body size. This phenotype is due to resistance to insulin-like peptides 
in peripheral tissues. NLaz is up-regulated (fold change: 4.0) under HSD conditions. 
However, lowering NLaz gene dose (flies heterocygous for NLaz null mutation) 
protects against insulin resistance and returns glucose levels to normal values [76]. 
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Since NLaz is expressed in neurons and neuroblast, as grasshopper Laz does, and it 
is secreted by developing axons [72], a role in axon growth and pathfinding is expected 
for NLaz. However, no gross defects have been observed during nervous system 
development in NLaz-KO flies. Several interesting relationships have been found, 
though, between NLaz and developmental processes in different tissues: 
- The protein Lola is a critical transcription factor in nervous system development, 
orchestrating midline crossing by CNS axons [84]. NLaz is down-regulated (fold 
change: -2.40) in Lola defective embryos [85], suggesting that NLaz is a down-stream 
target of Lola. In addition, Lola is also involved in construction or function of neural 
circuits throughout the lifespan of the fly. This includes dendritic and axonal 
development of adult olfactory projection neurons [86]. These results may indicate a 
role of NLaz in axon outgrowth. 
- Krüppel (Kr) is a transcription factor that plays a critical role in segmentation and 
organ formation during the last stages of embryogenesis. For example, a role for Kr in 
fat body formation is well documented [87]. A strong association between Kr and NLaz 
has been reported by chromatin immunoprecipitation and in vitro binding to DNA [88]. 
- Gp93 is an essential protein in Drosophila since homozygous mutant animals die 
at the third larval stage as a consequence of pronounced defects in midgut epithelium. 
Gp93 mutant larvae exhibit a starvation-like metabolic phenotype, including 
suppression of insulin signaling and extensive mobilization of amino acids and TAG. 
NLaz is almost absent in fly larvae, but it is up-regulated (fold change: 6.0) in GP93 
animals [89]. 
- A null mutant of the activating transcription factor 3 (ATF3-KO) causes a 
complex larval lethal phenotype characterized by fat body lipid overload and starvation 
signaling from the gut. NLaz is found up-regulated (fold change: 2.24) due to the hyper-
activation of stress cascades, including the JNK pathway [90]. 
- NLaz is also related with the development of sexual structures. The hormone 
receptor 39 (Hr39) is required for the normal development and function of the 
spermatheca in females. When Hr39 is missing, spermatheca presents obvious defects, 
causing sterility. NLaz expression is highly repressed in Hr39-KO animals [91]. 
Additionally, NLaz has been identified as a seminal fluid protein in D. melanogaster 
and D. simulans, being transferred from males to females during mating [64]. Thus, 
these findings suggest a role for NLaz in sperm maturation. 
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NLaz expression is also related to the circadian clock. NLaz expression cycles only 
in the body when head and body gene expressions were analyzed separately [92]. 
Finally, as it happens with GLaz, no ligands have been described for NLaz so far. 
Therefore, it would be critical to provide more details about the molecular mechanism 
of action of this Lipocalin. 
 
ApoD: Apolipoprotein D. 
 
ApoD orthologs are found in species from the phylum chordata. Most of the 
available information comes from studies with human or mouse ApoD, and this section 
will focus on them. 
The human ApoD gene (hApoD) is located in the third chromosome (3q26.2), and 
is composed of 3 exons and 4 exons. Chordate Lipocalins typically contain 7 exons, but 
exons 4 to 7 are fused in hApoD [5]. However, 6 exons are found in the mouse ApoD 
(mApoD) because of a singular 5’-UTR intron [93]. 
ApoD is broadly expressed and present in many fluids [94]. It is remarkable the 
high levels of ApoD expression during development. Especially interesting is the 
evolutionary pattern of ApoD expression in chordates. Amphioxus ApoD is expressed 
in tissues derived from mesoderm and endoderm, whereas in mammals and birds there 
is a shift to ectodermal derivatives [95]. Besides, cell type expression changes as well. 
ApoD is expressed by subsets of neurons and glial cells in chicken [96], while adult 
mouse, rat and humans express ApoD only in glial cells [97-100]. On the other hand, 
ApoD is the most consistently up-regulated gene during brain aging in mammals 
[101,102]. 
 
The hApoD mature protein, after secretory signal peptide removal, is composed by 
169 amino acids. ApoD is a kernel Lipocalin with two disulfide bridges formed by Cys 
8-114 and 41-165 [103]. Additionally, hApoD has a fifth Cys (residue 116) which 
allows for the formation of ApoD homodimers, or heterodimers with Apo-AII or Apo-B 
[104,105]. 
hApoD has been recently crystallized and its structure solved. The hApoD 
apoprotein structure was deposited in the Protein Data Bank (PDB: 2HZR), as well as 
the holoprotein form in complex with progesterone (2HZQ) [106]. The crystal structure 
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the speculation of ApoD interacting directly with (high dense Lipocarticles) HDL and 
membranes [107]. 
The structures of free ApoD and its complex with progesterone are almost identical: 
Only small conformational changes in side-chains are detected. Progesterone, deeply 
introduced in the pocket, is tightly packed between the aromatic side chains of Phe89 
and Trp127. Additionally, Tyr46 serves as an anchor forming a hydrogen bond with the 
ketone group of the progesterone [106]. 
Arachidonic acid (AA) is another well characterized ApoD ligand [108,109]. The 
ApoD crystal structure is compatible with AA binding, and a model of its binding 
shows ligand-protein contact points in common with the progesterone-ApoD crystal 
[106] (fig.4C and 4D). 
The wide calyx of ApoD allows the binding of hydrophobic molecules of different 
nature. Besides progesterone [108-112] and AA [108,109], other molecules that ApoD 
can bind are retinol and retinoic acid [28]. The ability of ApoD to bind other molecules 
such as cholesterol [108,113] or bilirubin [109,114] is less clear. 
hApoD has two glycosylation sites: Asn45 and Asn78. The hApoD crystal was 
obtained from recombinant protein produced in Escherichia coli, and thus glycosylation 
is absent in the resolved structure. In any case, two different glycosylation patterns have 
been reported: in plasma and in apocrine secretion. Interestingly, both, Asn45 and 
Asn78 oligosaccharide trees are terminated in sialic acid in plasma, whereas in apocrine 
secrection, only the Asn45 tree terminates in sialic acid [115,116]. 
 
Many studies in the mouse as a model organism have pointed out the protective 
properties of ApoD. Endogenously, mApoD is up-regulated under oxidative stress 
caused by PQ exposure [117], and this up-regulation is mediated by the JNK pathway 
[118], sharing activation networks with NLaz [67]. The ectopic expression of hApoD in 
flies and mice confers higher resistance to PQ [75,117] and OC43 coronavirus [119]. In 
contrast, mice lacking ApoD show a decreased resistance to PQ, higher levels of lipid 
peroxidation in the brain, and an altered transcriptional response to oxidative stress 
[117,118,120]. Moreover, ApoD presence is required to get a proper response after 
sciatic nerve injury [121]. 
A defensive ApoD capacity against oxidative insults has been corroborated in 
cellular and in vitro models. ApoD-KO astrocytes are more sensitive to PQ, and an 
exogenous addition of ApoD partially recovers this phenotype [118]. In vitro studies 
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have provided a really interesting mechanistic model. n-HETE (hydroxyeicosatetraenoic 
acid) and n-HpETE (hydroperoxyeicosatetraenoic acid) are products of AA oxidation. 
ApoD will bind HpETEs and, with the involvement of Met93, will catalyze their 
reduction to the corresponding HETEs [122,123]. Met93 is conserved in mammalian 
ApoD and chicken ApoD but absent in more ancestral ApoD orthologs, as for example 
in salmon and amphioxus. Surprisingly, ApoD protein from amphioxus also shows 
antioxidant activity in vitro [124]. 
 
Interestingly, ApoD-KO mice show behavioral differences in locomotor and 
memory tests [117,118]. A putative explanation could be found in the fact that ApoD-
KO mice suffer alterations in brain receptor and neurotransmiters composition 
[118,125-127]. 
 
In addition to the control of lipid peroxidation, many connections between ApoD 
and lipids are often established. Indeed, ApoD received its name because it was the 
fourth apolipoprotein discovered [128]. ApoD was identified in human plasma as a 
component of HDL, and less abundant in other lipoparticles [114,129]. Inside HDL 
particles, ApoD is predominant in HDL3 [130,131], which are small, dense and protein 
enriched lipoparticles. Typically, minor bioactive lipid components are preferentially 
associated with dense HDL3 particles [132].  
Looking at fatty acids composition, ApoD-KO mice show an increase in a set fatty 
acid in brain extracts. Highlights linoleic acid (LA, 18:2), eicosadienoic acid (20:2), 
both are ω-6 FA, and docosahexaenoic acid (DHA, 22:6) [133]. An influence of ApoD 
over FA management was also observed in a cellular model. Cells tranfected with ApoD 
are able to incorporate higher amounts of AA. This fact suggested that ApoD could help 
to stabilize the plasma membrane and avoid AA oxidation [134]. 
 
In humans, ApoD is up-regulated in many pathological situations, including 
schizophrenia [135], Alzheimer’s [136-138], Parkinson’s disease [139] and multiple 
sclerosis [140]. Additionally, ApoD levels are altered in several types of cancers 
[94,141-143]. 
Several disease-causing mutations in ApoD have been described. Intron 1 and 
intron 2 polymorphisms are associated with a higher risk of Alzheimer’s disease in 
African and Finnish populations respectively [144,145]. These polymorphisms could be 
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affecting mRNA processing. Three distinct missense mutations have been identified in 
an African-black population associated with alterations in lipid metabolism [146]. None 
of these mutations (F36V, Y108C, T158K) are located within the ligand-binding cavity, 
but the ApoD tertiary structure could still be compromised. For instance, Y108C is 
located really close to C114 and C116, and could likely affect the formation of disulfide 
bridges and result in a loss of function [106]. 
 
The study of Laz, GLaz, NLaz and ApoD experimental data discloses a number of 
points in common, which will synergically lead to a better understanding of their 
biological function. 
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Objectives 
 
The aim of this thesis is to understand the biological processes where Lazarillo and 
related Lipocalins are involved, and how their function is affected by modifications in 
their ligand-binding ability or subcellular localization. 
 
To accomplish this general plan, four specific objectives were carried out: 
 
1. Analysis of GLaz and NLaz influence on the organism homeostasis, including 
gender and age as experimental variables. I will try to distinguish shared and specialized 
functions of GLaz and NLaz. 
 
2. Comparative study of ligand-binding properties of Lazarillo and its homologs 
NLaz and hApoD. I will discern common binding patterns as well as specie-specific 
ligands that could underlie newly acquired functions. 
 
3. In vivo identification of NLaz physiological roles that depend on ligand binding. 
 
4. Evaluation of Laz protective properties. I will test whether this protection can be 
achieved from the plasma membrane. 
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Results 
 
 
 
• Chapter 1 
“Sex-dependent modulation of longevity by two Drosophila homologues of human 
Apolipoprotein D, GLaz and NLaz”. 
• Chapter 2 
“Lipid binding properties of human ApoD and Lazarillo-related Lipocalins: 
functional implications for cell differentiation”. 
• Chapter 3 
“Ligand-binding dependent functions of the Lipocalin NLaz: an in vivo study in 
Drosophila”. 
• Chapter 4 
“Grasshopper Lazarillo, a GPI-anchored Lipocalin, increases Drosophila longevity 
and stress resistance, and functionally replaces its secreted homologue NLaz”. 
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CHAPTER 1 
 
Sex-dependent modulation of longevity by two 
Drosophila homologues of human Apolipoprotein D, 
GLaz and NLaz. 
 
Summary 
 
polipoprotein D (ApoD), a member of the Lipocalin family, is the gene most 
up-regulated with age in the mammalian brain. Its expression strongly 
correlates with aging-associated neurodegenerative and metabolic diseases. Two 
homologues of ApoD expressed in the Drosophila brain, Glial Lazarillo (GLaz) and 
Neural Lazarillo (NLaz), are known to alter longevity in male flies. However, sex 
differences in the aging process have not been explored so far for these genes. Here we 
demonstrate that NLaz alters lifespan in both sexes, but unexpectedly the lack of GLaz 
influences longevity in a sex-specific way, reducing longevity in males but not in 
females. While NLaz has metabolic functions similar to ApoD, the regulation of GLaz 
expression upon aging is the closest to ApoD in the aging brain. A multivariate analysis 
of physiological parameters relevant to lifespan modulation uncovers both common and 
specialized functions for the two Lipocalins, and reveals that changes in protein 
homeostasis account for the observed sex-specific patterns of longevity. The response to 
oxidative stress and accumulation of lipid peroxides are among their common functions, 
while the transcriptional and behavioral response to starvation, the pattern of daily 
locomotor activity, storage of fat along aging, fertility, and courtship behavior 
differentiate NLaz from GLaz mutants. We also demonstrate that food composition is 
an important environmental parameter influencing stress resistance and reproductive 
phenotypes of both Lipocalin mutants. Since ApoD shares many properties with the 
common ancestor of invertebrate Lipocalins, we must benefit from this global 
comparison with both GLaz and NLaz to understand the complex functions of ApoD in 
mammalian aging and neurodegeneration. 
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1. Introduction 
 
ging and the regulation of an organism 
lifespan are complex traits that are the result 
of multiple factors, many of which are clearly 
inheritable. This fact has guided the quest for 
genes that regulate longevity. Many genetic 
interventions that alter the length of life have been 
documented in model organisms ranging from 
nematodes to rodents [for recent reviews see 1,2]. 
They reveal the involvement of a basic set of 
conserved pathways, being the nutrient sensing 
pathways (the insulin and insulin-like growth 
factor signalling (IIS) and the target of rapamycin 
(TOR) pathway) the best known examples [3-6]. 
These studies are leading the search for genes in 
humans that perform similar functions and can 
become candidates for pharmacological 
interventions to achieve a longer and healthier life. 
Either genetic association studies or transcriptome 
analysis are the main approaches to aging research 
in humans [1,2,7]. It is striking that in a meta-
genome study where the changes in brain 
transcriptome have been compared between mice, 
monkeys and humans, Apolipoprotein D (ApoD) 
was revealed as the most robust age-dependent up-
regulated gene in the brain conserved across 
species [8]. The same is true for a meta-array 
analysis using mouse, rat and human expression 
data in different tissues, where ApoD appears as 
the gene most consistently over-expressed with age 
[9]. Not surprisingly, the expression of ApoD is 
highly boosted by a collection of traumatic, 
pathological and degenerative nervous system 
conditions in humans as well as by cancer and age-
related metabolic diseases [reviewed by 10]. 
It is widely accepted that many of the genes that 
regulate longevity participate in defence or repair 
mechanisms that counteract the accumulation of 
damage to cell components with age. Thus, many 
of these genes are also thought to be important for 
the onset of a wide array of diseases where age is a 
major risk-factor. Neurodegenerative diseases are 
no exception. The study of ApoD and its 
homologous genes in model organisms should 
therefore prove relevant to the understanding of 
aging in general, and of the aging nervous system 
in particular. 
ApoD is a member of the Lipocalin family, 
small secreted lipid-binding proteins. At least three 
other Lipocalin genes are also expressed in the 
nervous system of mammals: retinol binding 
protein, RBP [11], L type prostaglandin D 
synthase, L-PGDS [12], and Lipocalin 2 (also 
called NGAL) [13]. In Drosophila, two genes are 
the closest homologues to ApoD: Glial Lazarillo 
(GLaz) and Neural Lazarillo (NLaz). They are 
expressed in the nervous system in a cell-type 
specific manner [14]. A third Drosophila 
Lipocalin, Karl, is not expressed in the nervous 
system [15]. Both GLaz and NLaz are known to 
regulate stress resistance and lifespan in male flies 
[15-17]: loss-of-function mutants have a reduced 
longevity while gain-of-function manipulations 
result in extended lifespan. GLaz also influences 
fat storage [16] while NLaz regulates the metabolic 
response to stress by systemic inhibition of the IIS 
pathway [15]. Protection against oxidative stress in 
the nervous system has also been demonstrated for 
mammalian ApoD [18], revealing a sufficient 
degree of functional conservation between ApoD 
and the Lazarillo genes expressed in the nervous 
system of Drosophila.  
Single gene analyses of aging mutants often 
overlook pleiotropy and effects of other gene 
family members expressed in the same tissues. 
Also, in a few cases, the original interpretations 
derived from studies of classical longevity mutants 
[19,20] have been challenged when other 
physiological, environmental [21], or genetic [22] 
factors have been taken into account. This fact 
highlights the need for a comprehensive 
understanding of the many effects of single gene 
mutations, as well as of the gene-environment 
interactions that are relevant to aging and lifespan 
determination. 
Particularly, sex differences in the aging 
process are a very relevant issue that has not been 
explored so far for these genes. Almost all the 
work published on this group of Lipocalins 
(ApoD/Lazarillo) has been performed in males 
only. This work was triggered by the consistent 
A 
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observation that one of the Drosophila Lipocalins 
(GLaz) alters longevity in a sex-dependent manner 
in any genetic background tested: only null mutant 
males reduce their longevity, while null mutant 
females live as long as wild type flies. The lack of 
NLaz, on the other hand, shortens lifespan in both 
sexes. This work is at the same time an attempt to 
understand the origin of such a sex-specific 
phenotype, and an exhaustive search for the 
physiological processes in which these Lipocalins 
intervene, with the final goal of uncovering the 
interesting labor division structure of the two 
Drosophila Lipocalins homologous to ApoD.  
 
 
2. Material and Methods 
 
2.1. Fly strains and husbandry.  
Flies were grown in a temperature-controlled 
environmental incubator at 25ºC, 60% relative 
humidity, under a 12h light-dark cycle. 
Food recipes: (A) “Valladolid-standard” food: 
wet yeast 84 g/l, NaCl 3.3 g/l, agar 10 g/l, wheat 
flour 42 g/l, apple juice 167 ml/l, and propionic 
acid 5ml/l. (B) “Carolina” Instant Food (Carolina 
Biological Supplies). (C) “Caltech” food: dry 
yeast 15 g/l, agar 4.5 g/l, dextrose 50 g/l, sucrose 
25g/l, corn meal 83 g/l, phosphoric acid 0.6 ml/l, 
and propionic acid 4ml/l.. 
GLaz and NLaz null mutants were generated in 
a w1118 background as previously described 
[16,23]. Mutations were outcrossed into a Canton-
S wild type strain for five generations to obtain a 
homogeneous background with less than 5% of the 
original genomic background. Isogenic sister lines 
containing the wild type allele of GLaz and NLaz 
(line G10: GLaz +/+, NLaz +/+), or the mutant allele 
(lines G2: GLaz -/-, NLaz +/+ and N5: GLaz+/+, NLaz 
-/-) were selected by PCR screening for GLaz, and 
PCR followed by SceI restriction digest for NLaz. 
In a last round of outcrosses, a set of fly strains 
with white eyes were generated in the same way 
outcrossing with w1118-CS10. The line w1118-CS10, a 
gift from Seymour Benzer (Caltech), is a 10 
generation outcross of w1118 into the Canton-S 
background. A set of lines with white eyes were 
thus generated: lines CGW and CNW14 as wild 
type isogenic controls (GLaz +/+, NLaz +/+), GW 
line (GLaz -/-, NLaz +/+) and NW5 line (GLaz+/+, 
NLaz -/-). Most of the experiments were carried out 
with G10 as wild type control and G2 and N5 as 
experimental lines unless otherwise noted. 
 
2.2. Wolbachia test.  
The absence of infection by Wolbachia pipiens in 
all fly strains was tested by PCR of genomic DNA 
extracts. The following primers against the rRNA-
16S gene of Wolbachia were used:  
5’-GAAGATAATGACGGTACTCAC-3’,  
5’-GTCAGATTTGAACCAGATAGA-3’ and  
5’-GTCACTGATCCCACTTTA-3’.  
Program: 2 min 94ºC; (30 sec 94ºC, 30 sec 60ºC, 
45 sec 72ºC) x15; (30 sec 94ºC. 30 sec 52ºC, 75 
sec 72Cº) x15; 7 min 72ºC. DNA from Wolbachia-
infected Dilofilaria immitis worms was used as 
positive control. Primers and a positive control 
DNA were kindly provided by Dr. F. Simon (Univ. 
Salamanca). 
 
2.3. Lifespan analysis.  
At least 100 flies of each genotype were collected 
within 24h of eclosion, separated by sex under 
brief CO2 anaesthesia, housed in groups of 25, and 
maintained at 25ºC. Dead flies were counted and 
surviving flies were transferred to new vials with 
fresh food twice a week. 
 
2.4. Oxidative stress, starvation, and desiccation 
resistance.  
Flies collected as described for the longevity 
analysis were separated by sex in groups of 25 
when they were 3 days old. Application of 
different stressors was performed as follows. 
Paraquat treatment: After a period of dry 
starvation (3 hours) flies were transferred to vials 
with filter papers soaked with 1 ml of 10% 
sucrose-20mM paraquat (Sigma). Incubation 
proceeded in the absence of light and deaths were 
scored every 4-8 h. 
Wet starvation treatment: Starting at 3 days of 
age, flies were transferred to vials with 1% agar in 
water. Dead flies were scored every 4-8 h. 
Dry starvation treatment (desiccation): Starting 
at 3 days of age, flies were transferred to empty 
vials. Dead flies were scored every 4-8 h. 
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2.5. Body weight, fat content, and protein 
content. 
Total wet weight, dry weight after evaporation of 
water, and fat-free dry weight after extraction of 
neutral lipids with diethyl ether, was performed as 
previously described [16]. The protein content per 
fly was determined with the microBCA kit 
(Pierce). Three independent experiments with 
measurements in triplicate were performed at 3 and 
30 days of age. 
 
2.6. Lipid peroxidation levels.  
A spectrophotometric assay was used to determine 
the concentration of free malondialdehyde (MDA-
586, Bioxytech) as previously described [16]. 
Three independent experiments with measurements 
in triplicate were performed at 3 and 30 days of 
age. 
 
2.7. Population reproductive output. 
Three populations of 10 males x 10 virgin females 
per genotype were housed in 50 ml food bottles 
(250ml plastic bottle). Eggs laid were counted 
every day after transferring parents into a new 
bottle, and the number of adults emerging from 
each bottle was counted till the culture was 
exhausted. Egg and adult progeny production was 
scored during 7 days (age of parents: 5-11 days). 
An estimate of fecundity and fertility per female in 
the population per day was calculated. 
 
2.8. Courtship behaviour and reproduction.  
Courtship and mating tests were performed during 
60 min using male-female pairs of 4-5 day-old flies 
under a watch glass used as an observation 
chamber, as described previously [24]. The 
courtship index (C.I.) represents the proportion of 
time a male spends actively courting the female for 
10 min. Copulation features as mating time, mating 
latency and mating performance (%) were scored 
for 60 min. Offspring numbers and sex ratio 
(male/female) from each mated female that yielded 
progeny were scored during two weeks. 
 
2.9. Hunger driven short-term food intake 
behaviour.  
Two groups of 20 flies per sex, previously food-
deprived for 19h on 1% agar in water, were fed for 
5 minutes on 4ml of 10% sucrose, 1% agar, 
supplemented with 0.5% food dye FD&C Blue 
No.1 (E-133 European Union, provided by 
Proquimac). After feeding, the flies were 
anesthetized with CO2 and homogenized in PBS. 
After a short spin to pellet tissue debris, 
absorbance of the homogenate was measured at 
625nm. Background absorbance was corrected 
with fly samples of the same genotype subjected to 
the same procedure without the dye. The 
experiment was repeated twice and performed with 
the white-eyed fly lines (see above) to avoid 
disturbances of the absorbance spectrum due to the 
eye pigment. 
 
2.10. Circadian spontaneous locomotor activity. 
Individual flies at 3 days of age were transferred to 
monitor tubes containing fresh food. Their 
locomotor activity was monitored using the 
Drosophila Activity Monitoring System 
(Trikinetics, Waltham, MA) with a cumulative 
sampling rate of 15 min, in a temperature-
controlled environmental incubator at 25ºC, 60% 
relative humidity, under a 12h light-dark cycle. 
Five monitors were used, each housing 5 
flies/sex/genotype and a sixth monitor recorded 
light, temperature and humidity. Monitoring was 
performed for 6 days, but analysis included data 
starting on day 3 (6 days of age) to avoid variations 
due to habituation to the housing conditions. 
 
2.11. Climbing ability. 
Flies were collected and separated by sex in groups 
of 10 as described for the longevity analysis. Tests 
were performed as previously described [16], after 
a minimum of 24 hours after anaesthesia, at 3 and 
30 days of age. 
 
2.12. qRT-PCR: GLaz and NLaz gene 
expression.  
Flies of each genotype were collected within 24 
hours of eclosion, separated by sex under brief 
CO2 anaesthesia, and housed in groups of 25. They 
were transferred to fresh food vials twice a week 
until the day of processing (3, 30 and 60 days). 
When preceded by wet starvation, gene expression 
measurements were performed at 15 hours of 
treatment (see above). We separated heads and 
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bodies. RNA extracted from heads should 
represent a good approximation to the expression 
in the brain, which makes most of the head tissue. 
RNA extracted from the body, which includes the 
relatively large thoracic ganglia, represents an 
approximation to the global expression level in 
whole flies. 
Heads from 50 flies were cut and total RNA 
was extracted using TRIzol (Invitrogen). RNA 
concentration was measured with a Nanodrop 
spectrophotometer. Reverse transcription was done 
with the PrimeScriptTM RT reagent Kit (Takara) 
according to the manufacturer instructions by using 
Oligo-dT primers and random hexamers. Primers 
of equal amplification efficiency were designed for 
GLaz (5’-GCGAACAATCGAAGTTTTCC-3’ and 
5’-ACAAGATGGCGAAGTTCTCG-3’), NLaz 
(5’-CGAGTACGCAGCCTATCCAT-3’ and 5’-
CCAGGTAGTTGGCCTTCGT-3’) and the 
ribosomal protein L18 (RPL18, endogenous 
control) (5’-AGAACCGACCCCAAATCC-3’ and 
5’-CGACCACGATGGTAGACTCC-3’). 
Quintuplicate PCR reactions were performed for 
each RNA sample using the SYBR® Premix Ex 
TaqTM (Takara) according to the manufacturer 
instructions in a Rotor-Gene RG-3000 thermal 
cycler (Corbett Research). Cycling conditions were 
30 sec 95ºC, (5 sec 95ºC, 15 sec 55ºC, 15 sec 
72ºC) x 35. 
Melting curves were established for all 
conditions to check for the absence of unspecific 
amplifications. 
RNA transcription levels were determined by 
the method of direct comparison of CT values and 
relative quantities calculated by the ∆∆CT method 
[25]. Transcripts were normalized to RPL18 for 
each condition. We transform the data as Log 2-∆∆Ct 
and then represent them as fold changes. In this 
way, up- and down-regulations are symmetrically 
scaled around one. Statistically significant 
differences of pairwise gene transcriptional 
changes were evaluated with a Mann-Whitney U-
test, using ∆CT of each replica (calculated by 
subtracting the average CT of the reference gene). 
The level of significance was set at p<0.05. 
 
2.13. Statistics and principal component 
analysis. 
Statistical analyses were performed with 
Statgraphics plus (v 5.0) software. Student’s t-Test 
was used to assess two-sample comparisons (with 
the exception of qRT-PCR data, see above) with 
p<0.05 as threshold for significant changes. 
To find patterns of covariation among all the 
physiological parameters measured, we performed 
a principal component analysis (PCA). The 
average of each parameter was arranged in two 
matrices (Tables S1-S2), one with 25 variables 
measured at 3 days of age, and another with 7 
variables measured at 3 and 30 days of age. 
Neither longevity data nor Lipocalin expression 
data were included, in order to render the analysis 
“blind” to the genotype (the dependent variable) 
and lifespan (the variable we want to explain). The 
analysis was also blind to sex and age, since it is 
performed for 6 independent entries (2 sexes per 
genotype) or 12 independent entries (6 entries per 
age). 
 
3. Results and Discussion  
 
3.1. The nervous system Lipocalins GLaz and 
NLaz influence longevity in a sex-specific 
manner. 
The loss of either GLaz [16] or NLaz [15] is 
known to reduce the lifespan of male flies. 
However, here we report that females reduce their 
lifespan when NLaz is absent, but their lifespan is 
similar to control female flies in the absence of 
GLaz (Fig. 1A, B). The same results are obtained 
before and after changing the genetic background 
for both mutations (from w1118 to CantonS, not 
shown; median survival effects stated in Fig. 1 
legend). The absence of Wolbachia infection, as a 
potential lifespan-reducing cause, was confirmed 
by PCR tests (see Fig. S1 and section 2.2. in 
Methods). 
These observations led us to search for causal links 
that might explain how GLaz regulates longevity 
differently in males and females, and to find the 
fine structure of functional relationships between 
the two nervous system Drosophila Lipocalins.
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females. The increase of GLaz expression with age 
in female brains echoes the pattern followed by 
ApoD in mice, macaques, and humans [8]. 
The fact that NLaz expression in females shows 
an opposite pattern, suggests that different 
regulatory elements are responsible for the 
temporal control of each Lipocalin, and that GLaz 
gene regulation must have commonalities with the 
age-dependent networks controlling ApoD 
expression in the mammalian CNS. Also, these 
gene-regulation networks differ with sex for both 
Drosophila Lipocalin genes. 
Interestingly, the level of Lipocalins in the 
brain of young flies correlate with their longevity 
reduction when each Lipocalin is missing. Note 
that GLaz expression is the lowest in young wild 
type females, and its absence does not alter 
longevity. These data support the idea that early 
adulthood represents a critical period for Lipocalin 
function, affecting parameters that will result in 
lifespan alterations later on. 
The relative contribution of head and body in 
Lipocalin expression also varies with sex (Fig. 
1D). In young females, GLaz has the highest ratio 
body/head. In males, the expression of both 
Lipocalins is higher in the brain than in the body, 
with NLaz again showing higher expression levels 
than GLaz.  
 
3.3. Starvation triggers a differential expression 
of Lipocalins in the brain. 
The males of both mutants had been already 
described as starvation sensitive [15,16], and NLaz 
expression is known to be induced by starvation 
[15]. However, our previous works used different 
regimes of starvation (wet or dry starvation) and 
were performed only in males. Here we analyze in 
detail how brain expression of the two Lipocalins 
is altered upon food deprivation (without water 
deprivation, to avoid a more complex stress). 
Expression of NLaz and GLaz in the fly head is 
differentially induced upon food deprivation in 
wild type flies (Fig. 2A,B). Interestingly, no 
induction of NLaz is observed in the head tissue 
where its expression is constitutively high. These 
data are compatible with NLaz working in the 
control of systemic metabolism and with the fat 
body tissue being a source of NLaz under stress 
conditions (as we had previously shown using a 
dry starvation paradigm) [15]. In contrast, GLaz is 
highly induced in the head upon starvation, 
suggesting that GLaz might be involved in a 
nervous system regulatory loop triggered by 
nutrient deprivation. These results show the 
existence of differential domains of action of the 
two Lipocalins. 
 
3.4. A multivariate analysis of the physiological 
parameters that contribute to lifespan 
modulation by Lipocalins. 
Given that longevity is the result of an intricate 
puzzle of interactions between genetic components 
and physiological and environmental variables, we 
need to uncover the full complexity of effects of a 
single mutation in order to learn how each gene 
alters the network of causal links underlying 
lifespan regulation. 
With that in mind, we have undertaken an analysis 
of multiple parameters and their dependence on 
NLaz and GLaz expression. We have screened 
variables including metabolic (levels of various 
metabolites, stress-nutrition relationships), 
behavioral (reproduction, food intake, locomotor 
activity), as well as stress resistance, and analyzed 
them by principal component analysis (PCA). PCA 
has been successfully used in a multitrait study by 
Baldal and others [26] pertaining starvation 
resistance and aging evolution, and by Andersen 
and others [27], in a study uncovering how heat 
stress and age induced maternal effects influence 
physiological parameters in the offspring. This 
type of analysis extracts features of the parameters 
variation as a set of new variables (the principal 
components, PCs) that are uncorrelated with one 
another and successively account for maximal 
amounts of variation. Our analysis was performed 
with 25 variables at 3d of age (Fig. 3A-B; Fig. 
S2A-B), and a subset of 7 variables mainly related 
to metabolic parameters at 30d of age (Fig. 3C, 
Fig. S2C-D). Values obtained for all variables are 
listed in supplementary tables (Tables S1-S2). The 
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PCA has uncovered sex, genotype, and age-
specific patterns. 
Some life history parameters clearly separate 
genotypes. The two principal components 
explaining 69% of the variation in the sample 
studied at 3d of age separate wild type flies from 
either mutant, and in turn segregate each mutant 
into opposite corners of the multivariate space 
(Fig. 3A). This pattern reflects the existence of 
specialized functions separating Lipocalin mutants 
from each other (component 1), as well as common 
functions separating both mutants from the wild 
type (component 2). For example, lipid 
peroxidation and relative fat content contribute to 
the separation of wild type from either mutant 
(black labels in Fig. 3B). Variables in the domain 
of reproduction, locomotor activity, food intake 
and metabolism (relative water content, starvation 
resistance) separate GLaz from NLaz mutants (red 
and green labels in Fig. 3B). 
Other life history parameters contribute to sex or 
age differences regardless of genotype (Fig. S2). 
Metabolic parameters (wet weight, protein content 
or lipid peroxidation), response to stress 
(starvation, desiccation or paraquat resistance) and 
diurnal vs. nocturnal locomotor activity are 
important variables in the separation of sexes in all 
genotypes (Fig. S2A-B). In the analysis of 
variables at two ages (Subset 2) it is interesting 
that only females are segregated by age in the 
component 1 by 2 plot (explaining 63% of de 
variance). Metabolic parameters (relative water 
content in opposition to relative fat) and climbing 
ability have the most weight for the separation of 
young female flies from old female flies in all 
genotypes (Fig. S2C-D).  
 
3.5. Sex-specific modulation of longevity by 
GLaz is dependent on metabolic parameters 
related to protein homeostasis. 
Studying the multivariate space, we searched for 
components that would cause GLaz mutant 
females to cluster with WT females, and would 
therefore explain the observed longevity curves. 
Interestingly, the stronger association of GLaz-/-
females with wild type flies arises in the PCA 
analysis performed for the subset of 7 variables 
measured at both 3 and 30d of age (Fig. 3C). The 
association only occurs for young GLaz mutant 
females, further supporting the idea that the 
function of Lipocalins in early adulthood is crucial 
for longevity determination. Young wild type 
females, with their low levels of GLaz expression, 
show a combination of parameters similar to that 
of GLaz-/- young females. Old GLaz mutant 
females, however, are displaced to the opposite 
corner of the component 2 by 3 plane of the 
multivariate space (arrows in Fig. 3C). The 
variables with more weight in the “mutant GLaz 
females –  wild type” association are the protein 
content and relative fat free content (with a 
negative weight, red labels) and the wet weight and 
relative water content (with a positive weight, 
green labels). Variables related to lipids (relative 
fat content or lipid peroxidation levels) do not 
contribute to this association. 
Our analysis indicates that the patterns of 
metabolism, especially during early adulthood, 
contribute importantly to the final outcome in 
longevity, resulting in a shorter lifespan in NLaz 
mutants and in GLaz mutant males, but a similar 
lifespan in GLaz mutant females and wild type 
flies. Some of the parameters included in our PCA 
analysis are further described and discussed 
hereafter. 
 
3.6. Energy intake and homeostasis are altered 
through aging in the absence of Lipocalins. 
The loss-of-function mutants of both Lipocalins 
show pleiotropic effects at different levels of 
energy management (intake-balance-expenditure, 
Fig. 4A) that contribute to their segregation in the 
multivariate space (Fig. 3A-B). Particularly, the 
PCA analysis shows that energy management 
differences between genotypes are part of the 
functional specialization between both Lipocalins, 
and also contribute to the unaltered lifespan in 
females lacking GLaz (Fig. 3C). 
In addition, the behavioral response to 
starvation is increased in young NLaz-/- flies, but 
not in GLaz-/- flies (Fig. 4B). We have previously
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Genotype/Sex  Total Activity  
Diurnal 
Activity  
Nocturnal 
Activity  
Sunrise 
Activity  
Sunset 
Activity  
WT males  463.1 ± 14.2  203.69 ± 9.9  69.23 ± 7.4  76.21 ± 11.6  113.97 ± 18.6  
GLaz-/- males  615.22 ± 52.3a  137.19 ± 31.8a  212.07 ± 36.1b  116.64 ± 18.4a  149.33 ± 17.8  
NLaz-/- males  412.03 ± 35.1  188.89 ± 35.7  37.74 ± 7.7b  99.03 ± 3.0a  89.37 ± 4.2  
WT females  710.05 ± 27.5  416.43 ± 17.0  46.16 ± 17.3  93.85 ± 5.4  153.61 ± 23.7  
GLaz-/- females  660.17 ± 74.7  361.89 ± 29.4a  41.79 ± 25.6  53.12 ± 1.7b  203.37 ± 21.9  
NLaz-/- females  415.19 ± 28.7b  264.43 ± 15.4b  17.19 ± 8.0  53.98 ± 3.7b  59.59 ± 2.9b  
 
 
Table 2. Courtship behavior is altered in Lipocalin mutants. 
Courtship behavior parameters obtained from experiments shown in Fig. 6D-E. Average ± Standard Error is 
represented. Bold lettering indicates statistical differences assayed by Student’s T-test (p<0.05): a Different from WT-M 
x WT-F pairs, b Different from mutant-M x mutant-F pairs. 
 
being off-set in GLaz mutants, both at the emission 
and reception levels. Interestingly, the GLaz or 
NLaz mutants who successfully mate show longer 
mating latencies (Table 2), but this effect is 
cancelled when mutant males are paired with wild 
type females.  
The altered mating behaviors could modify the 
final reproductive output of the population. 
However, the fertility of successfully mated 
mutants does not differ from wild type values (Fig. 
S3A). Thus, we can conclude that in experiments 
performed in fly populations (Fig. 6B) the GLaz-/- 
eggs that do not reach adulthood are mostly 
unfertilized eggs, while the fertilized ones reach 
adulthood at a normal rate, discarding major 
developmental problems also for GLaz-/- mutants.  
In addition, we analyzed the lifespan of virgin 
females, which results in a pattern identical to the 
one observed for mated females: similar in wild 
type and GLaz-/- and shortened in NLaz-/- mutants 
(Fig. S3B). These virgin females do lay eggs, 
although all of them are unfertilized. The putative 
differential constraint to lifespan is not therefore 
dependent on the energy spent by the female in 
producing eggs proper. 
Even though reproduction has been shown to 
correlate negatively with lifespan in many cases 
[21,30,31], instances of genetic interventions that  
alter longevity and reproductive output 
independently have also being documented [32,33] 
[34,35], challenging the existence of a direct causal 
relationship between reproduction and lifespan. 
Lipocalin mutants support the latest view, since the 
sex differences observed in longevity cannot be  
fully explained by a net reduction in the energy 
spent in the production of eggs. The control of 
courtship behaviors are part of the pleiotropic 
functions of the two nervous system Lipocalins 
clearly deserving future investigation.  
 
3.9. Environment-genotype interactions: Food 
composition influence on Lipocalins 
phenotypes.  
Food composition is an important environmental 
parameter that influences stress resistance and 
reproductive output. We have performed a 
nutritional analysis of three common fly food 
recipes including the standard one used in our 
laboratory, and the one used by collaborators that 
have also worked on NLaz or GLaz function (Fig. 
7A, see Methods). Each recipe differs in the 
amount of yeast and the source of sugar. However, 
a clear pattern emerges. For wild type flies, the 
higher the proportion Net Fat / Total 
Carbohydrates (Fig. 7B), the higher the fertility 
(Fig. 7C) and the lower the oxidative stress 
resistance (Fig. 7D-F). 
Characterizing this interaction in the fly strains 
used in our analysis has been important, since the 
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3.10. ¿How do brain Drosophila Lipocalins help 
us to understand the aging process?  
Several general ideas relevant to aging and lifespan 
determination are supported by our study. 
3.10.1. Early adulthood is a crucial period for 
lifespan determination.  
Experiments where the IIS pathway was 
manipulated at different time points in life, both in 
C. elegans [32] and Drosophila [33], have shown 
that in order for this pathway to influence lifespan, 
it needs to operate exclusively during adulthood, 
with such an influence decreasing at older ages. 
Two lines of evidence suggest that a brain 
Lipocalin critical period also exists early in 
adulthood for their influence on lifespan: (1) their 
temporal expression pattern in wild type flies, and 
(2) the clustering of GLaz mutant females with 
wild type flies only at young ages in the 
multivariate space of metabolic parameters.  
This time period, critical for both IIS and 
Lipocalin function, is coincident with the 
reproductive period of the organism (both in 
worms and flies), and could be interpreted in the 
light of the disposable soma theory of aging [38], 
where natural selection forces are predicted to 
decline sharply once the organism is no longer 
engaged in passing its genes to the next generation 
[39]. Lipocalin function would be under selection 
in early adulthood only, and subsequent 
consequences of Lipocalin expression on the aging 
brain or body would be exaltations of this early 
adulthood selected functions [40].  
3.10.2. The sex-specific lifespan modulation by 
Lipocalins is better explained by metabolic than by 
reproduction phenotypes. 
In accordance to the disposable soma theory, 
our first working hypothesis was that GLaz mutant 
females maintain a lifespan similar to the wild type 
because they would be able to allocate more 
resources to maintenance and less to reproduction. 
We then confirmed that GLaz mutant females 
reproduce less and survive more. However, since 
NLaz mutant females reduce both fecundity and 
lifespan, we must conclude that survival and 
reproduction are in this particular case uncoupled. 
Curiously, the PCA analysis shows that it is the 
alteration of metabolic parameters related to the 
protein content of the fly what mainly accounts for 
the observed sex differences in longevity. The final 
protein content and the fat free dry weight of the 
organism depends of protein synthesis, which has a 
strong evolutionary conservation among the 
genetic modifiers of aging [41].  
NLaz is also related to the control of 
metabolism. When NLaz is expressed in the fat 
body, it is able to repress IIS activity in systemic 
target tissues. Also, the loss of NLaz increases 
signaling through IIS [15]. The experiments in this 
work predict that, in addition, NLaz must be a 
negative regulator of food intake. NLaz is thus 
expected to fulfill a role similar to Leptin in the 
nervous system, inhibiting food intake and 
promoting energy expenditure. Loss of NLaz 
mimics therefore the Leptin deficiency state in 
mouse models of obesity [42,43]. Curiously, mice 
where the neural/brain specific insulin receptor is 
knocked out, exhibit increased food intake and 
mild adiposity [44], just as the NLaz mutant flies. 
A direct interaction of ApoD with the cytoplasmic 
portion of the Leptin receptor has been suggested 
[45], although it is still questionable how a 
secreted Lipocalin can access the cytoplasmic side 
of the plasma membrane for such an interaction to 
occur. 
In contrast with NLaz, GLaz is not regulated by 
JNK in the peripheral tissues [15]. Here we 
demonstrate that it is instead induced by food 
deprivation in the brain, where no NLaz 
transcriptional response is detected. This pattern of 
differential transcriptional response in the brain 
further supports the existence of specialized 
functional domains for these two Lipocalins. 
 
3.11. Two brain Lipocalins in Drosophila: a 
labor division strategy in longevity regulation.  
Our work highlights that the two Drosophila 
Lipocalins expressed in the nervous system have 
both functional redundancies and specializations. 
The response to oxidative stress and accumulation 
of lipid peroxides are among their common 
functions, while the transcriptional and behavioral 
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response to starvation, the pattern of daily 
locomotor activity, storage of fat along aging, 
fertility, and courtship behavior differentiate NLaz 
from GLaz mutants. This framework is guiding our 
current research, as more details need to be 
elucidated. However, we can already start 
questioning: how many of these shared or unique 
functions are conserved in the mammalian 
homologues also expressed in the brain? 
The basal position of ApoD in the phylogenetic 
tree of vertebrate Lipocalins [46,47] suggests that 
ApoD shares many properties with the common 
ancestor of invertebrate Lipocalins. However, we 
have to take into account that neither GLaz nor 
NLaz is a true orthologue of ApoD. Our molecular 
phylogenetic analyses strongly suggest that the 
Drosophila Lipocalins originated from an 
independent duplication event, taking place within 
the invertebrate lineage. Subsequently, the 
resulting genes have diverged both in their protein 
coding sequence and their regulatory sequences. 
Since ApoD in the adult mammalian brain is 
expressed in glial cells, one might be tempted to 
directly conclude that GLaz is the closest 
Drosophila homologue. Furthermore, the 
expression data we report in this work strongly 
suggest that GLaz regulation through aging is most 
similar to the robust increase of mammalian ApoD 
in the aged brain [8,9]. Interestingly, ApoD is most 
similar to GLaz in protein sequence, but to NLaz in 
the intron-exon structure of the gene [48]. We have 
also data showing that ApoD is up-regulated by 
oxidative stress in astrocytes, and that this 
induction is mediated through the JNK pathway 
(Bajo-Grañeras, Ganfornina and Sanchez, 
unpublished observations), which is comparable to 
the NLaz JNK-mediated induction by stress in 
Drosophila [15]. Thus, if we want to extrapolate 
the Drosophila data to learn about the functions of 
ApoD in mammalian aging and neurodegeneration 
we must benefit from a global comparison with 
both GLaz and NLaz, as the one reported here. 
To understand the multigenic control of aging, 
we need to take into account that a layer of 
complexity is added due to the fact that each gene 
has pleiotropic effects, and each one has differing 
degrees of specialization or redundancy with 
members of the same gene family. This fact 
represents a daunting complication for the task of 
predicting the actions of putative anti-aging or 
anti-neurodegeneration drugs. However, 
complexity should not keep us from investigating 
till we get a comprehensive understanding of the 
aging process. 
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Table S1. Matrix for Principal Component Analysis. Subset 1. 
Averages of the 25 variables measured in 3 day-old flies. Transcription of GLaz or NLaz and longevity parameters are 
not included. 
 
ProtRelFatFreeRelFatRelWaterWet WLipidPeroxDesicStarvPQVariable acronism:
64,42101,785,4101,2138,7119,316,566,029,9N_F_3 
33,1299,875,6103,195,7275,910,058,529,9N_M_3 
56,1192,581,9105,8136,3100,028,045,076,2G_F_3 
33,3395,968,9106,294,5132,918,025,064,8G_M_3 
53,3295,4105,5101,0141,445,330,579,0108,0WT_F_3 
33,62100,0100,0100,0100,057,322,854,3110,0WT_M_3 
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43,20132,9396,1665,60643,53709,135,684,457,197,9N_F_3 
34,63153,21169,76105,62600,71706,338,784,457,197,9N_M_3 
7,05338,9688,53275,16825,131100,298,441,663,7511,3G_F_3 
18,24248,89194,40617,82407,561025,387,541,663,7511,3G_M_3 
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38,027,010,06,219,017,7-2,008-0,923N_F_3 
35,524,024,06,219,017,7-2,063-2,059N_M_3 
33,313,836,71,53,74,7-1,932-1,180G_F_3 
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BEHAVIOR
Genotype_Sex_Age Lipid Peroxidation Wet Weight
Relative Water 
Content
Relative Fat 
Content
Relative FatFree 
Weight Protein content Climbing ability
WT_M_3 57.32 100 100 100 100 33.62 7.16
WT_F_3 45.32 141.39 101.02 105.45 95.41 53.31 8.15
G_M_3 132.89 94.45 106.21 68.90 95.89 33.32 7.46
G_F_3 99.96 136.27 105.83 81.87 92.45 56.11 8.42
N_M_3 275.92 95.66 103.05 75.56 99.79 33.11 8.65
N_F_3 119.33 138.73 101.15 85.42 101.68 64.42 5.61
WT_M_30 112.26 100 100 100 100 36.48 6.31
WT_F_30 81.71 140.74 97.85 146.81 90.36 56.88 14.45
G_M_30 122.10 91.50 104.90 59.30 101.18 37.50 11.24
G_F_30 160.12 114.25 99.05 80.63 108.78 78.66 14.24
N_M_30 404.30 101.78 98.82 125.06 96.77 32.68 12.07
N_F_30 109.95 143.30 95.91 156.52 96.40 49.68 17.64
Variable acronism: LipP WW RW RFat RFatFr Prot Climb
METABOLISM
 
 
Table S2. Matrix for Principal Component Analysis. Subset 2. 
Averages of the 7 variables measured in 3 day-old and 30 day-old flies. Transcription of GLaz or NLaz and longevity 
parameters are not included. 
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Chapter 2 
 
Lipid binding properties of human ApoD and 
Lazarillo-related Lipocalins:  
Functional implications for cell differentiation. 
 
 
Summary 
 
Apolipoprotein D (ApoD) and its homologues, Lazarillo (Laz) and Neural Lazarillo 
(NLaz), are involved in longevity regulation, stress resistance and lipid metabolism. 
They belong to the Lipocalin family, characterized by a conserved tertiary structure: an 
eight-stranded β-barrel wrapping around a ligand binding pocket.  
Using tryptophan fluorescence titration we have uncovered several novel ligands for 
NLaz, ApoD and Laz, all with apparent dissociation constants in the low micromolar 
range.  
Retinoic acid (RA), retinol, fatty acids and sphingomyelin are shared ligands. 
Though frequently associated with ApoD, cholesterol did not show strong binding to 
human ApoD, while NLaz and Laz did bind the related sterol, ergosterol. Searching for 
species-specific ligands, ApoD shows a selective affinity for the endocannabinoid 
anandamide, whereas 2-acylglycerol does not bind. NLaz binds the pheromone 7-
tricosene, but not 7,11-heptacosadiene or 11-cis-vaccenyl acetate. 
To clarify the functional relevance of ligand-binding at the cellular level, we 
analyzed the effect of ApoD, Laz and NLaz preloaded with RA on neuronal 
differentiation. Our results show that ApoD is necessary and sufficient to allow for RA 
differentiating activity. Both ApoD and NLaz successfully deliver RA to immature 
neurons, driving neurite outgrowth. 
We conclude that ApoD, NLaz and Laz bind selectively to a different but 
overlapping set of lipid ligands. This multispecificity can explain the varied functions 
they carry physiologically. 
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1. Introduction 
 
ipocalins are an ancient and functionally   
diverse family of proteins characterized by 
their ability to bind and transport a variety of 
ligands, including in some cases bioactive 
lipids. Noted examples of functional Lipocalin-
lipid associations include (i) Retinol Binding 
Protein (RBP) and retinol [1], (ii) Apolipoprotein 
M (ApoM) and sphingosine-1-phosphate (S1P) [2] 
and (iii) the enzyme Prostaglandin D Synthase (L-
PGDS) and its substrate prostaglandin-H2 (PGDH2) 
[3]. Despite limited sequence identity, the 
Lipocalin three-dimensional structure: an eight-
stranded antiparallel ?-barrel with accessory ?- 
and 310 helices, is well conserved through 
evolution. The Lipocalin fold forms a cup, or 
calyx, with a central cavity, which serves as a 
ligand-binding site [4]. 
Apolipoprotein D (ApoD) is an extracellular 
glycosylated Lipocalin expressed with a wide 
temporal and tissue distribution. Although detected 
in liver, spleen, skin and placenta, ApoD is mostly 
present in serum and nervous system [reviewed by 
5]. Plasma ApoD is mainly associated with high-
density lipoproteins (HDL), but can also be found 
in very low- and low-density lipoproteins (VLDL, 
LDL) [6,7]. ApoD nervous system expression has 
been studied during development [8-10], and it is 
known to increase during prefrontal cortex 
maturation, a period marked by active lipid 
metabolism [11]. On the other hand, ApoD is the 
most consistently up-regulated gene during brain 
aging in mammals [12,13]. ApoD levels are also 
elevated in many neurodegenerative diseases, 
including Alzheimer’s [14], Parkinson’s [15], 
schizophrenia [16] and multiple sclerosis [17]. In 
the mouse model of Niemann-Pick type C (NPC) 
disease [18], caused by deficiencies in cholesterol 
metabolism and management, ApoD expression is 
also up-regulated. 
ApoD is considered the most ancient 
vertebrate Lipocalin and has homologues in many 
other phyla [19,20]. Neural Lazarillo (NLaz) from 
the fruitfly Drosophila melanogaster and Lazarillo 
(Laz) from the grasshopper Schistocerca 
americana are two of the most studied ApoD 
homologues. Many ApoD, NLaz and Laz functions 
are conserved during evolution, and include 
protection against oxidative stress, and longevity 
and metabolism regulation [21-27]. Oxidative 
stress protection has been established for ApoD 
homologues in vivo, and the ApoD molecule itself 
exhibits anti-oxidant properties in vitro [28,29]. 
The regulation of ApoD and NLaz expression are 
also conserved, as both are controlled by the JNK 
signaling pathway under stress conditions [22,26]. 
Furthermore, ApoD and NLaz have been proposed 
as functional links between the nervous system and 
adipose tissue both in mammals and insects 
[22,30]. 
The biochemical mechanism by which ApoD 
and related Lipocalins perform their function is not 
understood, though their hydrophobic pockets and 
potential ligands are obvious candidates to be 
explored. The wide range of tissue expression and 
physiological roles of ApoD, NLaz and Laz 
suggest that particular functions are dependent on 
specific ligands. Thus, determining the ligand 
specificity of these Lipocalins is essential to define 
their molecular mechanism. 
Several ligands have been described for 
ApoD, but not without controversy. Progesterone-
ApoD binding has been documented [31-35] and 
the complex co-crystallized [36]. In addition, 
arachidonic acid (AA) [34,35], retinol, and retinoic 
acid (RA) [37] are in vitro ApoD ligands. 
However, a consensus has not been reached on 
whether bilirubin [7,35], odorants like E-3-methyl-
2-hexenoic acid [35,38] or other steroids, such as 
cholesterol [34,39] and pregnenolone [33,35], are 
bona fide functional ApoD ligands. 
Laz shows positive binding for RA, AA, 
linoleic acid (LA) and palmitic acid (PA) [40]. 
However, the Drosophila NLaz ligand preferences 
have not been characterized. 
The aim of this work is to identify new 
putative lipophilic ligands for the ApoD-related 
Lipocalins, which should contribute to understand 
how they perform their physiological functions in 
different tissues and cellular contexts. Placing 
these results in an evolutionary context will help us 
distinguish derived versus ancestral protein-lipid 
functional associations. Finally, we assay at the 
cellular level the effect of ApoD-RA binding pair 
L 
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on a particular biological function: the 
differentiation of neurons in culture. 
 
2. Materials and Methods 
 
2.1. Cell cultures. 
Drosophila S2 cells were cultured as previously 
described [27]. Human neuroblastoma cell lines 
SH-SY5Y and M17 were grown at 37ºC in a 
saturated humidity atmosphere containing 5% CO2 
in DMEM (Dulbecco’s Modified Eagle’s Medium, 
Lonza Iberica) supplemented with glucose (4.5 
g/l), heat-inactivated 10% FBS (fetal bovine 
serum, Lonza Iberica), 1% L-Glutamine, 
antibiotics (penicillin, 10 U/μl; streptomycin, 10 
μg/μl; amphotericin B, 25 μg/ml; Lonza Iberica), 
and 1% non-essential amino acids (NEAA, Lonza 
Iberica). The culture medium was replaced twice a 
week, and cells were subcultured at 90% 
confluence. 
 
2.2. Cloning and protein purification of NLaz, 
Laz and ApoD. 
The NLaz full-length cDNA, translating into 
residues 1-224 (CG33126, Uniprot reference 
Q9NAZ4, FlyBase entry FBgn0053126), and a 
fragment of Lazarillo cDNA encoding a 192 
residue fragment missing the GPI signal peptide 
(Uniprot reference P49291), were subcloned into 
the pRmHa3 vector using EcoRI and NotI sites. 
This system expresses the cloned sequences under 
the control of an inducible Drosophila 
metallothionein promoter and incorporates a C-
terminal poly-histidine sequence allowing for 
protein purification from conditioned medium. 
NLaz-pRmHa3 or Lazarillo-pRmHa3 plasmids 
were co-transfected with a pCoBlast selection 
vector (conferring blasticidin resistance) into 
Drosophila S2 cells. Protein expression induction 
and purification were performed as previously 
described [27], adding two rounds of size 
exclusion chromatography purification after the 
initial metal affinity chromatography (Fig. S1B-D). 
Bacterial recombinant Laz was purified from 
the periplasmic space of E. coli as previously 
described [40]. Human ApoD  (hApoD) was 
purified from breast cystic fluid (Fig. S1A and 
S1D) by ion-exchange chromatography (UNO-Q, 
BioRad) in 25 mM Tris pH 8.0 followed by size 
exclusion chromatography (P60, BioRad) in 50 
mM Tris pH 8.0, 75 mM NaCl. Protein purity was 
determined by SDS-PAGE and integrated optical 
density of the protein bands stained with 
Coomassie was measured, resulting in 91% purity 
for ApoD and >98% purity for NLaz and Laz (Fig. 
S1). 
 
2.3. Ligand binding assays by tryptophan 
fluorescence titration. 
Fluorescence measurements were conducted 
with a Shimadzu RF-5301PC spectrofluorometer 
in a quartz cuvette (Hellma 105.251-QS, 3 mm-
path length). Temperature was held at 22 ± 0.1ºC. 
The excitation wavelength was 295 nm (selective 
for tryptophan residues). Emission was recorded 
from 327 to 400 nm with slit width set at 5 nm. 
The peak observed at 340 nm was measured and 
used to calculate the apparent equilibrium 
dissociation constant (KD). Data analysis was 
performed with the RFPC software package 
(Shimadzu). NLaz and the control protein α1-
microglobulin were diluted to a concentration of 1 
μM in 10 mM phosphate buffer, 150 mM NaCl, 1 
mM EDTA at pH 7.0. Laz and hApoD were 
diluted to a concentration of 0.5 μM in the same 
buffer, so that the starting intrinsic fluorescence of 
all proteins lies within the same dynamic range of 
measurement. The ligands tested were: retinoic 
acid, retinol, non-esterified cholesterol, ergosterol, 
β-estradiol, palmitic acid (Sigma); palmitoyl-
sphingomyelin, arachidic acid, 7(z)-tricosene, 
7(z),11(z)-heptacosadiene, 11-cis-vaccenyl acetate, 
2-arachidonylglycerol, anandamide, palmitoyl-
linoleyl-phosphoethanolamine (Cayman); and 20-
hydroxyecdysone (Santa Cruz Biotechnology). All 
ligands were dissolved in N,N-dimethylformamide 
(DMF; Sigma) to make concentrated stock 
solutions within their solubility range. A four step 
titration was performed, adding each time 1 µl 
aliquots of the ligand to a 100 µl volume of protein 
solution. The mixtures were equilibrated for 3 min 
in the dark before the fluorescence was recorded. 
The fluorescence spectrum in the presence of a 
ligand was subtracted from a DMF baseline 
obtained by titration of the protein with the same 
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amounts of carrier without ligand. The corrected 
fluorescence at 340 nm versus ligand concentration 
was fitted as previously described [37,40]. KD was 
calculated under the assumption of a single binding 
site, consistent with known Lipocalin structural 
properties, regardless of whether ligand binding 
enhances or quenches tryptophan fluorescence. A 
tryptophan residue conserved along the entire 
Lipocalin family is located at the binding pocket 
surface, and is predicted to be the residue 
responsible for most of the intrinsic fluorescence 
changes observed. The specificity of protein 
fluorescence variation was tested by performing 
the assay with the protein denatured with 5 M 
guanidine hydrochloride in the same buffer for 21 
h before measurement (Fig. S2). 
 
2.4. Neuronal cell line differentiation assay. 
SH-SY5Y or M17 cells were seeded at 
20,000/cm2 in 24 well plates (Nunc) with standard 
medium. After 12 h, the medium was replaced. 
New medium was added with or without serum or 
additives (protein, ligand or equimolar amounts of 
both protein and ligand). Retinoic acid and retinol 
stock solutions were prepared in ethanol and 
diluted in medium to a final concentration of 1 or 
10 μM. The carrier concentration was kept at 0.1 % 
(v/v). The concentrations of hApoD, NLaz and 
Lazarillo were measured by MicroBCA-assay 
(Pierce) and the proteins were diluted in sterile 
PBS to prepare the working protein stocks. 
Equimolar protein-ligand mixtures were incubated 
in the dark at room temperature for five minutes to 
allow for complexation before addition to cells. 
SH-SY5Y cultures were analyzed after 4-6 days of 
growth in the presence of additives, and M17 
cultures were analyzed after 3-4 days of growth. 
Photomicrographs were analyzed with 
NISelements software (Nikon) with morphological 
differentiation determined by the number of 
neurites (processes longer than 50 μm) present per 
field [41]. 
 
2.5. Statistical analysis. 
Statistical analyses were performed with 
Sigma Plot software (v 11.0). Kruskal-Wallis one-
way ANOVA on Ranks followed by Dunn’s 
multiple comparison post-hoc tests were used in 
the analysis of neurite promoting activity of 
Lipocalins. A p-value < 0.05, marked with an 
asterisk, was used as a threshold for significant 
changes. Two asterisks were used for p <0.001. 
 
3. Results and Discussion 
 
3.1. Binding properties of ApoD and its related 
insect homologues. 
Intrinsic fluorescence titration was used to 
characterize the ligand binding capacities of ApoD, 
NLaz and Laz, an approach that has been 
successfully employed in many other Lipocalin 
binding studies [e.g.: 37,40]. A panel of 15 small 
hydrophobic molecules was tested, including lipids 
with different size, shape, chemical properties and 
biological functions. Ligands identified in other 
studies were also included. 
Previous studies were carried out using 
proteins recombinantly expressed in E.coli [35,40]. 
Since the three Lipocalins are glycoproteins, we 
performed our study with their glycosylated forms, 
avoiding undesired effects on the calyx structure or 
binding properties due to the lack of glycosylation. 
To perform the binding assays we purified the 
proteins either from native sources (ApoD) or from 
a eukaryotic expression system (NLaz and Laz). 
 
3.1.1. Retinol and retinoic acid: classical 
Lipocalin ligands. 
Retinol and retinoic acid (RA) are common ligands 
for most Lipocalins, including ApoD and Laz 
[37,40]. The Lipocalin retinol binding protein 
(RBP) delivers retinol to several target tissues [42], 
and the physiological relevance of RBP-retinol 
interaction has been reported, for RBP mutations 
preventing retinol binding cause night blindness 
[43]. 
RA and especially retinol bind to ApoD with 
high affinity [37]. Our binding studies confirm that 
ApoD tightly binds retinol and RA (Fig. 1A and 
1D) with KD values of 0.2 ?M for the ApoD-retinol 
and 4 ?M for ApoD-RA interactions (Table 1). 
The higher affinity of ApoD for retinol over RA 
reported here is in agreement with previous results 
[37]. 
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A study of bacterially-expressed recombinant 
grasshopper Laz binding to RA reported a KD in 
the low micromolar range [40]. Here we have 
confirmed the Laz-RA interaction with bacterially-
expressed Laz (Fig. S3A), as well as with the 
glycosylated eukaryotic Laz produced by S2 cells 
(Fig. 1C). Binding to both forms results in similar 
KD (Table 1). Additionally, retinol was evaluated 
as a Laz ligand with positive results (Fig. 1F). RA 
and retinol have well known critical roles during 
vertebrate development [44]. The recent 
quantification of RA in locust embryos [45], 
previously thought to be absent in insects, suggests 
an involvement of Laz-retinol or -RA interactions 
in the Laz known functions during insect 
development [46]. 
 
Binding specificities for retinol and RA 
were also conserved in NLaz (Fig. 1B and 1E), 
with KD values similar to those for ApoD or Laz 
(Table 1). Taken together, the binding of retinol or 
RA to both NLaz and Laz suggests a putative 
conserved physiological role for ApoD-related 
Lipocalins in insects, which lack a recognizable 
RBP ortholog [19]. 
To determine whether ApoD, NLaz or Laz 
binding to RA was dependent on the protein 
tertiary structure, denatured forms of all three 
Lipocalins were used in parallel binding assays, 
with the result that GuHCl denaturation hinders 
RA binding to ApoD, NLaz and Laz (Fig. S2). We 
conclude that an intact Lipocalin calyx is required 
for specific binding. 
 
 
 
Figure 1. Relative fluorescence intensity of hApoD and its insect homologues NLaz and Laz exposed to 
increasing concentrations of retinoic acid or retinol.  
hApoD and Laz protein concentration was 0.5 μM in 10 mM phosphate buffer, 150 mM NaCl, 1 mM EDTA at pH 7.0. 
NLaz concentration was 1 μM in the same buffer. (A) hApoD-RA; (B) NLaz-RA; (C) Laz-RA; (D) hApoD-retinol; (E) 
NLaz-retinol; (F) Laz-retinol. Dots represent the mean of at least 5 independent titrations. 
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3.1.2. Lipids present in HDL particles and 
plasma membrane are putative ligands for 
ApoD-related Lipocalins. 
ApoD was initially discovered as a component of 
HDL [47], where it is disulfide-linked to ApoA-II 
[48]. This discovery suggested that cholesterol is a 
potential ApoD ligand. Here we find no ApoD-
cholesterol interaction in the micromolar range 
(Fig. 2A) in agreement with previous results where 
no interaction [34] or interaction in the millimolar 
range [39] were found, far from the low 
micromolar to nanomolar KD values typical of 
physiologically relevant Lipocalin-ligand 
interactions [49]. Although ApoD is not able to 
bind non-esterified cholesterol with high affinity, 
many studies have shown a relationship between 
ApoD expression and cholesterol levels in tissues 
or organisms, or have proposed cholesterol binding 
as a physiological mechanism [e.g.: 50,51]. For 
example, ApoD is up-regulated in a mouse model 
of NPC disease [18] where cholesterol metabolism 
is impaired. Also, the addition of ApoD to 
organotypic hippocampal cultures reduced the 
amount of 7-ketocholesterol (an oxidized from of 
cholesterol) after kainate-induced excitotoxicity 
[52]. Although these results are suggestive of 
cholesterol binding, the observed correlations 
between ApoD and cholesterol levels cannot be 
ascribed to a direct cholesterol-ApoD interaction.  
Drosophila cannot synthesize sterols and 
requires a dietary source. Ergosterol is the major 
sterol in the yeast-based Drosophila food used in 
laboratories [53]. Interestingly, NLaz and Laz can 
bind ergosterol with KD values of 2 and 2.1 µM 
respectively (Fig. 2B-C). This finding differs from 
that obtained for hApoD-cholesterol interaction, 
and invites to test in vivo the physiological 
relevance of NLaz/Laz-ergosterol binding. 
Sphingomyelin (SM) is the major 
sphingolipid in HDL particles and plasma 
membranes. SM has high affinity for cholesterol, 
and both lipids pack tightly forming lipid rafts and 
caveolae [54]. SM also regulates cholesterol efflux 
from cellular membranes to HDL via the ATP-
binding cassette [55]. A connection of ApoD with 
SM is supported by the enrichment in SM of 
ApoD-containing blood lipoparticles [6], and by 
the role played by ApoD in maintaining peripheral 
nerve myelin sheath [56], a cell compartment that 
contains a high concentration of SM. Here we find 
that ApoD and the related insect Lipocalins NLaz 
and Laz bind palmitoyl-SM (Fig. 2D-F) with KD 
values of 1.3 µM (ApoD), 4.6 µM (NLaz) and 2.7 
µM (Laz). The Laz-SM interaction has a similar 
KD value when using the bacterially-expressed 
form of Laz (Fig. S3B). Thus, SM is a common 
ligand for this group of Lipocalins, with ApoD 
exhibiting a higher affinity for SM than NLaz or 
Laz (Table 1). The number of carbons in the 
sphingoid base differ across species [54] and could 
potentially explain the differential affinities 
observed. Here, we used SM with a C18:1 
sphingoid base, one of the typical forms found in 
humans, whereas C14:0 and C14:1 are the major 
sphingoid base isoforms in insects [54]. 
Since this is the first report of binding of SM 
to any Lipocalin, and SM binding is conserved for 
ApoD, NLaz and Laz, SM could be a ligand for 
other Lipocalins. We tested SM binding to α1-
microglobulin (α1-mg), a Lipocalin more distantly 
related to the ApoD group [19]. No binding 
interaction was detected for α1-mg and SM (Fig. 
S3D), demonstrating the specificity of this assay 
and suggesting that SM could be a specific ligand 
restricted to the ancient metazoan Lipocalins, 
including ApoD and its insect related Lipocalins 
(NLaz and Laz). Retinol binding to α1-mg was 
used as a positive control (Fig. S3C). With these 
findings, the question of whether ApoD-cholesterol 
relationships found in vivo [18,52] are indirectly 
mediated by ApoD control of SM content of 
membranes or lipoprotein particles is also open for 
further research. 
Membrane phospholipids have been also 
suggested as ApoD ligands, though previous 
studies failed to show binding to phosphocholine 
[34]. We tested the binding of ApoD, NLaz and 
Laz to phosphoethanolamine, with PA as 
substituent in position 1 and LA in position 2 
(PLPE). Neither ApoD nor its insect homologues 
(NLaz and Laz) showed positive binding (Fig. S4). 
Thus, with the available data, we can discard 
phospholipids as probable ligands for the ApoD 
Lipocalin group. An interesting antecedent is 
found in the Lipocalin literature: ApoM is only 
able to bind phospholipids with high affinity when 
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they have been previously oxidized [57]. This 
property is still open for ApoD and other 
Lipocalins and might be related to the protective 
functions of many family members. 
 
3.1.3. Binding to steroid hormones. 
ApoD was characterized as a progesterone-binding 
protein from the cystic fluid of women with breast 
gross cystic disease [31]. This was confirmed by 
co-crystallizing ApoD and progesterone [36], and 
many groups have studied the role of ApoD in 
breast cancer [reviewed by 58]. Steroid hormone 
regulatory elements have been identified in the 
ApoD promoter, also suggesting such a link [59]. 
However, we show here that ApoD does not bind 
17β-estradiol  (Fig. 3A), the other main steroid 
hormone involved in reproduction, as previously 
reported [32]. 
The steroid hormone 20-Hydroxyecdysone 
(20-E) plays crucial roles in larval molting and 
metamorphosis [reviewed by 60]. No binding was 
detected for NLaz with 20-E in the micromolar 
range of concentrations (Fig. 3B), as we reported 
for bacterially-expressed recombinant Laz [40]. 
Therefore, ApoD, NLaz and Laz show a varied 
specificity for steroids. ApoD binds progesterone 
with high affinity, but it does not bind cholesterol 
or 17β-estradiol. A possible explanation could be 
the presence of a hydroxyl substituent in position 3 
of the cholesterol and 17β-estradiol molecules, 
which is replaced with a carboxyl group in 
progesterone. On the other hand, NLaz and Laz 
bind ergosterol but not 20-HE, which has two 
hydroxyl groups in positions 2 and 3. 
 
3.1.4. Fatty acids and related lipids. 
Fatty acids have been frequently identified as 
Lipocalin ligands [reviewed by 49]. Both ApoD 
and Laz bind AA (20:4) [34,35,40], which is 
released from membrane phospholipids by 
phospholipase-A2, is a substrate for eicosanoids 
synthesis, and plays a critical role in inflammation 
and tissue homeostasis. Protection of AA oxidation 
by binding to ApoD, preventing its conversion to 
isoprostanes, has been suggested as a putative 
ApoD mechanism of action [52]. 
The relationship between ApoD and AA is 
also extended to neurological disorders. ApoD 
levels are increased in certain brain areas of 
patients with Alzheimer’s disease [14], Parkinson’s 
disease [15] or schizophrenia [16]. A common 
characteristic in these three pathologies is a 
reduction in the levels of AA in the brain [61-63]. 
Increased ApoD levels could be interpreted as an 
attempt to correct for low AA levels, to maintain 
the fluidity properties of plasma membranes and 
the function of AA signaling pathways. 
As ApoD-AA binding has already been well 
established, we tested if NLaz can bind other fatty 
acids such as arachidic acid (ArA) or PA, which 
are abundant in Drosophila sphingolipids and 
glycerophospholipids respectively [53]. Figure 4B-
C shows a positive binding with ArA and PA. The 
estimated KD were 4.5 µM and 4.7 µM for NLaz-
ArA and NLaz-PA respectively. 
NLaz-PA binding and the previously known 
Laz-PA binding [40], led us to test whether PA 
binding was also conserved in ApoD. Figure 4A 
shows the titration of PA with ApoD, resulting in a 
calculated KD of 3.3 µM. These results contrast 
with a previous report where ApoD does not 
measurably bind to PA [34]. 
 
3.1.5. Endocannabinoids and ApoD. 
Endogenous cannabinoids, or endocannabinoids 
(EC), are lipid modulators of synaptic activity and 
are involved in memory, anxiety, movement and 
pain. Predominant ECs include anandamide (AEA) 
and 2-arachidonoylglycerol (2-AG). AEA and 2-
AG are both synthesized from membrane AA 
glycerophospholipid precursors [reviewed by 64]. 
How ECs are released from cells and how 
they reach their targets is a major issue in the field. 
Recent studies have identified intracellular AEA 
transport proteins, but the question is still open on 
whether extracellular EC-transporter proteins exist 
[see 65 for a review]. It has been suggested that 
Lipocalins, due to their lipid binding pocket, could 
be responsible for EC mobilization inside the brain 
[66]. Three Lipocalins are normally expressed in 
the human brain: L-PGDS, RBP and ApoD. RBP 
and PGDS ligands are well known and their 
functions have been established. ApoD appears 
therefore as a likely candidate for EC binding. 
NLaz is also a brain Lipocalin, but the classical 
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cannabinoid receptors are absent in the Drosophila 
brain [67]. 
These results, along with ApoD binding to the 
EC precursor AA [34,35], point to this Lipocalin as 
an endocannabinoid carrier. We tested whether 
ApoD binds to 2-AG or AEA, and found 
measurable binding with AEA (KD 1.6 µM) (Fig. 
4D, E). This is the first experimental evidence
 showing an interaction between ApoD and the 
endocannabinoid system. This selective binding 
profile of ApoD is particularly noteworthy, and 
future in vivo experiments with ApoD-KO and 
ApoD-overexpressor mice might confirm a 
physiological role for ApoD in the 
endocannabinoid system. 
 
 
 
 
 
Figure 2. Intrinsic fluorescence changes of hApoD, NLaz and Laz upon incubation with different lipids present 
in biological membranes.  
(A) Stable fluorescence of hApoD upon exposure to increasing concentrations of cholesterol. (B) NLaz fluorescence 
enhancement by ergosterol. (C) Laz fluorescence enhancement by ergosterol. (D-F). Palmitoyl-sphingomyelin enhances 
the fluorescence of hApoD, NLaz and Laz. Dots represent the mean of at least 3 independent titrations. 
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3.1.6. NLaz binding to Drosophila pheromones. 
Pheromones are bioactive lipids involved in the 
regulation of courtship behavior and mating. NLaz 
null mutant (NLaz-KO) flies exhibit a dramatically 
low courtship index compared to their isogenic 
controls [23,27]. As a first step to understand the 
mechanistic origin of this phenotype, we tested 
whether NLaz is able to bind Drosophila 
pheromones. 
11-cis-vaccenyl acetate (cVA) is the most 
studied Drosophila pheromone, and acts 
selectively through the Or67b odorant receptor in 
both sexes [68]. LUSH is the extracellular carrier 
for cVA and undergoes a conformational change 
that triggers cVA release and binding to the Or67b 
receptor [69]. We tested NLaz as an alternative 
pheromone-binding protein for cVA, but did not 
detect significant binding (Fig. 3E).  
Other Drosophila cuticular sex pheromones 
are unsaturated long-chain hydrocarbons 
synthesized from fatty acid precursors. PA, a 
ligand of NLaz, is also the substrate of Desat1, a 
PA desaturase that triggers an enzymatic 
pheromone synthesis pathway [70]. 
Drosophila hydrocarbon pheromones are 
dimorphic: monoene hydrocarbons are 
predominant in males, and dienes in females [71]. 
We tested whether NLaz is able to bind two of the 
major Drosophila pheromones: the 7-tricosene (7-
T, 23:1) and 7,11-heptacosadiene (7,11-HD, 27:2). 
Figure 3C shows positive binding of NLaz to 
monoene 7-T, whereas no binding was detected 
with the diene 7,11-HD (Fig. 3D). The estimated 
KD of 7-T binding to NLaz is 4.5 µM. 7-T increases 
Drosophila female sexual receptivity, making flies 
to mate faster and more often with males that have 
higher levels of 7-T, while low levels of 7-T 
reduces courtship success [72]. We propose that 
NLaz could be acting as a pheromone carrier 
protein for 7-T, in a way similar to the LUSH-cVA 
pair [69]. 
 
 
Figure 3. Binding assays of hApoD and NLaz with hormones and pheromones. 
 (A) β-estradiol does not alter the intrinsic fluorescence of hApoD. (B) NLaz does not bind 20-hydroxyecdysone. (C) 
NLaz selectively binds the pheromone 7(z)-tricosene, whereas no interaction was detected for 7(z),11(z)-
heptacosadiene (D), or 11-cis-vaccenyl acetate (E). Dots represent the mean of at least independent 3 titrations. 
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Figure 4. Interaction study of fatty acids and arachidonic acid-related molecules with hApoD and/or NLaz. 
 (A, B) hApoD and NLaz bind palmitic acid. (C) NLaz is also able to bind arachidic acid. (D-E) Binding of ApoD to 
endocannabinoids. hApoD does not bind 2-arachidonyl glycerol (D), but anandamide successfully interacts with hApoD 
enhancing its fluorescence (E). Dots represent the mean of at least independent 3 titrations. 
 
 
3.2. ApoD-RA interaction is required for 
neuronal differentiation in culture. 
Finally, we assayed whether any of the binding 
properties of the ApoD-related Lipocalins have 
direct in vivo consequences. For that purpose, we 
chose a neuronal cell model (SH-SY5Y and M17 
cell lines), and RA as a well-defined common 
ligand for these proteins. 
RA has a crucial role during brain 
development, being required to induce early 
progenitors to adopt a neural fate. During 
embryogenesis there is a requirement for a precise 
timing of exposure to RA and a coordinated pattern 
of expression of retinoic acid receptors (RARs) 
[see 44 for a general review].  
SH-SY5Y is a human neuroblastoma cell line 
that has been established as a model of neuronal 
differentiation [41,73]. Under RA treatment SH-
SY5Y cells develop long processes, and cells with 
processes longer than 50 µm have been considered 
as morphologically differentiated [41]. The 
presence of at least 1% serum [74] or exogenous 
albumin is required to obtain differentiation of SH-
SY5Y cells by RA [75]. On the contrary, SH-
SY5Y cells quickly enter the apoptosis pathway 
under serum deprivation [76]. 
ApoD plays an active role during nervous 
system development, where it is mainly expressed 
by glial cells, but is also present in neurons [8-10]. 
ApoD has been previously related with cell 
differentiation. Lopez-Boado el al. [77] first 
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Figure 5. Physiological role of RA and hApoD in neuronal differentiation. 
(A) SH-SY5Y cells growing in complete medium (10% FBS) with ethanol carrier. (B-C) Cells cultured in complete 
medium after 4-6 days of incubation with 10 μM RA (B) or 1 μM RA (C) in ethanol. (D) Cells cultured in serum-free 
medium plus carrier. (E-G) Serum-free medium was supplemented with 1 μM RA (E), 1 μM hApoD (F) or a mixture of 
1 μM RA and 1 μM hApoD (G). Cell growth was monitored after 4-6 days in culture. (H) Quantification of the number 
of neurites observed per field. Bars represent the quantification of 8-18 fields per condition from 5-6 independent 
experiments. Kruskal-Wallis one-way ANOVA on Ranks (p < 0.001) followed by Dunn’s multiple comparison post-
hoc test. In SH-SY5Y cells hApoD is able to substitute for FBS to allow maturation and neurite growth. 
 
 
described that human breast cancer T-47D cells 
differentiate under RA treatment. In these 
conditions T-47D cells accumulate lipid droplets 
and increase ApoD levels, both at mRNA and 
protein levels. This process is RARα-dependent 
[78]. Moreover, Kosacka et al. [30,51] have shown 
that ApoD might act as a neurotrophic adipokine 
and exerts differenciating and synaptogenic effects 
in dorsal root ganglion neurons. On the other hand, 
when SH-SY5Y cells are transfected with p73, a 
transcription factor of the p53 family involved in 
neuronal differentiation, cells differentiate to 
mature neurons in an ApoD-dependent manner 
[79].  
Initially, we confirmed that SH-SY5Y extend 
neurites under standard differentiation conditions 
(Fig. 5B and 5C). When serum was removed from 
the medium, cell survival decreased dramatically 
and no differentiation was achieved even in the 
presence of RA, ApoD, NLaz or Laz (Fig. 5E-F 
and 6A-B). However, cells do differentiate and 
develop numerous long processes if we add ApoD 
preloaded with RA (Fig. 5G) in the absence of 
serum. These results show that ApoD is necessary 
and sufficient to allow for RA differentiating 
activity. 
To validate as general the effects of ApoD-
RA on neuronal differentiation, we used another 
human neuroblastoma cell line, M17, and obtained 
identical results (Fig. S5 and S6B). 
Thus, ApoD loaded with RA produces 
neuronal differentiation and promotes 
neuritogenesis even under serum deprivation 
conditions. Since RA solubility in water is limited, 
we propose that ApoD could be acting as a carrier 
protein for RA. Astrocytes act as a source of ApoD 
10% FBS + EtOH
10% FBS + 10 μM RA
10% FBS + 1 μM RA
0% FBS + EtOH
0% FBS + 1 μM RA
0% FBS + 1 μM hApoD
0% FBS + 1μm RA + 1 μM hApoD
A
B
C
D
E
F
G
H
N
um
be
r o
f P
ro
ce
ss
es
 / 
fie
ld
0
2
4
6
8
10
12 p<0.001
10% FBS 0% FBS
0.1%
EtOH
10 ?M
RA
1 ?M
hApoD
1 ?M RA
1 ?M hApoD
1 ?M
RA
1 ?M
RA
0.1%
EtOH
Results (Chapter2) 
 
93 
 
[26] and also provide RA and contribute to RA 
homeostasis [80]. ApoD could therefore deliver, or 
make available, RA from astrocytes to neuronal 
precursors in vivo. 
Finally, we tested whether NLaz or Laz can 
also mediate the differentiation effect of RA on 
SH-SY5Y cells. RA-preloaded NLaz also induces 
neuronal differentiation, but in a less efficient way 
than ApoD-RA or serum-RA (Fig. 6C and E). 
However, the lengths of processes produced by 
NLaz-RA are similar to those under ApoD-RA or 
serum-RA treatment (Fig. S6A). On the other 
hand, SH-SY5Y cells treated with Laz-RA do not 
show a different number of processes than control 
cells (Fig. 6D and E). 
In summary, SH-SY5Y cells treated with 
ApoD or NLaz, but not Laz, preloaded with RA 
are able to survive and differentiate in serum free 
medium, developing long processes. These results 
indicate that not every RA binding protein is able 
to trigger the differentiation program. Since NLaz-
RA is not as successful as ApoD-RA in triggering 
SH-SY5Y differentiation, our results also suggests 
that a specific interaction, perhaps with an ApoD 
receptor, is further required to obtain the full 
effect. NLaz interaction with this putative receptor 
in mammalian cells might not be as favorable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Effects of long-term 
RA and/or NLaz-Laz treatments 
on SH-SY5Y cell differentiation. 
Cells grown in serum-free 
medium containing. 
 (A) 1 μM NLaz, (B) 1 μM Laz, (C) 
1 μM RA plus 1 μM NLaz or (D) 1 
μM RA plus 1 μM Laz. (E) 
Quantification of neurites observed 
per field normalized by the number 
of cells per field in each condition. 
Bars represent the quantification of 
8-16 photographs from 4-5 
independent experiments. Kruskal-
Wallis one-way ANOVA on Ranks 
(p<0.001) followed by Dunn’s 
multiple comparison post-hoc test. 
NLaz and RA are able to induce 
some degree of differentiation on 
SH.SY5Y cells, whereas Laz does 
not produce any effect. 
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3.3. ApoD and its insect related Lipocalins: 
conservation and divergence of ligand binding 
properties.  
Many studies have shown that human ApoD, 
Drosophila NLaz and Schistocerca Laz share 
functional properties in the organism: regulation of 
lifespan, lipid and carbohydrate metabolism 
control and protection against oxidative stress or 
starvation [21,22,26,27,56]. This work extends the 
knowledge of ligand binding for ApoD and Laz, 
and presents an extensive ligand screening for 
NLaz. 
Our ligand-binding studies show that ApoD-
NLaz-Laz similarities also extend to their 
biochemical and lipid binding properties. 
Homology modeling of the structures of Laz and 
NLaz (Fig. 7) also show the presence of predicted 
ligand binding sites, broadly consistent with the 
conserved structures of Lipocalins and the ligand 
specificities reported here. The modeled calyces of 
the insect Laz and NLaz are somewhat smaller in 
total volume and with moderately greater polar 
character than the ApoD calyx. As most 
Lipocalins, NLaz binds retinol and RA. Besides, 
fatty acids and SM are ligands common to ApoD 
and its insect related Lipocalins. These ligands can 
be therefore predicted to be related with in vivo 
common functions of ApoD, NLaz and Laz. In 
addition, species-specific ligands are first 
described here. AEA binding to ApoD and 7-T to 
NLaz might represent new functions acquired by 
these Lipocalins during their divergent evolution. 
ApoD, NLaz and Laz can be considered as 
moonlighting proteins, and that pleiotropy is 
reflected on the high number of putative 
hydrophobic ligands. Their ligands belong to 
different groups of lipids, exhibiting different 
shapes and biochemical properties. In spite of this 
high variability and apparently promiscuous 
binding, ApoD, NLaz and Laz show a quite 
exquisite selectivity between very similar lipidic 
species. For example, ApoD binds the 
endocannabinoid AEA, but not 2-AG, and NLaz 
binds the pheromone 7-T but not 7,11-H. 
Taken together, our ligand screening and the 
neuronal cell based assay should help us 
understand how ApoD, NLaz and Laz perform 
their known biological functions, and how much of 
each function can be dependent on the particular 
lipidic ligand involved. Furthermore, the discovery 
of new putative ligands for these Lipocalins opens 
the door to explore new functions of ApoD and 
Lazarillo in vivo. 
 
 
 
Figure 7. Homology models of Laz and NLaz. 
Cutaway views of the molecular surfaces of the crystal 
structure (PDB accession code 2HZQ, [36]) of ApoD 
(A) and the homology models of Laz (B) and NLaz (C) 
are shown, colored by electrostatic potential, 
highlighting the calyces. Images were prepared with the 
PyMOL Molecular Graphics System, Version 1.3 
(Schrödinger, LLC.). The progesterone ligand of ApoD 
is shown in a licorice stick representation, colored by 
atom type. Homology models were generated with 
SWISS-MODEL using the crystal structure of 
insecticyanin from the tobacco hornworm Manduca 
sexta (PDB accession code 1Z24, [81]) as a template. 
Results (Chapter2) 
 
95 
 
 
 
 
 
Table 1.  
Comparative of apparent KD values for the binding of various ligands to Lipocalins 
(average value ±  S.D.). 
 
Protein Ligand KD n 
hApoD 
All-trans-Retinoic Acid 4.0±2.6 8 
Retinol 0.2±0.1 7 
Cholesterol n/d 3 
Palmitoyl Sphingomyelin 1.3±0.5 6 
Palmitic Acid 3.3±0.6 8 
PLPE n/d 3 
β-Estradiol n/d 7 
2-Arachidonyl-Glycerol n/d 3 
Anandamide 1.6±1.3 10 
NLaz 
All-trans-Retinoic Acid 1.40±1.6 9 
Retinol 0.9±1.2 10 
Ergosterol 2.7±0.7 6 
Palmitoyl Sphingomyelin 4.6±0.2 8 
Palmitic Acid 4.7±0.2 6 
Arachidic Acid 4.5±0.7 3 
PLPE n/d 8 
7(Z)-Tricosene 4.5±0.6 6 
7(Z),(11)-Heptacosadiene n/d 6 
11-cis-Vaccenil-Acetate n/d 5 
20-Hydroxyecdysone n/d 3 
Lazarillo (S2) 
All-trans-Retinoic Acid 3.0±1.1 8 
Retinol 2.1±0.6 5 
Ergosterol 2.0±0.1 7 
Palmitoyl Sphingomyelin 2.7±0.2 7 
PLPE n/d 5 
Lazarillo (E.coli) All-trans-Retinoic Acid 2.6±1.8 3 Palmitoyl Sphingomyelin 3.0±2.6 3 
α1-microglobulin 
Retinol 1.4±0.1 4 
Palmitoyl Sphingomyelin n/d 3 
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Supplementary Figures  
 
 
Figure S1.  
Expression and purification of hApoD from human breast cystic fluid, and NLaz and Laz from S2 cells. 
Size-exclusion chromatography elution profile of hApoD (P60) (A), NLaz (analytical grade-200 column) (B), and Laz 
(analytical grade-200 column) (C). (D) SDS-PAGE analysis of the purified Lipocalins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. 
Lack of retinoic acid binding to hApoD (A), NLaz (B) and Laz (C) 
under denaturing conditions. Binding assays were performed either in 
the standard buffer or after 21 h incubation with 5 M guanidine 
hydrochloride. Lipocalins-RA interaction depends on the protein 
tertiary structure. 
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Figure S3. Additional intrinsic fluorescence titration studies. 
Recombinant Laz purified from E. coli reproduces the binding pattern of Laz purified from S2 cells. (A) Laz binds 
retinoic acid and (B) palmitoyl-sphingomyelin. A different Lipocalin (α1-mg) also binds retinol (C), but does not bind 
palmitoyl-sphingomyelin (D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. S4. Additional intrinsic fluorescence titration studies. 
(A) hApoD, (B) Nlaz and (C) Laz do not bind the phospholipid 
PLPE. 
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Figure S5.  
Confirmation of the physiological role of RA and hApoD in M17 cells, a different human neuronal cell line.  
Morphology changes of M17 cells growing in complete medium with (A) ethanol carrier, and after treatment with (B) 
10 μM RA or (C) 1 μM RA in complete medium. (D) Cells in serum-free medium with ethanol carrier. (E-G) Cell 
differentiation after 4-6 days of treatment with (E) 1 μM RA, (F) 1 μM hApoD, or (G) 1 μM RA plus 1 μM hApoD. (H) 
Quantification of the number of neurite processes /field normalized by the number of cells/field in each condition. Bars 
represent the quantification of 10-25 fields per condition from 3 independent experiments. Kruskal-Wallis one-way 
ANOVA on Ranks (p<0.001) followed by Dunn’s multiple comparison post-hoc test. In M17 cells, hApoD is also able 
to substitute for serum and to allow maturation and neurite growth. 
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Figure S6. 
Quantification of neurite length upon RA-induced differentiation of (A) SH-SY5Y or (B) M17 neuronal cell lines. No 
changes are observed in the length of neurites between treatments. Kruskal-Wallis one-way ANOVA on Ranks 
(p>0.05). 
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CHAPTER 3 
 
Ligand binding-dependent functions 
 of the Lipocalin NLaz:  
An in vivo study in Drosophila. 
 
 
Summary 
 
NLaz (Neural Lazarillo) is a Drosophila Lipocalin induced upon stress, and able 
to regulate longevity, stress resistance, and locomotor and mating behaviors. NLaz 
modulates the IIS pathway; however its biochemical mechanism of action is still 
unknown. Here we test whether ligand binding to the Lipocalin hydrophobic pocket is 
required to perform NLaz functions. We use point-mutant versions altering the binding 
pocket (NLazL130R, NLazY47A) and other control mutant versions of NLaz. We express 
the proteins in Drosophila S2 cells and assay their survival-promoting potential. Ligand 
binding, tested by tryptophan fluorescence titration, revealed NLazWT binds retinoic 
acid, ergosterol and the pheromone 7(z)-tricosene, while NLazL130R binds only retinoic 
acid. Using site-directed transgenesis in Drosophila we analyze which physiological 
functions depend on NLaz ligand binding ability, constituting the first organism test of a 
ligand binding-deficient Lipocalin. NLaz-dependent lifespan reduction, paraquat and 
starvation sensitivity, aging markers accumulation, and deficient courtship are rescued 
by ubiquitous expression of NLazWT, but not of NLazL130R. The transcriptional 
responses to aging and paraquat show a larger set of aging-responsive genes dependent 
on the integrity of NLaz ligand binding properties. Inhibition of IIS activity by NLaz, 
and modulation of oxidative-stress and infection responsive genes appear as ligand 
binding-dependent processes, all of them impacting the process of aging. 
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1. INTRODUCTION 
 
ipocalins are a large family of small 
extracellular proteins characterized by their 
well conserved β-barrel structure embracing an 
internal cavity able to bind small ligands, most of 
them hydrophobic or amphipathic [1]. For some 
Lipocalins we have a good approximation to the 
role played by their native ligand. For instance, 
Retinol Binding Protein (RBP) transports vitamin 
A within the retina [2]; Siderocalin (Lcn2 or 
NGAL) sequesters iron-binding molecules and 
provides a bacteriostatic mechanism against 
infections [3]; and Crustacyanins carry the pigment 
giving color to the carapace of crustaceans [4]. 
However, the panoply of different physiological 
functions in which Lipocalins are involved keeps 
increasing, and in the vast majority of cases a lipid 
transport function is presupposed but not tested. 
A set of Lipocalins, including the most ancient 
within the metazoan lineage [5-7], has been 
functionally linked to the response of organisms or 
cells to different forms of stress and to the 
modulation of metabolism, key parameters 
regulating senescence and longevity [reviewed by 
8]. Among these are the Lazarillo related 
Lipocalins, a group including the Drosophila 
Lipocalins Neural Lazarillo (NLaz) and Glial 
Lazarillo (GLaz) [9] and the vertebrate 
Apolipoprotein D (ApoD). The expression of these 
Lipocalins, both within and outside the nervous 
system, is boosted by oxidative or metabolic stress 
and they provide an endogenous mechanism of 
protection particularly important in situations of 
aging and neurodegeneration [10-17]. 
NLaz is induced under the control of the stress 
responsive JNK pathway, and is able to negatively 
regulate the IIS pathway [13,18]. NLaz expression 
increases stress resistance and longevity, but also 
serves other apparently unrelated functions by 
regulating fecundity, food-intake and locomotor 
and courtship behaviors [15,19]. Whether all NLaz 
functions are carried out using a common 
biochemical mechanism or this Lipocalin can exert 
different functions depending on the ligand 
available for binding in different physiological 
situations is still unknown.  
 
Studies testing Lipocalins ligand binding 
abilities in vitro are abundant [20-22], including 
ApoD and Lazarillo-related Lipocalins ([23-27], 
and unpublished work by the authors). In addition, 
many Lipocalins have been extensively studied at 
the molecular level, revealing particular residues 
and regions of the protein scaffold that are 
important for their ligand binding properties 
[20,22,28-31]. The biochemical and biophysical 
properties of Lipocalin-ligand interactions have 
been reproted for some family members, either by 
solving their crystal structure with the ligand 
bound to the pocket [32,33] or by site-directed 
mutagenesis of residues contributing to the pocket 
interactive surfaces [21,22,30,31,33-37]. Amino 
acid substitutions that naturally occur in the 
binding pocket of RBP result in vitamin A 
deficiency causing night blindness [38]. Also, 
thanks to their very robust folding, the Lipocalins 
have been used as starting point for protein 
engineering. Using site-directed random 
mutagenesis followed by selection techniques, an 
increasing set of so-called “Anticalins” has been 
generated with various specific target-binding 
activities, many of them with potential therapeutic 
benefits [for a review see 39].  
In spite of the many known Lipocalin mutant 
forms that result in deficient ligand binding in 
vitro, the studies analyzing their effects outside the 
test tube are rare. Mutant forms of Prostaglandin D 
synthase (L-PGDS) have recently been tested for 
their ability to promote cell survival in H2O2 
treated neuronal cultures [40]. A mechanism 
involving the titration of a free thiol in the protein 
without alterations of ligand-binding capacity has 
been found. Modifications of the binding-pocket of 
the Lipocalin C8γ have been tested for hemolytic 
activity [30]. Also, Correnti et al. [35] have found 
that Siderocalin binding pocket mutants that cannot 
bind siderophores in vitro lose their bacteriostatic 
activity when added to bacterial cultures. 
The purpose of this study is to test whether 
NLaz functions are dependent on ligand binding. 
We designed different mutant forms of NLaz and 
tested them at three levels of analysis. We assayed 
their ligand binding capacity in vitro, their cell 
survival promoting activity in a cell culture system, 
and their effect on longevity, stress resistance, 
L 
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behavior and downstream transcriptional responses 
in vivo. We were able to compare the physiological 
effects of wild type and mutant NLaz expression 
without the confounding effect of transgene 
insertion site in the genome by the use of site-
directed transgenesis in Drosophila. This is, to our 
knowledge, the first in vivo test of the 
physiological outcome derived from a ligand 
binding-deficient Lipocalin at the organism level. 
 
 
2. MATERIAL AND METHODS 
 
2.1. Homology modeling of NLaz 3D structure. 
 
The NLaz model was obtained from the Swiss 
Model Repository platform [41,42], built using the 
atomic coordinates of hApoD [PDB entry: 2HZQ] 
as the best template [26]. 
 
2.2. S2 cells culture. 
Drosophila S2 cells were maintained as semi-
adherent cultures at 27ºC in Express-Five medium 
(Gibco) supplemented with 10% L-Glutamine, 50 
U/ml Penicillin, and 50 μg/ml Streptomycin. The 
culture medium was replaced twice a week. 
 
2.3. Cloning and cell lines generation. 
NLaz cDNA, translating into residues 1-224 
(CG33126, Uniprot reference Q9NAZ4, FlyBase 
entry FBgn0053126), was subcloned using the 
EcoRI and NotI sites into the pRmHa3 vector 
(Bunch et al. 1988; Sanchez et al. 2008). This 
system expresses the cloned sequence under the 
control of the inducible Drosophila metallothionein 
promoter, and the presence of a C-terminal His-tag 
sequence allows for protein purification from the 
culture medium. 
NLazL130R-pRmHa3 was generated by direct 
mutagenesis of NLazWT-pRmHa3 following the 
Quick Change Site Direct Mutagenesis method 
(QIAgen). Table S1 lists the oligonucleotides used 
for mutagenesis, cloning, and sequencing. 
The NLazWT-pRmHa3 or NLazL130R-
pRmHa3 plasmids were co-transfected with the 
selection vector pCoBlast (conferring blasticidin 
resistance) into Drosophila S2 cells using 
FuGENE6 (Roche) at 3:1 (v:w) ratio according to 
the manufacturer instructions. Transfected cells 
were selected with 25 μg/ml blasticidin-S for 3 
weeks (Invitrogen). 
 
2.4. Purification of NLazWT and NLazL130R 
proteins. 
S2 cells expressing the recombinant protein 
NLazWT or NLazL130R were grown in spinner flasks 
with blasticidin-free medium, upon induction with 
1mM CuSO4 for 5-7 days. The secreted NLaz 
proteins were purified from the cell medium by 
immobilized metal affinity chromatography using 
Ni-NTA resin (5-Prime). The NLaz proteins were 
further purified by two rounds of size exclusion 
chromatography (Superdex preparative grade 75 
and analytical grade 200, Amersham Biosciences) 
in PNEA buffer (25 mM PIPES, 150 Mm NaCl, 
1mM EDTA, 0.02% NaN3) (Fig. S1-A). The 
purified proteins were deglycosylated by treatment 
with peptide-N-glycosidase F (PNGase-F) from 
Flavobacterium meningosepticum (New England 
Biolabs) after denaturation following the protocol 
supplied by the manufacturer. The purified 
proteins were analyzed by 12% SDS-PAGE (Fig. 
S1-B). 
 
2.5. Ligand binding assays by tryptophan 
fluorescence modification 
Fluorescence measurement were conducted in a 
Shimadzu RF-5301PC spectrofluorometer with a 
quartz cuvette (Hellma; type 105.251-QS, light 
path length of 3 mm). Temperature was held at 22 
± 0.1ºC by a Peltier thermostat. Excitation 
wavelength was 295 nm (mainly selective for 
tryptophan). Fluorescence emission was recorded 
from 327 to 400 nm with slits width set at 5 nm. 
The peak at 340 nm was measured and used to 
calculate Kd. Each titration was performed in 100 
μl. 
The NLaz protein was diluted at 1 μM in 10 
mM phosphate buffer, 150 mM NaCl, 1 mM 
EDTA at pH 7.0. The ligands tested were Retinoic 
Acid (Sigma), Ergosterol (Sigma) and 7(z)-
Tricosene (Cayman), and were dissolved in N,N-
dimethylformamide (DMF) (Sigma). 
The fluorescence spectrum in the presence of 
the ligand was subtracted from a DMF baseline 
obtained by titrating the protein with the same 
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amounts of carrier without ligand. The data of 
corrected fluorescence at 340 nm vs. the total 
concentration were fitted as previously described 
[23,24], and a Kd was estimated with the 
assumption of a single binding site. 
 
2.6. Generation of transgenic flies by site-
specific transgenesis. 
NLaz loss-of-function mutant (NLaz-KO) was 
generated in a w1118 background [43] and crossed 
with a w1118-CS wild type line to generate the NW5 
line used in this study [13]. 
The full wild type NLaz cDNA (coding for a 
224 residue polypeptide) was subcloned into the 
pUASt-attB vector [44] (Gen Bank entry 
EF362409 and FlyBase entry FBmc0003002) 
using the EcoRI site and sequenced to confirm the 
right orientation. NLazL130R and NLazY47A point 
mutations were generated by site-directed 
mutagenesis of the wild type NLaz. A C-terminal 
truncated version of NLaz was generated by 
amplifying a cDNA fragment translating into 
residues 1-176 of NLaz. NLazN165S was identified 
by sequencing as a polymorphism in some of our 
wild type fly stocks. All these NLaz versions were 
subsequently subcloned into the pUASt-attB 
vector. The constructs were sequenced to confirm 
the absence of undesirable mutations. See table S1 
for oligonucleotides used for mutagenesis and 
cloning. 
The PhiC31 system-mediated [44] 
transformation of Drosophila strain “y1 M{vas-
int.Dm}ZH-2A w*; M{3xP3-RFP.attP}ZH-86Fb”  
(BL4749) was used to generate fly lines with the 
UAS:NLazWT or UAS:NLaz mutated versions, 
yielding transgene integration into chromosomal 
position 86Fb. 
 
2.7. Fly Handling. 
Flies were grown in a temperature-controlled 
environmental incubator at 25 ºC under a 12h 
light-dark cycle. The stocks were routinely 
maintained in tubes containing our standard 
medium [16]. 
To drive the expression of the NLaz transgenes, 
the driver da:Gal4 (ubiquitous expression) line was 
crossed with pUASt-NLaz fly lines or w1118 flies 
(to generate driver-only control flies). Only males 
were employed (except for courtship experiments 
where both sexes are involved). 
The absence of infection by Wolbachia pipiens 
in our fly strains was tested by PCR of genomic 
DNA extracts (Fig. S1-C) as previously described 
[15]. Primers against the rRNA-16S gene of 
Wolbachia were used (Table S1). The PCR 
conditions were: 2 min 94°C; (30s 94°C; 30 s 
60°C; 45 s 72 °C)×30; 7 min 72°C. DNA from 
Wolbachia-infected Dirofilaria immitis worms was 
used as a positive control. Primer sequences and a 
positive control DNA were kindly provided by Dr. 
F. Simon (Univ. Salamanca). 
 
2.8. Drosophila Lifespan Analysis. 
Flies were collected within 24 h of hatching and 
allowed to mate for 2-3 days. They were then 
separated by sex under brief CO2 anesthesia and 
housed in groups of 20-25. Every three days, flies 
were transferred to fresh media without anesthesia 
and scored for viability. From 76 to 147 
individuals were analyzed per genotype. The 
viability tests were carried out at 25ºC. 
 
 
2.9. Oxidative Stress, Toxicity and Desiccation 
Stress Assays. 
 
2.9.1. Assays in flies. Flies were collected and 
separated by sex as described for the longevity 
analysis. All tests were carried out at 25ºC. From 
67 to 156 individuals were analyzed per genotype 
and condition. The following treatments were 
used: 
 
2.9.1.1. Starvation-desiccation Stress Assay. 
Starting at 3 days of age, flies were transferred to 
empty plastic vials. Dead flies were scored every 
2–7 hours. 
 
2.9.1.2. Paraquat Toxicity Assay. Flies were kept 
on regular food until the experiment started (3 or 
30 days-old), starved 3h at 25ºC and transferred to 
vials with filter papers soaked in 10% sucrose-20 
mM paraquat (Sigma) solution in water. Dead flies 
were scored every 2–7 hours. 
 
Results (Chapter 3) 
 
110 
 
2.9.2. Assays in cell cultures. S2 cells were seeded 
at a density of 2x106/ml in 24-well plates, and 20 
mM hydrogen peroxide (H2O2) was used as an 
oxidant. Fifty nM of pure NLazWT or NLazL130R 
protein were added to the culture medium 30 min 
before H2O2 treatment. Trypsin Inhibitor (TI) from 
soybean (Sigma) was assayed at the same 
concentration as a control protein. Protein 
concentrations were determined with the Micro-
BCATM protein assay (Pierce). Two hours after 
treatment, cells were stained with Trypan Blue 
(Invitrogen) and counted in a haemocytometer. 
Cell viability was determined as the percentage of 
live cells. Each condition was assayed in 
quadruplicate, and at least two measurements were 
made in each culture well. 
 
2.10. Behavioral Assays. 
 
2.10.1. Climbing Assay. Flies (50 days-old) were 
placed in empty vials, and after a resting period of 
10 min the animals were tapped to the bottom of 
the tube and the number of individuals able to 
climb 5 cm in 6 sec was recorded. The assay was 
repeated three times at 1 min intervals. 
 
2.10.2. Courtship behavior. Courtship and mating 
tests were performed during 60 min using virgin 
male–female pairs of 3-4 day-old flies under a 
glass clock cover (40 mm diameter) used as an 
observation chamber. The courtship index (C.I.) 
represents the proportion of time a male spends 
actively courting the female for the first 10 min. 
Copulation features such as mating time, mating 
latency and mating performance (%) were scored 
for 60 min. The test was performed in the first 1-3 
h of the fly daylight period. 25-30 
couples/genotype were included in this study. 
 
2.11. Metabolic Measurements. 
Flies (4-5 days-old) were analyzed in basal 
situation and after 8 hours of starvation. Two 
independent groups of 15 flies per genotype and 
condition were analyzed. A set of kits were 
employed for triglycerides (BioSystems, Spain), 
glucose (Sigma, USA) and glycogen (Sigma, USA) 
measurement, following the manufacturer’s 
instructions, and absorbance was registered by a 
Versamax microplate reader (Molecular Devices). 
 
2.12. AGE assay. 
Fluorescent AGEs (advanced glycation end 
products) were measured according to Oudes et al. 
[45] with minor modifications. Flies were 
homogenized in 1 ml of PBS containing 10 mM 
EDTA. Cuticle and other debris were removed by 
centrifugation for 5 min at 11000 g. Supernatants 
were digested by addition of 10 mg/ml trypsin 
(Sigma). Following incubation for 24 h at 37ºC the 
digested homogenates were centrifuged and 
filtered through a 0.22 μm sterile filter. Filtrates 
were diluted up to an absorbance range of 0.02-
0.05 units at 365 nm. Fluorescence (excitation and 
emission wavelengths of 365 and 440 nm, 
respectively) was measured in three aliquots of 
each filtrate with a Shimadzu RF-5301PC 
spectrofluorophotometer at 25ºC. 
 
2.13 Quantitative RT-PCR gene expression 
array. 
RNA from 25 homogenized flies per genotype 
and condition was extracted with QIAzol and 
RNeasy Mini Kit (Qiagen) according to the 
manufacturer instructions. We used SYBR Green 
and designed a custom qRT-PCR array 
(SABiosciences) with 4 replicas per sample to 
study gene expression changes generated by the 
expression of NLazWT or its mutant versions. RNA 
transcription profiles were determined by the 
method of direct comparison of Ct values and 
relative quantities calculated by the ΔΔCt method 
[46]. Table S3 shows the list of genes explored and 
their relationship to the physiological output that 
motivated its selection. A fold regulation ≥ 2 and p 
< 0.05 for at least one genotype was established for 
the gene to be considered as a PQ or aging-
responsive gene.  
 
2.14. Immunoblots 
Fly proteins were extracted from the phenol 
phase after QIAzol RNA isolation. Protein 
concentrations were determined with the Micro-
BCATM protein assay (Pierce). 25 μg of total 
protein/lane where transferred to a nitrocellulose 
membrane (BioRad). Membranes where blocked 
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with 2.5% BSA, 2.5% non fat milk and 0.4% 
gelatin. Mouse anti-ubiquitin (P4D1) (Cell 
Signaling) was used as primary antibody, and 
HRP-conjugated goat anti-mouse IgG (Dako) as 
secondary antibody. Non-transferred proteins that 
remained in the SDS-PAGE where stained with 
Coomassie R-250 (BioRad) for normalization 
purposes. Membranes were developed with ECL 
(Millipore) and the integrated optical density of the 
inmunoreactive protein bands was measured in 
images taken within the linear range of the camera 
(VersaDoc, BioRad) avoiding signal saturation. 
Blots were run as duplicates, and one 
representative experiment is shown. 
 
2.15. Statistical Analysis. 
Statistical analyses were performed with 
SigmaPlot (v 11.0) software. A p< 0.05 was 
defined as a threshold for significant changes. 
Particular tests used are stated in figure legends. 
 
 
3. RESULTS 
 
In order to design mutations that could result in 
altered ligand-binding properties we used NLaz 
tertiary structure model generated in the Swiss 
Model platform (Fig. 1). Using the well-known 
ligand-protein interactions of the closely related 
ApoD [26] we designed two types of binding-
pocket mutants: 1) L130R (Fig. 1B) is predicted to 
obstruct binding by introducing a large side change 
and charged residue facing the pocket. 2) Y47A 
(Fig. S2 A) is predicted to enlarge the binding-
pocket size by introducing a smaller side change 
residue of similar biochemical properties and that 
might consequently alter ligand binding interaction 
in more subtle ways. As a control, another point 
mutation was selected. A NLaz allele with a serine 
in position 165 was found in our wild-type fly 
stocks, while an asparagine in that position appear 
in the databases by more recent genome 
sequencing. In this work the N165 version was 
selected as the reference wild-type protein, 
matching the current entries in genomic databases. 
The NLazN165S version might represent a 
polymorphism present among laboratory flies. 
Since N165 lies outside the binding pocket (Fig. 
S3 A), it serves to analyze the physiological 
outcomes of expressing an NLaz point mutant 
unrelated to ligand binding. 
In addition to binding pocket mutants, we 
explored the effect of deleting a C-terminal 
extension (residues 177-192, Fig. S4 A) that is 
unique to NLaz within the Lipocalin family [47]. 
This C-terminal tail is similar in size to the GPI-
anchoring signal peptide present in the ancient 
Lazarillo of grasshoppers and other insects [19,48], 
but shows a quite different amino acid 
composition. Aside of serving as a different control 
for the binding pocket mutants, the function of this 
putative evolutionary vestige is also explored in 
this work. 
 
3.1. Monitoring NLaz-ligand interactions in 
vitro by intrinsic fluorescence analysis 
The wild type and mutant versions of the NLaz 
pocket were expressed using an inducible 
expression system in Drosophila S2 cells. The 
proteins were purified from the culture medium by 
affinity chromatography against a C-terminal His-
tag followed by two rounds of size exclusion 
chromatography to reach a purity > 99% (Fig. S1 
A). The proteins produced by S2 cells were 
successfully secreted into the culture medium, are 
glycosylated and show signs of intramolecular 
disulfide bonds, as expected for a correctly folded 
native NLaz protein (Fig. S1 B). We centered our 
biochemical analysis in the ligand-binding 
properties of NLazWT and NLazL130R versions. 
We used tryptophan fluorescence titration to 
assay the interaction of NLaz with different 
ligands. One of the two tryptophan residues in 
NLaz, W128, is predicted to be located within the 
binding pocket. Its modification by interaction 
with ligands in the pocket could either quench or 
enhance its fluorescence emission. All-trans-
retinoic acid (RA) produced quenching of the 
emitted fluorescence (Fig. 2 A-B) in both 
NLazWTand NLazL130R. Since RA is known to bind 
most Lipocalins tested so far [24,49-51], it is a 
good probe of the correct folding of the S2 
expressed proteins. We then tested ergosterol, the 
functional equivalent to mammalian cholesterol in 
insects, and proved that it produces an enhanced 
fluorescence over the carrier baseline in NLazWT 
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3.2. NLazWT has stronger cell-survival 
promoting activity than NLazL130R under 
oxidative stress in a cell-culture based assay. 
In order to test the biological activity of the wild 
type and ligand binding-deficient NLaz, we treated 
non-transfected S2 cell cultures with H2O2 and 
measured cell viability by trypan blue exclusion 
analysis (Fig. 3). Neither version of NLaz protein 
nor an unrelated control protein (Trypsin Inhibitor, 
TI) had effects on the viability of untreated cells. 
Upon a pro-oxidant treatment the viability of 
control cells was reduced to 45%. No rescue was 
observed when the culture was supplemented with 
the control protein TI, but a significant increase in 
viability was obtained with both NLazWT and 
NLazL130R. The increase in viability produced by 
NLazWT was nevertheless significantly higher than 
that obtained with the pocket mutant NLazL130R. 
 
 
 
 
Figure 3. NLazWT has stronger cell survival 
promoting activity than NLazL130R over S2 cells 
under oxidative stress. 
Drosophila S2 cell viability measured by trypan blue 
dye exclusion. S2 cells improve their survival upon 
exposure to hydrogen peroxide (20 mM H202) when 50 
nM of exogenous pure NLazWT or NLazL130R proteins 
are added to the culture medium. Trypsin Inhibitor (TI, 
50 nM), added as a control unrelated protein, does not 
influence cell survival. One-way ANOVA (p<0.001) 
followed by Holm-Sidak multiple comparison post-hoc 
test indicates that the recovery of viability obtained with 
NLazWT is significatively larger than that obtained with 
NLazL130R.
3.3. Monitoring survival-promoting activity of 
NLazWTand mutant forms in vivo. 
The wild type and the four mutant versions of 
NLaz were placed downstream of an UAS 
(upstream activated sequence) containing a 
promoter to make its expression controlled by the 
Gal4/UAS system in Drosophila. Using PhiC31-
mediated transformation all transgenes were 
integrated into the fly genome in position 86Fb of 
chromosome 3, an otherwise neutral site with no 
phenotypic effects known due to insertion 
mutations. With this strategy, genetic background 
differences and positional effect differences in 
expression levels are avoided, allowing for a 
proper comparison of the effects of different 
versions of NLaz on the physiological parameters 
of the fly. In this work we analyze the effects of 
ubiquitous expression of the transgenes using the 
daughterless:Gal4 (da:Gal4) driver.  
 
3.3.1. Drosophila resistance to paraquat 
throughout aging is differentially modulated by 
NLaz mutant versions. 
We have previously demonstrated that NLaz 
expression, and that of its mammalian homologue 
ApoD, is induced via JNK signaling activation 
upon exposure to the oxidative stress generator 
paraquat [10,13]. This expression of NLaz/ApoD is 
required to promote survival in oxidative stress 
conditions [12,13,53]. 
When flies are exposed to paraquat and NLazWT 
is overexpressed with a ubiquitous pattern (da:Gal4 
driver), young 3 day-old flies increase only slightly 
their survival (Fig. 4A), but aged flies (30 day-old) 
experience a 13.6 and 40.2% increase in median 
and maximal survival respectively (Fig. 4B and 
Table 2). In contrast, over-expression of the pocket 
mutant NLazL130R even decreases survival of flies 
(13.5 and 8.9% decrease in median and maximal 
survival of aged flies, Fig. 4A-B and Table 2). 
When the expression of NLazWT or NLazL130R is 
performed in a NLaz null background (flies 
homozygous for the allele NLazNW5) only a partial 
rescue is obtained with the ligand-binding impaired 
version while the wild type NLaz completely 
restores sensitivity to PQ to the same level attained 
with a single copy of wild type NLaz in its native 
locus (heterozygous +/NLazNW5 flies) (Fig. 4C).  
No protein added
NLazWT (50 nM)
NLazL130R (50 nM)
TI (50 nM)
H2O2
(20 mM)
0 20 40 60 80 100 12
Survival (%)
**
ANOVA
p<0.001
**
**No protein added
NLazWT (50 nM)
NLazL130R (50 nM)
TI (50 nM)
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On the contrary, over-expression of the mutant 
version NLazY47A, that alters the binding pocket in 
a different way (Fig. S2A), does not differ from 
NLazWT expression, being able to increase median 
and maximal survival (52.6 and 24.9% 
respectively, Fig. S2B-C and Table S2) in aged 
flies treated with PQ. In the absence of native 
NLaz, however, the rescue obtained with this 
version of NLaz is also partial (Fig. S2D). Taken 
together, these results are in agreement with a need 
for proper ligand binding activity in order for NLaz 
to exert its protective effect upon oxidative stress. 
NLazN165S, bearing a mutated residue located 
outside the binding pocket (Fig. S3 A), results 
notwithstanding in extended survival upon PQ 
treatment in both young and aged flies and in flies 
lacking native NLaz as well (Fig. S3 B-D, and 
Table S2). Whether this NLaz allele represents a 
natural beneficial polymorphism existing in 
naturally occurring fly populations deserves further 
studies. 
The mutant NLazΔ177-192 is also predicted not to 
alter the ligand binding properties of NLaz. 
However, it has a survival-promoting activity 
similar to NLazWT in young flies and larger than 
NLazWT in aged flies (Fig. S3 A-B). In the NLaz 
null mutant background this truncated version of 
NLaz produces a partial rescue of median survival 
but a complete rescue of maximal survival (Fig. S3 
C and Table S2). These data again reinforce the 
idea that the interference of ligand binding activity 
generated by the L130R mutation, but not other 
NLaz protein modifications, decreases 
significantly the NLaz protective effects upon PQ 
exposure. The milder modification of the ligand 
binding pocket caused by the Y47A mutation 
produces a protein that in vivo has functional 
properties more similar to the wild-type version of 
NLaz. 
 
3.3.2. An intact binding pocket is required to 
rescue the Drosophila lifespan-reduction 
phenotype of NLaz null mutation. 
Since resistance to oxidative stress is often 
correlated with extended longevity, we tested the 
ability of each mutant form to rescue the decrease 
in lifespan caused by the absence of NLaz [13]. 
The mutants that do not alter the ligand-binding 
pocket show either similar (NLazN165S) or enhanced 
(NLazΔ177-192) lifespan-expanding activity 
compared with flies expressing NLazWT from the 
same locus (Fig. S3-S4; Table S2). The pocket 
mutant NLazY47A is able to rescue median survival 
but not maximal survival, in contrast with the 
ubiquitous expression of NLazWT, which rescues 
maximal but not median survival (Fig. S2, Table 
S2). Interestingly, expressing the ligand binding-
deficient NLazL130R in NLaz null background 
results in a lifespan shorter than that of the null 
mutant (Fig. 4D, Table 2). This result is 
compatible with a requirement for adequate ligand 
binding activity in NLaz in order to obtain a wild 
type-like longevity pattern. However, it also 
suggests a potential dominant-negative effect of 
the NLazL130R protein. Interactions of NLazL130R 
with NLaz functional partners without carrying the 
ligand might be more deleterious than the absence 
of NLaz. 
 
3.3.3. Drosophila resistance to metabolic stress 
is partially dependent on the ligand-binding 
pocket structure and requires the C-terminal 
tail of NLaz. 
Resistance to metabolic stress is also correlated 
with an extended longevity, and we have described 
how NLaz expression can be triggered upon 
starvation-desiccation conditions and modulate 
metabolism by acting on the IIS pathway [13]. 
Consequently, a loss of NLaz decreases resistance 
of flies to the lack of nutrients and water.  
As expected, the over-expression of NLazWT 
significantly increases the resistance of NLaz null 
flies to starvation-desiccation stress (Fig. 4E, Table 
2) producing a survival curve similar to that of the 
heterozygous +/NLazNW5 control. However, all 
point mutant versions of NLaz produce only a 
partial rescue of the null mutant phenotype (Fig. 
4E, S2-F and S3-F, Table 2). 
Interestingly, the truncation of the C-terminal 
tail of NLaz in NLazΔ177-192 does not rescue the 
starvation-desiccation sensitivity phenotype (Fig. 
S4, Table 2), suggesting that this region might be 
important for an NLaz molecular interaction 
required to attain its survival-promoting activity 
upon metabolic stress 
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Figure 4. NLazL130R shows lower survival promoting activity than NLazWT upon aging or exposure to oxidative 
and metabolic stress. 
(A) Resistance to paraquat of 3 day old flies with ubiquitous over-expression of NLazWT or NLazL130R in wild type 
background is not significantly different from that of control flies. However, over-expression of NLazWT confers more 
resistance to paraquat than over-expression of NLazL130R.  
(B) Upon aging (30 day-old flies) resistance to paraquat is increased by ubiquitous over-expression of NLazWT. 
However, old flies over-expressing NLazL130R are still more sensitive to paraquat than control flies. ( 
C) Three day-old NLazNW5 homozygous flies are more sensitive to paraquat exposure than control flies. NLazWT 
ubiquitous over-expression rescues this phenotype completely. However, NLazL130R expression is only able to exert a 
partial rescue.  
(D) In the absence of added stress, null NLaz fly mutants show a reduced lifespan compared with control flies. This 
longevity reduction is rescued by ubiquitous over-expression of NLazWT (evident in terms of maximal survival; see 
Table 2). However, over-expression of NLazL130R fails to rescue NLaz loss-of-function shortened longevity, showing a 
lifespan even shorter than that of NLazNW5homozygous flies.  
(E) Three day-old NLazNW5 flies are more sensitive to starvation-desiccation stress than control flies. NLazWT 
ubiquitous over-expression also rescues this phenotype while NLazL130R expression is only able to exert a partial rescue. 
To compare survival distributions, log-rank tests were performed (p-values shown in each panel) followed by Holm-
Sidak multiple comparison post-hoc tests. 
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Background ♂ da> UAS transgene N Experiment
ANOVA
Sig 
Median Survival 
or 
 Behavior Success 
Maximal 
Survival 
Sig %Change Sig %Change 
WT (w1118) NLaz
WT [2M] 
NLazL130R [3M] 
67-68 
67-70 
Paraquat 
(3 d) * 
n/s 
n/s 
 
23.14 
-13.92 
 
n/s 
* 
-6.50 
-6.50 
WT (w1118) 
 
NLazWT [2M] 
NLazL130R [3M] 
 
67-71 
67-74 
Paraquat 
(30 d) ** 
** 
* 
13.56 
-13.46 
** 
* 
40.16 
-8.90 
NLazNW5 
 
NLazWT [2M] 
NLazL130R [3M] 
 
147-
126 
147-76 
Longevity ** ** ** 
1.75 
-15.79 
** 
** 
17.65 
-19.72 
NLazNW5 
 
NLazWT [2M] 
NLazL130R [3M] 
 
153-
128 
153-93 
Paraquat 
(3 d) ** 
** 
** 
90.4 
36.09 
** 
** 
46.04 
23.68 
NLazNW5 
 
NLazWT [2M] 
NLazL130R [3M] 
 
119-
150 
119-76 
Desiccation ** ** * 
22.26 
22.26 
** 
n/s 
21.74 
0.00 
NLazNW5 
 
NLazWT [2M] 
NLazL130R [3M] 
 
29-29 
29-25 Courtship ** 
* 
n/s 
600 
200   
NLazNW5 
 
NLazWT [2M] 
NLazL130R [3M] 
 
95-88 
95-29 
Climbing 
(50 d) * 
n/s 
n/s 
46.17 
-23.23   
 
 
 
 
Table 2. Effects of NLazWT and NLazL130R ubiquitous expression in flies survival and behavior. 
Summary of the survival parameters and behavioral scores obtained with different experimental paradigms in flies. In 
over-expression experiments (WT background) the statistics are presented for the comparisons of each NLaz version 
with the driver alone control (w1118;da:Gal4/+). In rescue experiments, the comparisons presented are with the driver 
alone in heterozygous null NLaz mutant background (w1118;+/NLazNW5;da:Gal4/+). All UAS:NLaz transgenes are 
located in the same locus of the genome (86Fb in chromosome 3). ** = p<0.001, * = p<0.05. 
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3.4. Fly locomotor and reproductive behaviors 
also depend on NLaz binding pocket structure. 
Locomotor behavior can be used to evaluate the 
extent of neurodegeneration or functional decline 
of the nervous system with age. We have shown 
that a loss of NLaz leads to an accelerated aging 
[19] and that young NLaz mutants have defective 
daily locomotor activity patterns [15]. Here we use 
climbing ability to assay locomotor performance. 
Upon aging, flies bearing the null mutation of 
NLaz lose significantly their ability to climb (Fig. 
5A). Flies expressing NLazL130R perform as poor as 
the null mutant in the climbing test, while 
ubiquitous overexpression of NLazWT is able to
 produce a partial rescue when replacing the 
absence of native NLaz. Therefore, ligand binding 
disruption does interfere with the contribution of 
NLaz to the regulation of locomotor abilities. 
Male courtship performance, also significantly 
reduced in the null NLaz flies ([15] and Fig. 5B), is 
rescued by NLazWT, while the courtship index of 
NLazL130R expressing males is more similar to the 
null mutant flies than to the wild type control (Fig. 
5B). This result, together with the inability of 
NLazL130R to bind a key male pheromone (Fig. 2F), 
indicates that NLaz binding to specific ligands is 
required as part of the mechanisms controlling 
courtship behavior.  
 
 
 
 
 
 
 
Figure 5. Fly locomotor and 
reproductive behaviors depend of 
NLaz pocket structure. 
(A) Fly climbing ability was tested in 
50 day old individuals. NLazNW5 flies 
show a reduced success in the climbing 
test than that of control flies. This 
phenotype is partially rescued by a 
ubiquitous over-expression of NLazWT, 
but not of NLazL130R. Kruskal-Wallis 
one-way ANOVA on ranks (p=0.018) 
followed by Dunn’s multiple 
comparison post-hoc test. 
(B) Courtship behavior index is 
reduced in NLazNW5 flies. NLazWT 
ubiquitous over-expression rescues this 
phenotype completely. However, 
NLazL130R expression results in a 
courtship index more similar to the null 
mutant than to the wild type control.  
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3.5. Measurements of metabolic state: NLaz 
binding ability conditions energy storage and 
the metabolic response to starvation. 
Energy management and metabolism is tightly 
linked to longevity regulation and the rate of aging 
[reviewed by 8]. We have previously shown that 
NLaz null mutants have alterations of triglycerides, 
glucose and glycogen levels both in basal 
conditions and upon starvation [13]. In response to 
stress [13] or to a high sugar diet [18] NLaz is 
induced and exerts a negative regulation on the IIS 
pathway.  
Here, we explore the effects of expressing 
NLazWT and NLazL130R in the null mutant 
background.  A decrease in basal levels of 
triglycerides is produced by the absence of NLaz. 
This phenotype is rescued by NLazWT, but not by 
NLazL130R (Fig. 6A). However, the alteration of the 
binding pocket of NLaz does not influence glucose 
or glycogen basal stores (Fig. 6B and 6C), since 
NLazL130R expression results in basal levels similar
 to those obtained with NLazWT. In contrast, the 
expression of NLazY47A, NLazN165S or NLazΔ177-192 
rescues the loss of triglycerides phenotype as 
effectively as the NLazWT transgene (Fig. S2-G, 
S3-G and S4-G). Thus, only the regulation of 
triglyceride stores is dependent on NLaz ligand-
binding abilities, and particularly on the ligand 
binding impairment caused by the NLazL130R 
mutation. 
The metabolic response to eight hours of 
starvation-desiccation stress is also altered by the 
absence of NLaz ([13,18] and Fig. 6). However, 
both NLazWT and NLazL130R produce similar rescue 
effects on metabolite concentrations in starvation 
conditions, with a complete rescue of triglyceride 
and glycogen and a partial rescue of glucose levels. 
Therefore, energy storage management in response 
to starvation appears as independent of NLaz 
ligand binding pocket in these flies, where the 
transgenes lack the regulatory regions of the native 
gene and the native gene expression is absent. 
 
 
 
 
Figure 6. Effects of NLazWT and NLazL130R in the metabolic homeostasis of the fly. 
(A) Glycogen storage levels only show differences between wild type and NLazNW5 flies. Two-way ANOVA (p=0.012) 
followed by Holm-Sidak multiple comparison post-hoc test.  (B) TAG amounts are dependent on NLaz genotype and 
NLaz binding pocket structure. TAG levels are reduced in NLazNW5 flies compared to control flies. When NLazWT and 
NLazL130R are ubiquitously over-expressed in the NLazNW5 genetic background, differences in TAG with respect to 
control are only found for NLazL130R flies. Two-way ANOVA (p=0.003) followed by Holm-Sidak multiple comparison 
post-hoc test. (C) Glucose levels depend on NLaz genotype, but not on NLaz binding pocket structure. NLazNW5 flies 
present lower levels of glucose compared with control flies. No differences were found between NLazWT and NLazL130R 
over-expressing flies. Two-way ANOVA (p<0.001) followed by Holm-Sidak multiple comparison post-hoc test.  
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3.6. Aging related markers accumulate early in 
NLaz null mutant and their rescue is dependent 
on NLaz pocket integrity. 
We have previously shown that the accumulation 
of oxidized forms of sugars (AGEs), which are 
reliable biomarkers of normal aging-related 
damage, is accelerated in the NLaz null mutants 
[19]. The increase in fluorescent AGEs caused by 
the lack of NLaz is fully rescued by the ubiquitous 
expression of NLazWT, but not by NLazL130R (Fig. 
7A), indicating that the beneficial action of NLaz 
in the delay of age-related damage is dependent of 
its ligand-binding ability. 
Likewise, the accumulation of 
polyubiquitinated proteins, which also occur upon 
normal aging mostly due to a decreased efficiency 
of the protein quality control systems (autophagy 
and proteasome), is accelerated in the NLazNW5 
null mutant and only NLazWT is able to partially 
rescue this phenotype (Fig. 7B). 
 
3.7. Transcriptional responses to oxidative 
stress or aging are modulated by NLaz and are 
differentially rescued by NLazWT and NLazL130R 
transgenes. 
The expression of a set of 40 genes was explored 
in flies of four genotypes (Fig. 8) using a custom 
qRT-PCR array (see Methods). Genes were 
selected to monitor the state of metabolism-
regulating pathways, aging and stress biomarkers, 
lipid and carbohydrate metabolism, and 
pheromonal and neuropeptide signaling. The other 
two known Drosophila Lipocalin genes (GLaz and 
Karl) were also included together with genes 
related to the innate immune response, given the 
infection-protective effect known for Karl [13]. In 
addition to technical controls, four potential 
housekeeping genes were included. Among those, 
in agreement with the criteria of Ponton et al. [54], 
RpL32 is the one with least variation among 
genotypes and conditions, and was used as 
reference for the analysis. Each genotype was 
explored under basal conditions (3 day-old flies), 
upon PQ exposure (17 h treatment, 3 day-old flies), 
and with aging (30 day-old flies). 
In untreated young flies, the differences 
between genotypes are small, and only three genes 
fulfill our criteria of altered expression (see 
Methods) in the NLaz null mutant with respect to 
heterozygous control flies (Table S4). Among 
these, the expression pattern of the Lipocalin Karl 
is of particular interest: its expression decreases in 
the NLaz null mutant and is recovered by both 
NLazWT and NLazL130R ubiquitous expression. 
PQ exposure provoked a transcriptional 
response in 23 of the 40 genes studied, while aging 
modified the expression of 24 genes. In Figure 8 
we analyze the subsets of responding genes where 
NLazWT or NLazL130R revert the transcriptional 
change observed in the NLaz null mutant. NLaz 
ubiquitous expression rescues the effects of PQ in 
12 genes (Fig. 8A) representing approximately half 
the sample of responding genes (Fig. 8B). 
Interestingly, the NLaz effect on aging-responding 
genes is wider, with a rescue observed in 17 genes 
(Fig. 8C) representing three quarters of the sample 
(Fig. 8B). Furthermore, a differential rescue by the 
NLazWT transgene is particularly enriched in the 
aging-responding gene sample with approximately 
half the rescuing effects being dependent on a 
functional ligand binding pocket of NLaz. 
In the transcriptional response to PQ we found 
three genes whose expression is differentially 
rescued by the NLazWT transgene (boxed in Fig. 
8A). They are functionally related to lifespan 
modulation (Lsp2, [55]), detoxification, oxidative 
and heat stress response (GstE1, [56]), and 
regulation of neurogenesis by metabolism (Ilp4, 
[57]). In the response to aging, more genes show 
binding pocket-dependent rescue by NLaz (boxed 
in Fig. 8C). They include genes directly involved 
in the IIS pathway activity (InR, [8]) and oxidative 
stress responsive genes that are in turn regulated by 
the IIS pathway (Gadd45, [58]), genes downstream 
of the stress-responsive JNK pathway (puc, Karl 
and Hsp68, [13,59]), genes related to the immune 
response (the antibacterial peptide Drs and Karl, 
[13,60]), aging-modulated neuropeptides and 
synaptic proteins (Nplp3 and synaptogyrin [55]), 
as well as neuropeptides controlling food-intake 
(sNPF, also downstream of IIS pathway [61-63]). 
Among the tested genes, NLaz binding pocket-
dependent transcriptional changes were not 
observed for genes that we had selected for their 
direct relationship to pheromone synthesis, lipid 
homeostasis or lipid metabolism. 
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Figure 8. Transcriptional profile analysis shows ligand-dependent and independent NLaz modulation of stress 
and age-responsive pathways.  
(A) Subset of genes where the response to PQ shows dependence on NLaz genotype. Only genes with expression 
changes≥2, p < 0.05, and showing a rescuing effect by either of the NLaz transgenes are shown. Boxes point to genes 
with a rescue dependent on the binding pocket mutation (differential rescue). Genes with large expression changes are 
shown in separate graphs for scaling purposes. 
(B) Percent distribution of genes with transcriptional changes upon PQ or aging classified according to the ability of 
NLaz transgenes to revert the changes observed in the NLazNW5 null mutant genotype. 
(C) Subset of genes whose response to aging is NLaz-dependent. Inclusion criteria as in A. Boxes point at genes with 
binding pocket-dependent rescue, with dashed boxed showing cases with partial dependence (NLazL130R causing a 
partial rescue of the transcriptional change provoked by the null mutation). Genes with large expression changes are 
shown in separate graphs for scaling purposes. 
Student’s t-test was performed on the replicate 2-ΔCt values for each gene in each genotype. Fold regulation by either PQ 
or aging is shown as 2-ΔΔCt when the experimental condition produced an increase in expression, and as -1/2-ΔΔCt when 
the condition produced down-regulation of the gene. 
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accumulation of age-dependent markers, and it 
appears to show a dominant-negative effect in 
lifespan modulation. Therefore we demonstrate in 
vivo that the residue L130 is a key element in the 
ligand-binding abilities of NLaz, as it has been 
shown in vitro for its human homologue. The 
crystal structure of hApoD bound to progesterone, 
a ligand of the same structural class as ergosterol, 
shows the residue L129 (equivalent to L130 in 
NLaz) in direct contact with the ligand [26]. When 
modeling the binding of a very different lipid, 
arachidonic acid, the same residue shows up as an 
interacting partner in hApoD [26]. L130 lies in 
close proximity to a tryptophan residue conserved 
in the entire Lipocalin family (W127 in hApoD, 
W128 in NLaz), which is also known to be 
involved in the protein-ligand interaction and is 
probably responsible for most of the intrinsic 
fluorescence changes observed upon ligand-
binding in our assays. The residue Y47, equivalent 
to Y46 in hApoD, is known to interact with 
progesterone, but modeling predicts no interaction 
with arachidonic acid. This fact, plus its 
substitution by a non-obstructing residue, supports 
the milder physiological effects of this NLaz 
version when expressed in flies.  
Our analysis also shows that the ligand binding-
deficient version of NLaz (NLazL130R) cannot 
rescue particular behavioral phenotypes. Our data 
strongly support a specific function of NLaz as a 
mediator of pheromone signals, either at 
modulating their availability in the extracellular 
milieu or its reception by the sensory neurons in 
charge. 
Finally, the transcriptional changes monitored 
in our study clearly show that NLaz acts upstream 
of key pathways modulating the management of 
resources upon stress or aging. Many of the genes 
with NLaz-dependent responses to aging or PQ are 
in fact genes regulated by the IIS pathway, either 
as direct FOXO targets (Lip4, Gadd45, Sod2, 
Pepck, and sNPF) or downstream of the TOR 
pathway (Thor). This further supports our previous 
findings of a negative control of IIS activity by 
NLaz [13], and suggests additional consequences 
derived from NLaz function, some of which are 
dependent on the ligand-binding modification of 
NLazL130R.  
In light of the new findings we can refine our 
previous conclusions about a modulation of 
lifespan through the control of metabolism under 
stress conditions by NLaz. We previously 
proposed that the lifespan-expanding activity of 
NLaz was due to the systemic action of fat body-
derived NLaz on peripheral target tissues, 
inhibiting IIS and therefore repressing growth [13]. 
Also, we showed that a constitutive lack of NLaz 
function significantly increases the hunger-driven 
food intake behavior of the flies, and that they gain 
weight (particularly fat) with aging [15]. Now we 
find that NLaz mutants have increased expression 
of sNPF upon aging. This fact provides an 
explanation for the food intake and “age-related 
obesity” phenotypes, and highlights new actions of 
NLaz within the CNS. NLaz might exert a negative 
regulation of the expression of sNPF downstream 
of FOXO in the neuropeptidergic neurons, thus 
contributing, in addition to its systemic control, to 
the final metabolic-nutritional status and lifespan 
of the flies.  
We also find that under oxidative stress NLaz 
modulates the expression of Ilp4 in a binding-
pocket dependent manner. Ilp4 is one of the 
insulin-like peptides described to be part of the 
CNS specific pool, and it is known to contribute to 
neurogenesis reactivation during larval 
development [57], but not to organismal growth. 
Curiously, NLaz does not alter the expression of 
Ilp2, Ilp3 or Ilp5 [13], the systemic pool of insulin-
like peptides in Drosophila that control organismal 
growth. 
Our data therefore demonstrate that NLaz 
modulatory actions on various signaling processes, 
including IIS and pheromone signaling, have cell 
type-dependent responses within and outside the 
nervous system. Some, but not all functional 
outcomes are dependent on NLaz proper ligand-
binding capacity, conflicting with a simple 
hypothesis of NLaz as a lipid-carrier. The present 
work should place the foundations for a detailed 
dissection of the molecular mechanisms of NLaz 
and the contribution of its lipid ligands in each 
physiological system, with Drosophila as a 
powerful tool for in vivo analysis. 
 
 
Results (Chapter 3) 
 
124 
 
REFERENCES 
 
1. Akerström B, Borregaard N, Flover D, Salier J (2006) 
Lipocalins. Georgetown, Texas. 204 p. 
2. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, et 
al. (2007) A membrane receptor for retinol binding 
protein mediates cellular uptake of vitamin A. 
Science 315: 820-825. 
3. Correnti C, Strong RK (2012) Mammalian 
siderophores, siderophore-binding lipocalins, and 
the labile iron pool. J Biol Chem 287: 13524-13531. 
4. Wade NM, Anderson M, Sellars MJ, Tume RK, 
Preston NP, et al. (2012) Mechanisms of colour 
adaptation in the prawn Penaeus monodon. The 
Journal of Experimental Biology 215: 343-350. 
5. Sanchez D, Ganfornina MD, Gutierrez G, Marin A 
(2003) Exon-intron structure and evolution of the 
Lipocalin gene family. Mol Biol Evol 20: 775-783. 
6. Gutierrez G, Ganfornina MD, Sanchez D (2000) 
Evolution of the lipocalin family as inferred from a 
protein sequence phylogeny. Biochim Biophys Acta 
1482: 35-45. 
7. Ganfornina MD, Gutierrez G, Bastiani M, Sanchez D 
(2000) A phylogenetic analysis of the lipocalin 
protein family. Mol Biol Evol 17: 114-126. 
8. Kourtis N, Tavernarakis N (2011) Cellular stress 
response pathways and ageing: intricate molecular 
relationships. EMBO J 30: 2520-2531. 
9. Sanchez D, Ganfornina MD, Torres-Schumann S, 
Speese SD, Lora JM, et al. (2000) Characterization 
of two novel lipocalins expressed in the Drosophila 
embryonic nervous system. Int J Dev Biol 44: 349-
359. 
10. Bajo-Graneras R, Ganfornina MD, Martin-Tejedor 
E, Sanchez D (2011) Apolipoprotein D mediates 
autocrine protection of astrocytes and controls their 
reactivity level, contributing to the functional 
maintenance of paraquat-challenged dopaminergic 
systems. Glia 59: 1551-1566. 
11. Bajo-Graneras R, Sanchez D, Gutierrez G, Gonzalez 
C, Do Carmo S, et al. (2011) Apolipoprotein D 
alters the early transcriptional response to oxidative 
stress in the adult cerebellum. J Neurochem 117: 
949-960. 
12. Ganfornina MD, Do Carmo S, Lora JM, Torres-
Schumann S, Vogel M, et al. (2008) Apolipoprotein 
D is involved in the mechanisms regulating 
protection from oxidative stress. Aging Cell 7: 506-
515. 
13. Hull-Thompson J, Muffat J, Sanchez D, Walker 
DW, Benzer S, et al. (2009) Control of metabolic 
homeostasis by stress signaling is mediated by the 
lipocalin NLaz. PLoS Genet 5: e1000460. 
14. Navarro JA, Ohmann E, Sanchez D, Botella JA, 
Liebisch G, et al. (2010) Altered lipid metabolism in 
a Drosophila model of Friedreich's ataxia. Hum Mol 
Genet 19: 2828-2840. 
15. Ruiz M, Sanchez D, Canal I, Acebes A, Ganfornina 
MD (2011) Sex-dependent modulation of longevity 
by two Drosophila homologues of human  
 
 
 Apolipoprotein D, GLaz and NLaz. Exp Gerontol 
46: 579-589. 
16. Sanchez D, Lopez-Arias B, Torroja L, Canal I, 
Wang X, et al. (2006) Loss of glial lazarillo, a 
homolog of apolipoprotein D, reduces lifespan and 
stress resistance in Drosophila. Curr Biol 16: 680-
686. 
17. Ganfornina MD, Do Carmo S, Martinez E, Tolivia J, 
Navarro A, et al. (2010) ApoD, a glia-derived 
apolipoprotein, is required for peripheral nerve 
functional integrity and a timely response to injury. 
Glia 58: 1320-1334. 
18. Pasco MY, Leopold P (2012) High sugar-induced 
insulin resistance in Drosophila relies on the 
lipocalin Neural Lazarillo. PLoS One 7: e36583. 
19. Ruiz M, Wicker-Thomas C, Sanchez D, Ganfornina 
MD (2012) Grasshopper Lazarillo, a GPI-anchored 
Lipocalin, increases Drosophila longevity and stress 
resistance, and functionally replaces its secreted 
homolog NLaz. Insect Biochem Mol Biol 42: 776-
789. 
20. Zhang YR, Zhao YQ, Huang JF (2012) Retinoid-
binding proteins: similar protein architectures bind 
similar ligands via completely different ways. PLoS 
One 7: e36772. 
21. Gasymov OK, Abduragimov AR, Glasgow BJ 
(2010) pH-Dependent conformational changes in 
tear lipocalin by site-directed tryptophan 
fluorescence. Biochemistry 49: 582-590. 
22. Tcatchoff L, Nespoulous C, Pernollet JC, Briand L 
(2006) A single lysyl residue defines the binding 
specificity of a human odorant-binding protein for 
aldehydes. FEBS Lett 580: 2102-2108. 
23. Sanchez D, Ortega-Cubero S, Akerstrom B, Herrera 
M, Bastiani MJ, et al. (2008) Molecular interactions 
of the neuronal GPI-anchored lipocalin Lazarillo. J 
Mol Recognit 21: 313-323. 
24. Breustedt DA, SchÃ¶nfeld DL, Skerra A (2006) 
Comparative ligand-binding analysis of ten human 
lipocalins. Biochimica et Biophysica Acta (BBA) - 
Proteins and Proteomics 1764: 161-173. 
25. Vogt M, Skerra A (2001) Bacterially produced 
apolipoprotein D binds progesterone and arachidonic 
acid, but not bilirubin or E-3M2H. Journal of 
Molecular Recognition 14: 79-86. 
26. Eichinger A, Nasreen A, Kim HJ, Skerra A (2007) 
Structural Insight into the Dual Ligand Specificity 
and Mode of High Density Lipoprotein Association 
of Apolipoprotein D. Journal of Biological 
Chemistry 282: 31068-31075. 
27. Morais Cabral JH, Atkins GL, Sanchez LM, Lopez-
Boado YS, Lopez-Otin C, et al. (1995) Arachidonic 
acid binds to apolipoprotein D: implications for the 
protein's function. FEBS Lett 366: 53-56. 
28. Elenewski JE, Hackett JC (2010) Free energy 
landscape of the retinol/serum retinol binding 
protein complex: a biological host-guest system. J 
Phys Chem B 114: 11315-11322. 
Results (Chapter 3) 
 
125 
 
29. Kalikka J, Akola J (2011) Steered molecular 
dynamics simulations of ligand-receptor interaction 
in lipocalins. Eur Biophys J 40: 181-194. 
30. Chiswell B, Lovelace LL, Brannen C, Ortlund EA, 
Lebioda L, et al. (2007) Structural features of the 
ligand binding site on human complement protein 
C8gamma: a member of the lipocalin family. 
Biochim Biophys Acta 1774: 637-644. 
31. Gasymov OK, Abduragimov AR, Glasgow BJ 
(2009) Intracavitary ligand distribution in tear 
lipocalin by site-directed tryptophan fluorescence. 
Biochemistry 48: 7219-7228. 
32. Lovelace LL, Chiswell B, Slade DJ, Sodetz JM, 
Lebioda L (2008) Crystal structure of complement 
protein C8gamma in complex with a peptide 
containing the C8gamma binding site on C8alpha: 
implications for C8gamma ligand binding. Mol 
Immunol 45: 750-756. 
33. Zhou Y, Shaw N, Li Y, Zhao Y, Zhang R, et al. 
(2010) Structure-function analysis of human l-
prostaglandin D synthase bound with fatty acid 
molecules. FASEB J 24: 4668-4677. 
34. Abergel RJ, Clifton MC, Pizarro JC, Warner JA, 
Shuh DK, et al. (2008) The siderocalin/enterobactin 
interaction: a link between mammalian immunity 
and bacterial iron transport. J Am Chem Soc 130: 
11524-11534. 
35. Correnti C, Clifton MC, Abergel RJ, Allred B, 
Hoette TM, et al. (2011) Galline Ex-FABP is an 
antibacterial siderocalin and a lysophosphatidic acid 
sensor functioning through dual ligand specificities. 
Structure 19: 1796-1806. 
36. Kumasaka T, Aritake K, Ago H, Irikura D, 
Tsurumura T, et al. (2009) Structural basis of the 
catalytic mechanism operating in open-closed 
conformers of lipocalin type prostaglandin D 
synthase. J Biol Chem 284: 22344-22352. 
37. Sundaram M, Sivaprasadarao A, Aalten DM, 
Findlay JB (1998) Expression, characterization and 
engineered specificity of rat epididymal retinoic 
acid-binding protein. Biochem J 334 ( Pt 1): 155-
160. 
38. Biesalski HK, Frank J, Beck SC, Heinrich F, Illek B, 
et al. (1999) Biochemical but not clinical vitamin A 
deficiency results from mutations in the gene for 
retinol binding protein. Am J Clin Nutr 69: 931-936. 
39. Gebauer M, Skerra A (2012) Anticalins small 
engineered binding proteins based on the lipocalin 
scaffold. Methods Enzymol. 2012/01/11 ed. pp. 157-
188. 
40. Fukuhara A, Yamada M, Fujimori K, Miyamoto Y, 
Kusumoto T, et al. (2012) Lipocalin-type 
prostaglandin D synthase protects against oxidative 
stress-induced neuronal cell death. Biochem J 443: 
75-84. 
41. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede 
T (2009) The SWISS-MODEL Repository and 
associated resources. Nucleic Acids Res 37: D387-
392. 
42. Kopp J, Schwede T (2004) The SWISS-MODEL 
Repository of annotated three-dimensional protein 
structure homology models. Nucleic Acids Res 32: 
D230-234. 
43. Rong YS, Titen SW, Xie HB, Golic MM, Bastiani 
M, et al. (2002) Targeted mutagenesis by 
homologous recombination in D. melanogaster. 
Genes Dev 16: 1568-1581. 
44. Bischof J, Maeda RK, Hediger M, Karch F, Basler 
K (2007) An optimized transgenesis system for 
Drosophila using germ-line-specific phiC31 
integrases. Proc Natl Acad Sci U S A 104: 3312-
3317. 
45. Oudes AJ, Herr CM, Olsen Y, Fleming JE (1998) 
Age-dependent accumulation of advanced glycation 
end-products in adult Drosophila melanogaster. 
Mech Ageing Dev 100: 221-229. 
46. Livak KJ, Schmittgen TD (2001) Analysis of 
relative gene expression data using real-time 
quantitative PCR and the 2(-Delta Delta C(T)) 
Method. Methods 25: 402-408. 
47. Ganfornina MD, Kayser H, Sanchez D (2006) 
Lipocalins in Arthropoda: Diversification and 
functional explorations. In: Åkerström B, 
Borregaard N, Flower DR, Salier J-P, editors. 
Lipocalins. Georgetown, Texas: Landes Bioscience. 
pp. 49-74. 
48. Ganfornina MD, Sanchez D, Bastiani MJ (1995) 
Lazarillo, a new GPI-linked surface lipocalin, is 
restricted to a subset of neurons in the grasshopper 
embryo. Development 121: 123-134. 
49. Ahnstrom J, Faber K, Axler O, Dahlback B (2007) 
Hydrophobic ligand binding properties of the human 
lipocalin apolipoprotein M. J Lipid Res 48: 1754-
1762. 
50. Peng Y, Liu J, Liu Q, Yao Y, Guo C, et al. (2010) 
Conformational and biochemical characterization of 
a rat epididymis-specific lipocalin 12 expressed in 
Escherichia coli. Biochim Biophys Acta 1804: 2102-
2110. 
51. Zsila F, Bikadi Z, Simonyi M (2002) Retinoic acid 
binding properties of the lipocalin member beta-
lactoglobulin studied by circular dichroism, 
electronic absorption spectroscopy and molecular 
modeling methods. Biochem Pharmacol 64: 1651-
1660. 
52. Grillet M, Dartevelle L, Ferveur JF (2006) A 
Drosophila male pheromone affects female sexual 
receptivity. Proc Biol Sci 273: 315-323. 
53. Muffat J, Walker DW, Benzer S (2008) Human 
ApoD, an apolipoprotein up-regulated in 
neurodegenerative diseases, extends lifespan and 
increases stress resistance in Drosophila. Proc Natl 
Acad Sci U S A 105: 7088-7093. 
54. Ponton F, Chapuis MP, Pernice M, Sword GA, 
Simpson SJ (2011) Evaluation of potential reference 
genes for reverse transcription-qPCR studies of 
physiological responses in Drosophila melanogaster. 
J Insect Physiol 57: 840-850. 
Results (Chapter 3) 
 
126 
 
55. Bauer J, Antosh M, Chang C, Schorl C, Kolli S, et 
al. (2010) Comparative transcriptional profiling 
identifies takeout as a gene that regulates life span. 
Aging (Albany NY) 2: 298-310. 
56. Curtis C, Landis GN, Folk D, Wehr NB, Hoe N, et 
al. (2007) Transcriptional profiling of MnSOD-
mediated lifespan extension in Drosophila reveals a 
species-general network of aging and metabolic 
genes. Genome Biol 8: R262. 
57. Sousa-Nunes R, Yee LL, Gould AP (2011) Fat cells 
reactivate quiescent neuroblasts via TOR and glial 
insulin relays in Drosophila. Nature 471: 508-512. 
58. Moskalev AA, Smit-McBride Z, Shaposhnikov MV, 
Plyusnina EN, Zhavoronkov A, et al. (2012) Gadd45 
proteins: relevance to aging, longevity and age-
related pathologies. Ageing Res Rev 11: 51-66. 
59. Wang MC, Bohmann D, Jasper H (2003) JNK 
signaling confers tolerance to oxidative stress and 
extends lifespan in Drosophila. Dev Cell 5: 811-816. 
60. Wu SC, Liao CW, Pan RL, Juang JL (2012) 
Infection-induced intestinal oxidative stress triggers 
organ-to-organ immunological communication in 
Drosophila. Cell Host Microbe 11: 410-417. 
61. Lee KS, Kwon OY, Lee JH, Kwon K, Min KJ, et al. 
(2008) Drosophila short neuropeptide F signalling 
regulates growth by ERK-mediated insulin 
signalling. Nat Cell Biol 10: 468-475. 
62. Lee KS, You KH, Choo JK, Han YM, Yu K (2004) 
Drosophila short neuropeptide F regulates food 
intake and body size. J Biol Chem 279: 50781-
50789. 
63. Kahsai L, Kapan N, Dircksen H, Winther AM, 
Nassel DR Metabolic stress responses in Drosophila 
are modulated by brain neurosecretory cells that 
produce multiple neuropeptides. PLoS One 5: 
e11480. 
 
  
SUPPLEM
 
Figure. S1. 
(A) Purificat
extracts obta
(B) SDS-PA
its electroph
mobility are 
(C) Fly lines 
Primers again
worms infect
ENTARY
Protein puri
ion of NLazW
ined after met
GE analysis o
oretic mobilit
detected betw
used in this s
st the rRNA
ed with Wolb
 FIGURE
fications and
T and NLazL
al affinity chr
f NLazWT pu
y, while a la
een NLazWT a
tudy are free 
-16S gene of 
achia was use
S AND TA
 fly lines cha
130R from S2 
omatography
rified from S2
rge shift is o
nd NLazL130R
of Wolbachia
Wolbachia en
d as a positiv
BLES 
 
 
 
 
racterization
cells. Size-ex
 of culture me
 cells (right 
bserved afte
 purified from
 infection. PC
dosymbiont 
e control. 
 
 
 
 tests. 
clusion chrom
dia from stab
panel). The r
r deglycosyla
 S2 cells (lef
R of genomic
were used (T
atography e
ly transfected
edox-state of 
tion. No diff
t panel). 
 DNA extrac
able S1). DNA
Results
lution profile
 S2 cells.  
the protein a
erences in el
ts from all lin
 from Dirof
 (Chapter 3)
127
 
s of enriched
ffects slightly
ectrophoretic
es employed.
ilaria immitis
 
 
 
 
 
 
 
Results (Ch
 
128 
 
 
 
Figure S2: 
apter 3) 
Legend at page 130 
 
 
  
 
Figure S3: Legend at page 130 
Results
 
 (Chapter 3)
129
 
 
 
Results (Chapter 3) 
 
130 
 
Figure S2. Mutation Y47A in NLaz binding pocket alters fly survival but does not influence TAG basal levels. 
(A) Model of NLazY47A protein structure compared to NLazWT. Backbone and surface models are superimposed. A view 
facing the entrance of the binding pocket is shown. W128 (green). Y47 or A47 (orange). (B-C) Ubiquitous over-
expression of either NLazWT  or NLazY47A in wild-type background increases resistance to paraquat, particularly in aged 
flies (C, 30 day old). (D) Three day-old NLazNW5 flies are more sensitive to PQ exposure than control flies 
(heterozygous for NLaz native locus). NLazWT ubiquitous over-expression rescues this phenotype completely while 
NLazY47A is only able to exert a partial rescue. (E) Longevity analysis of NLaz null-mutant flies in the presence or 
absence of NLazY47A and NLazWT transgenes. NLazY47A is able to rescue median survival but not maximal survival. 
NLazWT rescues maximal but not median survival. (F) NLazY47A partially rescues the starvation-desiccation stress 
sensitivity of NLazNW5 flies. (G) The Y47A mutation of NLaz does not show any effect in triglycerides levels. Log-rank 
tests followed by Holm-Sidak multiple comparison post-hoc tests were used in B-F. One-way ANOVA followed by 
Holm-Sidak multiple comparison post-hoc test was used in G. 
 
Figure S3. NLazN165S variant expression alters stress resistance, but does not affect triglyceride basal levels.  
(A) Model of NLazN165S protein structure compared to NLazWT. Backbone and surface models are superimposed. A 
lateral view is shown. The binding pocket is pointed by an arrow and is outlined by a dashed line. N165 or S165 
residues are labeled in green. (B-C) Over-expression of NLazN165S in a wild-type genetic background is able to increase 
fly resistance against PQ when compared to control flies both at 3 days of age (B) and at 30 days of age (C). Log-rank 
tests followed by Holm-Sidak multiple comparison post-hoc tests. (D) Resistance to paraquat of young flies expressing 
NLazN165S in NLazNW5 null background is higher than that of heterozygous controls or flies rescued by NLazWT. (E) Null 
NLaz fly mutants show a reduced longevity compared with wild-type flies. The reduction in maximal lifespan is 
rescued by the ubiquitous over-expression of NLazWT and NLazN165S. (F) NLazN165S expression is only able to exert a 
partial rescue in starvation-desiccation test. (G) The N165S polymorphism of NLaz does not show any effect in 
triglyceride concentration in basal conditions. Log-rank tests followed by Holm-Sidak multiple comparison post-hoc 
tests were used in B-F. One-way ANOVA followed by Holm-Sidak multiple comparison post-hoc test was used in G. 
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Figure S4. A deletion of the C-terminal portion (177-192) of NLaz affects stress resistance, but it does not 
modify triglycerides storage. 
(A-B) Ubiquitous over-expression of both NLazWT and NLazΔ177-192 in wild-type background increases resistance to PQ 
in young flies (A). NLazΔ177-192 is more effective than NLazWT in reducing sensitivity to PQ in 30 day-old flies (B).     
(C) NLazΔ177-192 expression is only able to partially rescue against PQ exposure when expressed in NLazNW5 null mutant 
background. (D) The effect of NLaz null mutation in both median and maximal survival are rescued by NLazΔ177-192. 
(E) No rescue is achieved by ubiquitous NLazΔ177-192 expression in a starvation-desiccation test. (F) Deletion of NLaz C-
terminal portion does not have any effect in triglyceride basal amounts. Log-rank tests followed by Holm-Sidak 
multiple comparison post-hoc tests were used in A-E. One-way ANOVA followed by Holm-Sidak multiple comparison 
post-hoc test was used in F. 
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Table.S1. Primer sequences employed in this work. 
 
 
 
 
 
 
Application Primer Sequence 
Mutagenesis L130R 
5'-gccaatttcaaaattgtttggatccgcactcgtcagcgtgaaccttcagc-3' 
5'-gctgaaggttcacgctgacgagtgcggatccaaacaattttgaaattggc-3' 
Mutagenesis Y47A 
5'-gaagtgcatctacgccaacgccagtctcatagacaacagc-3' 
5'-gctgttgtctatgagactggcgttggcgtagatgcacttc-3' 
From pBS-II to pRmHa-3 
5’-caagaattctcagtggatagcgac-3’ 
5’-caagcggccgcggagccgcgcggcaccagtgccttttcaatggcatttgc-3’ 
NLaz-Δ177-199 
from pBSII-KS to pUASt-attB 
5’-cgaattctcagtggatagcgac-3’ 
5’-cgaattctcaaccatccaaccg-3’ 
Sequence pBSII-KS Universal Primer Set (CIC) 
Sequence pUASt-attB 
5’-gcagtaaagtgcaagttaaagtga-3’ 
5’tgtccaattatgtcacaccac-3’ 
Sequence pRmHa-3 5’ccagagcatctggccaatgtgc-3’ 
Wolbachia rRNA-16S 
5′-gaagataatgacggtactcac-3′ 
5′-gtcagatttgaaccagataga-3′ 
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Background ♂ da > UAS transgene N Experiment 
ANOVA 
Sig 
Median Survival  Maximal Survival 
Sig %Change Sig %Change 
WT (w1118) 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazY47A 
 
NLazΔ177-192 
 
67-72 
 
67-68 
 
67-70 
 
67-65 
 
67-71 
Paraquat  
(3 d) * 
* 
 
n/s 
 
n/s 
 
n/s 
 
n/s 
 
38.74 
 
23.14 
 
-13.92 
 
21.49 
 
21.49 
 
n/s 
 
n/s 
 
* 
 
n/s 
 
n/s 
-6.50 
 
-6.50 
 
-6.50 
 
0.00 
 
-6.50 
WT (w1118) 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazY47A 
 
NLazΔ177-192 
 
67-81 
 
67-71 
 
67-74 
 
67-94 
 
67-89 
Paraquat  
(30 d) ** 
** 
 
** 
 
* 
 
** 
 
** 
52.64 
 
13.56 
 
-13.46 
 
52.64 
 
86.94 
** 
 
** 
 
* 
 
** 
 
** 
65.00 
 
40.16 
 
-8.90 
 
24.89 
 
50.55 
NLazNW5 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazY47A 
 
NLazΔ177-192 
 
 
 
147-126 
 
147-76 
 
 
 
Longevity ** 
* 
 
* 
 
** 
 
n/s 
 
** 
3.50 
 
1.75 
 
-15.79 
 
8.77 
 
10.53 
** 
 
** 
 
** 
 
n/s 
 
** 
17.65 
 
17.65 
 
-19.72 
 
2.42 
 
17.65 
NLazNW5 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazY47A 
 
NLazΔ177-192 
 
153-106 
 
153-128 
 
153-93 
 
153-103 
 
153-120 
Paraquat 
(3 d) ** 
** 
 
** 
 
** 
 
** 
 
** 
181.51 
 
90.4 
 
36.09 
 
47.20 
 
47.20 
** 
 
** 
 
** 
 
n/s 
 
** 
46.04 
 
46.04 
 
23.68 
 
0.00 
 
46.04 
NLazNW5 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazY47A 
 
NLazΔ177-192 
 
119-122 
 
119-150 
 
119-76 
 
119-103 
 
119-122 
Desiccation ** 
** 
 
** 
 
* 
 
** 
 
n/s 
0.00 
 
22.26 
 
22.26 
 
0.00 
 
-6.97 
* 
 
** 
 
n/s 
 
* 
 
n/s 
10.39 
 
21.74 
 
0.00 
 
21.74 
 
0.00 
 
 
Table S2. Survival parameters. Comparison between NLazWT and NLaz mutant transgenic flies. 
Summary of the survival parameters obtained with different experimental paradigms in flies. Wild-type flies (expressing 
the driver alone, w1118 ; da:Gal4/+) were used as control in over-expression experiments, whereas NLaz-KO flies (w1118 ; 
NLaz NW5/NLaz NW5 ; da:Gal4/+) are the control in rescue experiments. All UAS:NLaz transgenes are located in the same 
locus of the genome (86Fb in chromosome 3).** = p<0.001, * = p<0.05. 
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Table S3. List of genes explored for NLaz-dependent transcriptional regulation.  
Gene Symbol Refseq # Official Name / Mamalian orthologue RT2 Cat.No. Functional category 
Act5C NM_001014725 Actin 5C PPD00467 Housekeeping 
Akt1 NM_169705 serine/threonine-protein kinase PPD09200 Metabolism control  (IIS pathway) 
bsk NM_164900 Basket / JNK PPD11004 Stress response pathway (JNK pathway) 
Cat NM_080483 Catalase PPD07567 Oxidative stress response (Foxo target) 
CG12374 NM_136975 Carboxypeptidase-like (Zn) CG12374 PPD04510 Age/Oxiative stress specific response (vs. starvation/infection) 
CG8147 NM_001038951 Alkaline phosphatase-like CG8147 PPD08516 Age/Oxiative stress specific response (vs. starvation/infection) 
Ddc NM_078876 Dopa decarboxylase PPD03531 Neurotransmitter/Hormonal systems 
desat1 NM_144474 Desaturase 1 PPD11642 Lipid / Hormonal systems 
Dpt NM_057460 Diptericin PPD05159 Immune response 
Drs NM_079177 Drosomycin PPD06186 Immune response 
foxo NM_142073 Forkhead box, sub-group O PPD08986 Metabolism control (IIS and Sir2 pathways) 
Gadd45 NM_136420 Growth arrest and DNA damage-inducible PPD03876 Oxidative stress response-DNA repair (Foxo target) 
Gapdh1 NM_001038847 Glyceraldehyde 3 phosphate dehydrogenase 1 PPD03944 Housekeeping 
GLaz NM_079003 Glial Lazarillo PPD04541 Lipocalin family / Oxidative stress response 
Gr66a NM_079247 Gustatory receptor 66a PPD06616 Chemoreception in pheromone sensing neurons 
GstE1 NM_137479 Glutathione S transferase E1 PPD05094 Oxidative stress response 
GstS1 NM_079043 Glutathione S transferase S1 PPD66725 Oxidative stress response 
Hr96 NM_079769 Hormone receptor-like in 96 PPD10079 Lipid homeostasis 
Hsp68 NM_001031945 Heat shock gene 68 PPD13069 Oxidative stress response (JNK pathway) 
Ilp4 NM_140104 Insulin-like peptide 4 PPD06800 Metabolism control / Neurogenesis control (IIS pathway) 
InR NM_079712 Insulin-like receptor PPD09691 Metabolism control (IIS pathway) 
Jafrac1 NM_058162 Thioredoxin peroxidase 1 PPD11559 Oxidative stress response (Foxo target) 
Karl NM_132520 Karl PPD00966 Lipocalin family / Immune response 
Lip4 NM_135574 Lipase 4 PPD02897 Metabolism control  (Foxo target) 
Lsd-1 NM_142926 Lipid storage droplet-1 PPD09917 Lipid metabolism 
Lsp2 NM_080077 Larval serum protein 2 PPD11062 Lifespan-Aging modulation 
Mgstl NM_079957 Microsomal glutathione S-transferase-like PPD10883 Oxidative stress response 
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Gene Symbol Refseq # Official Name / Mamalian orthologue RT2 Cat.No. Functional category 
mio NM_134812 Missing oocyte PPD02026 Lipid metabolism 
Nplp3 NM_144453 Neuropeptide-like precursor 3 PPD11605 Neural activity/ Lifespan-Aging modulation 
Prx2540-2 NM_078959 Peroxiredoxin 2540-2 PPD04249 Oxidative stress response 
puc NM_079549 Puckered (JNK-specific phosphatase) PPD08362 Stress response pathway  (JNK pathway) 
RpL18 NM_139834 Ribosomal protein L18 PPD06501 Housekeeping 
RpL32 NM_079843 Ribosomal protein L32 PPD10569 Housekeeping 
S6k NM_079217 RPS6-p70-protein kinase PPD06382 Metabolism control pathway 
Sir2 NM_058003 NAD-dependent histone deacetylase Sir2 PPD03110 Lifespan-Aging modulation /  Metabolism control 
sNPF NM_078881 Short neuropeptide F precursor PPD03613 
Neuropeptide hormones / Food intake regulation / Stress 
response 
Sod2 NM_057577 Superoxide dismutase 2 (Mn-SOD) PPD04905 Oxidative stress response 
Spt-I NM_136998 Serine palmitoyltransferase subunit I PPD04542 Lipid metabolism 
synaptogyrin NM_137064 Synaptogyrin PPD04615 Neural activity/ Lifespan-Aging modulation 
Thor NM_057947 Thor / 4E-BP (eIF4E binding protein) PPD02171 Metabolism control  (IIS - TOR pathways) 
Tk NM_141884 Tachykinin PPD08785 Neuropeptide hormones / Stress response 
to NM_079773 Takeout PPD10117 Lipid metabolism / Lifespan-Aging modulation 
whd NM_078961 Withered PPD04258 Lipid metabolism 
Controls 
DGDC SA_00146 Fly Genomic DNA Contamination PPD66893 Technical control 
RTC SA_00104 Reverse Transcription Control PPX63340 Technical control 
PPC SA_00103 Positive PCR Control PPX63339 Technical control 
 
 
Table S3. List of genes explored for NLaz-dependent transcriptional regulation.  
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-/- ; da>+ -/- ; da>Nlaz-WT -/- ; da>Nlaz-L130R 
Gene Symbol Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value 
Act5C 1,001 0,96843 1,289 0,08226 1,281 0,06374 
Akt1 -1,172 0,03538 -1,298 0,00568 -1,447 0,00460 
bsk -1,011 0,92925 -1,069 0,71340 -1,032 0,69246 
Cat -1,132 0,37087 -1,057 0,56660 1,145 0,45657 
CG1237 -1,038 0,45605 -1,534 0,00009 -2,228 0,00002 
CG8147 -1,483 0,00259 -10,367 0,00000 -3,809 0,00001 
Ddc 1,008 0,93340 1,047 0,68979 1,168 0,14218 
desat1 -1,051 0,46832 -1,243 0,04395 -1,078 0,27147 
Dpt 4,410 0,00002 63,570 0,00000 13,513 0,00000 
Drs -1,113 0,65387 4,599 0,00004 1,456 0,00750 
foxo -1,345 0,00976 -1,313 0,00438 -1,450 0,00158 
Gadd45 -1,307 0,12868 -1,220 0,13537 -1,060 0,72584 
Gapdh1 -1,352 0,19108 -1,425 0,05864 -1,303 0,07286 
GLaz 1,009 0,87518 -1,082 0,10049 -1,263 0,00782 
Gr66a -1,340 0,33279 -1,177 0,49413 1,247 0,47097 
GstE1 -1,191 0,68953 1,382 0,20157 1,241 0,29282 
GstS1 -1,301 0,00370 -1,962 0,00010 -1,838 0,00038 
Hr96 -1,076 0,48599 -1,295 0,02979 -1,015 0,83008 
Hsp68 -1,268 0,00516 -1,203 0,02425 -1,371 0,00223 
InR -1,586 0,00060 -1,929 0,00016 -1,383 0,01687 
Jafrac 1,101 0,19687 1,079 0,14682 1,022 0,76704 
Karl -2,434 0,00022 2,674 0,00000 1,026 0,77165 
Lip4 1,311 0,02100 -1,253 0,02485 -1,203 0,06966 
llp4 -4,167 0,02306 -4,076 0,03266 -3,060 0,04019 
Lsd-1 -1,271 0,00975 -1,992 0,00001 -1,618 0,00012 
Lsp2 1,088 0,56817 2,084 0,00010 -1,009 0,88738 
Mgstl -1,023 0,89408 1,203 0,17277 1,254 0,09054 
mio -1,895 0,03709 -2,085 0,06450 -2,276 0,04994 
Nplp3 -1,825 0,00030 -2,665 0,00002 -2,892 0,00003 
Pepck -1,624 0,00040 1,115 0,08810 1,276 0,00589 
Prx254 1,049 0,54468 -1,223 0,03380 1,150 0,09191 
puc -1,142 0,03390 -1,366 0,02986 -1,132 0,37226 
RpL18 1,160 0,55173 1,392 0,14750 1,757 0,00801 
RpL32 1,000 0,00000 1,000 0,00000 1,000 0,00000 
S6k -1,372 0,04942 -1,623 0,00530 -1,499 0,02345 
Sir2 1,050 0,60638 -1,093 0,17760 -1,019 0,72289 
sNPF -1,154 0,37812 -1,115 0,33652 -1,154 0,22055 
Sod2 -1,129 0,37138 -1,099 0,33513 -1,122 0,35336 
Spt-l 1,262 0,02655 1,009 0,90201 -1,075 0,41873 
synapt -1,226 0,00053 -1,169 0,00209 -1,163 0,20411 
Thor -1,277 0,00136 -1,354 0,00163 1,154 0,02945 
Tk -1,003 0,87159 -1,880 0,01431 -1,525 0,07503 
to -1,221 0,04269 -1,030 0,54535 -1,349 0,00015 
whd -1,473 0,00002 -1,579 0,00004 -1,353 0,03662 
 
Table S4. Gene expression comparisons in basal conditions.  
Expression in flies of each genotype was compared with the w1118 ; NLaz NW5/+ ; da:Gal4/+ control genotype at 3 days 
of age. p values are calculated based on a Student’s t-test of the replicate 2-∆Ct values for each gene in the control group 
and treatment groups. p values less than 0.05 are indicated in red. Up-regulations are shown in red and down-
regulations in blue. 
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+/- ; da>+ 
(PQ vs. Control) 
-/- ; da>+ 
(PQ vs. Control) 
-/- ; da>Nlaz-WT 
(PQ vs. Control) 
-/- ; da>Nlaz-L130R 
(PQ vs. Control) 
Gene Symbol Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value
Act5C 1,080 0,64586 1,084 0,67628 -1,137 0,14188 1,567 0,00000
Akt1 1,017 0,82186 1,450 0,00007 1,380 0,00123 1,571 0,00027
bsk -1,349 0,22559 1,046 0,86969 1,143 0,44734 1,279 0,03281
Cat -1,039 0,76239 1,556 0,00022 1,183 0,00295 1,524 0,01534
CG1237 -9,970 0,00000 -13,674 0,00000 -7,387 0,00000 -5,051 0,00000
CG8147 -27,606 0,00000 -44,839 0,00000 -5,805 0,00000 -13,511 0,00000
Ddc -1,516 0,01410 -1,337 0,02769 -1,354 0,00493 1,056 0,32784
desat1 -2,420 0,00010 -2,027 0,00001 -1,600 0,00248 -1,396 0,00021
Dpt 2,255 0,00004 1,991 0,00004 -20,740 0,00000 -2,257 0,00008
Drs 1,812 0,02333 2,340 0,00036 -2,473 0,00026 1,512 0,00036
foxo -1,774 0,00019 -1,251 0,01420 -1,442 0,00010 -1,072 0,16082
Gadd45 3,419 0,00037 7,415 0,00000 2,620 0,00000 4,614 0,00001
Gapdh1 -3,602 0,00342 -1,567 0,07232 -2,174 0,00263 -1,045 0,44976
GLaz -2,141 0,00002 -2,221 0,00000 -1,667 0,00000 -1,181 0,04135
Gr66a -1,025 0,88273 2,954 0,00068 1,821 0,00593 1,535 0,01218
GstE1 10,947 0,00440 16,078 0,00007 6,604 0,00080 16,503 0,00000
GstS1 -1,759 0,00054 -1,230 0,00161 1,028 0,74450 1,217 0,10148
Hr96 -1,127 0,16779 -3,406 0,37900 1,063 0,54653 1,172 0,01844
Hsp68 1,399 0,00282 5,755 0,00000 2,288 0,00001 1,732 0,00000
InR 1,897 0,00025 4,467 0,00000 3,141 0,00091 2,096 0,00084
Jafrac 1,425 0,00138 1,278 0,00169 1,183 0,00266 2,353 0,00001
Karl -1,894 0,00325 1,347 0,02570 -1,951 0,00005 1,719 0,00298
Lip4 2,035 0,00002 1,002 0,96271 2,575 0,00000 3,274 0,00000
llp4 -3,488 0,03697 2,117 0,18010 -1,140 0,58492 1,010 0,93531
Lsd-1 -1,962 0,00002 -2,408 0,00005 -1,036 0,27274 1,496 0,00007
Lsp2 -2,490 0,00216 1,346 0,00192 -3,066 0,00000 1,225 0,06080
Mgstl -1,434 0,05709 -1,209 0,15701 -1,551 0,00013 1,107 0,01213
mio 1,025 0,96199 2,531 0,00023 -1,079 0,79606 2,002 0,16243
Nplp3 -3,814 0,00001 -4,428 0,00002 -6,671 0,00000 -1,409 0,02443
Pepck 2,379 0,00021 4,731 0,00000 3,471 0,00002 2,212 0,00000
Prx254 2,950 0,00000 2,509 0,00001 1,732 0,00012 1,245 0,00331
puc 1,371 0,00356 2,508 0,00001 1,271 0,23545 1,576 0,09594
RpL18 1,146 0,58380 1,026 0,91643 1,106 0,51049 1,432 0,00059
RpL32 1,000 0,00000 1,000 0,00000 1,000 0,00000 1,000 0,00000
S6k -1,581 0,01124 -1,090 0,48048 -1,149 0,32823 1,051 0,74253
Sir2 -1,113 0,27683 1,311 0,01832 1,203 0,01185 1,151 0,00934
sNPF -1,148 0,22731 1,291 0,09971 1,122 0,18456 1,235 0,00856
Sod2 -1,663 0,00942 -1,314 0,02937 -1,523 0,00000 1,064 0,46572
Spt-l -1,404 0,00161 -1,628 0,00102 -1,245 0,00952 -1,080 0,36353
synapt -1,571 0,00005 -1,012 0,81790 -1,014 0,86483 1,034 0,85412
Thor 2,277 0,00007 4,880 0,00000 2,923 0,00001 2,299 0,00000
Tk -1,561 0,04728 -1,402 0,00588 1,484 0,01579 1,383 0,06986
to -1,183 0,08093 1,092 0,36494 1,318 0,00477 1,476 0,00005
whd -1,184 0,00271 1,270 0,00164 1,200 0,00603 1,115 0,53095
 
 
Table S5. Gene expression comparisons of flies treated with PQ with respect to control flies of each genotype.  
Flies were treated with PQ for 17 h at 3 days of age. p values are calculated based on a Student’s t-test of the replicate 2-
∆Ct values for each gene in the control group and treatment groups. p values less than 0.05 are indicated in red. Up-
regulations are shown in red and down-regulations in blu. 
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+/- ; da>+  
(30 d vs. 3 d) 
-/- ; da>+  
(30 d vs. 3 d) 
-/- ; da>Nlaz-WT  
(30 d vs. 3 d) 
-/- ; da>Nlaz-L130R  
(30 d vs. 3 d) 
Gene Symbol Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value
Act5C -1,542 0,06321 1,197 0,29363 -1,401 0,02413 2,156 0,00001 
Akt1 -1,672 0,00040 1,625 0,00192 -1,183 0,02144 1,806 0,00007 
bsk -1,837 0,02556 1,376 0,07002 -1,777 0,06654 1,875 0,00001 
Cat -1,140 0,59566 2,002 0,00058 1,043 0,64200 1,371 0,04269 
CG1237 -4,017 0,00000 -13,712 0,00000 -3,657 0,00000 -7,343 0,00000 
CG8147 -8,803 0,00000 -22,907 0,00000 2,798 0,00001 -1,316 0,00001 
Ddc -1,995 0,00307 1,068 0,58010 -1,713 0,00064 1,256 0,02046 
desat1 -1,288 0,02715 -1,771 0,00094 1,444 0,00859 -1,115 0,05137 
Dpt 1,171 0,23333 -1,130 0,22003 -3,122 0,00000 42,877 0,00000 
Drs -1,228 0,38725 2,511 0,00032 -4,091 0,00006 14,817 0,00000 
foxo -1,542 0,00102 -1,159 0,33855 -1,211 0,02149 1,387 0,00010 
Gadd45 -2,492 0,00519 13,009 0,00000 -1,167 0,08599 2,936 0,00001 
Gapdh1 -9,964 0,00018 1,433 0,08215 -5,559 0,00020 -3,726 0,00000 
GLaz -1,743 0,00095 -1,909 0,00002 -1,544 0,00000 1,054 0,37975 
Gr66a -1,385 0,36476 5,332 0,00015 1,324 0,20643 2,294 0,00013 
GstE1 -1,217 0,80575 26,472 0,00006 1,313 0,14101 4,203 0,00000 
GstS1 -4,133 0,00002 -1,053 0,49674 -2,662 0,00364 -1,360 0,01648 
Hr96 -1,678 0,00351 1,214 0,15648 -1,093 0,21807 1,335 0,00199 
Hsp68 -2,046 0,00005 6,524 0,00002 -1,970 0,00004 2,660 0,00000 
InR -2,084 0,00230 4,690 0,00011 1,042 0,59538 2,500 0,00004 
Jafrac -1,330 0,01034 1,632 0,00333 -1,189 0,00028 1,491 0,00054 
Karl -4,532 0,00007 1,622 0,01491 -1,255 0,00156 1,960 0,00002 
Lip4 -1,181 0,12714 1,067 0,51384 1,045 0,10813 1,686 0,00004 
llp4 -4,712 0,02160 3,039 0,02089 -3,311 0,29345 1,306 0,46516 
Lsd-1 -1,848 0,00003 -1,924 0,00016 1,934 0,00087 1,004 0,94163 
Lsp2 1,167 0,32893 1,717 0,00036 3,499 0,00000 2,975 0,00001 
Mgstl -1,816 0,01465 -1,060 0,55326 -1,362 0,01045 -1,145 0,01262 
mio -2,228 0,02669 2,815 0,00309 -2,186 0,52800 2,559 0,00214 
Nplp3 -28,416 0,00000 -1,792 0,00253 -10,340 0,00000 -3,613 0,00027 
Pepck 1,936 0,00003 5,351 0,00002 2,970 0,00011 1,335 0,00043 
Prx254 -2,002 0,00019 3,876 0,00011 -1,912 0,00001 -1,184 0,00754 
puc -1,840 0,00880 3,589 0,00002 -1,854 0,65336 3,579 0,00000 
RpL18 1,142 0,55893 1,465 0,12492 1,546 0,01499 1,307 0,01551 
RpL32 1,000 0,00000 1,000 0,00000 1,000 0,00000 1,000 0,00000 
S6k -1,825 0,00455 1,061 0,68089 -1,090 0,17141 1,473 0,00468 
Sir2 -1,373 0,00288 1,927 0,00048 -1,024 0,70739 1,790 0,00002 
sNPF -1,473 0,08927 1,492 0,01589 -1,206 0,10719 2,058 0,00002 
Sod2 -3,013 0,00072 1,194 0,13122 -1,899 0,00000 -1,563 0,00231 
Spt-l -1,284 0,03626 -1,303 0,05097 -1,448 0,00049 1,355 0,00208 
synapt -3,063 0,00000 1,473 0,00262 -2,000 0,00001 1,018 0,96504 
Thor -2,229 0,00001 6,340 0,00002 1,088 0,14582 1,326 0,00044 
Tk -2,567 0,00561 -1,181 0,06543 -1,490 0,04258 1,233 0,24832 
to -1,403 0,00485 1,492 0,00536 1,641 0,00029 2,100 0,00000 
whd -1,503 0,00081 1,548 0,00278 1,068 0,57877 1,382 0,02675 
 
Table S6. Gene expression of 30 day-old flies with respect to 3 day-old flies of each genotype.  
p values are calculated based on a Student’s t-test of the replicate 2-∆Ct values for each gene in the control group and 
treatment groups. p values less than 0.05 are indicated in red. Up-regulations are shown in red and down-regulations in 
blue. 
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Chapter 4 
 
Grasshopper Lazarillo, a GPI-anchored Lipocalin, 
increases Drosophila longevity and stress resistance, 
and functionally replaces its secreted homologue NLaz. 
 
Summary 
 
Lazarillo (Laz) is a glycosyl-phosphatidylinositol (GPI)-linked glycoprotein first 
characterized in the developing nervous system of the grasshopper Schistocerca 
americana. It belongs to the Lipocalins, a functionally diverse family of mostly secreted 
proteins. In this work we test whether the protective capacity known for Laz 
homologues in flies and vertebrates (NLaz, GLaz and ApoD) is evolutionarily 
conserved in grasshopper Laz, and can be exerted from the plasma membrane in a cell-
autonomous manner. First we demonstrate that extracellular forms of Laz have 
autocrine and paracrine protecting effects for oxidative stress-challenged Drosophila S2 
cells. Then we assay the effects of overexpressing GPI-linked Laz in adult Drosophila 
and whether it rescues both known and novel phenotypes of NLaz null mutants. Local 
effects of GPI-linked Laz inside and outside the nervous system promote survival upon 
different stress forms, and extend lifespan and healthspan of the flies in a cell-type 
dependent manner. Outside the nervous system, expression in fat body cells but not in 
hemocytes results in protection. Within the nervous system, glial cell expression is more 
effective than neuronal expression. Laz actions are sexually dimorphic in some 
expression domains. Fat storage promotion and not modifications in hydrocarbon 
profiles or quantities explain the starvation-desiccation resistance caused by Laz 
overexpression. This effect is exerted when Laz is expressed ubiquitously or in 
dopaminergic cells, but not in hemocytes. Grasshopper Laz functionally restores the 
loss of NLaz, rescuing stress-sensitivity as well as premature accumulation of aging-
related damage, monitored by advanced glycation end products (AGEs). However Laz 
does not rescue NLaz courtship behavioral defects. Finally, the presence of two new 
Lipocalins with predicted GPI-anchors in mosquitoes shows that the functional 
advantages of GPI-linkage have been commonly exploited by Lipocalins in the 
arthropodan lineage. 
 
142 
 
 
Results (Chapter 4) 
 
143 
 
1. Introduction 
 
azarillo (Laz) is a glycoprotein linked to the 
plasma membrane by a glycosyl-
phosphatidylinositol (GPI) tail, and first 
characterized in the developing nervous system of 
the grasshopper Schistocerca americana [1-3]. Laz 
is expressed in a specific subset of neuroblasts, 
neurons and ganglion mother cells of the central 
nervous system (CNS). In the peripheral nervous 
system (PNS) Laz is detected in all sensory 
neurons and in a group of enteric nervous system 
neurons [2,4]. Its expression is neither limited to 
the embryonic stage, since it continues throughout 
adulthood, nor to the nervous system. Outside the 
nervous system Laz is associated mainly with the 
excretory system: malpighian tubules and 
subesophageal body. During nervous system 
development, Laz is involved in the growth and 
guidance of developing pioneer axons. 
Grasshopper embryos treated with a monoclonal 
antibody against Laz show axonal aberrant growth 
and misdirection [2]. Lazarillo has been used as a 
marker of subsets of pioneer neurons also in other 
orthopterans, as in the economically important 
desert locust Schistocerca gregaria [5-8]. However 
a test for grasshopper Laz functions during 
adulthood has not been performed yet. 
Lazarillo belongs to the Lipocalin protein 
family, an ancient and functionally diverse family 
of secreted proteins that share a similar structural 
fold, often in the presence of low sequence 
similarity [9]. Their structure is defined by an 
eight-stranded antiparallel β-barrel that forms a 
binding pocket, usually hydrophobic [10-12]. 
Molecular phylogenetic studies have shown that 
arthropodan Lipocalins have diversified in five 
main groups [13]: a Laz-related clade of insect 
Lipocalins, a clade of Lipocalins found in 
Crustacea, a clade of biliproteins and related insect 
Lipocalins, and two large family expansions 
occurring in blood-feeding insects and arachnids. 
Grasshopper Laz has a basal position in the 
arthropodan Lipocalins phylogenetic tree, and the 
Laz-related clade is the closest relative to the 
chordate Lipocalin Apolipoprotein D (ApoD) 
[9,14].  
 
 
Lipocalins play a great number of different 
roles: bacteriostatic effect, retinoids transport, 
prostaglandins synthesis, control of reproductive 
behavior, and arthropod coloration among others 
[reviewed by 15]. The function of a given 
Lipocalin must be intimately related both with its 
hydrophobic ligands and with its site of expression. 
The nature of Laz physiological ligand(s) is still 
unknown, but a set of candidates has been studied 
in vitro. Lazarillo is able to bind retinoic acid and 
fatty acids [16]. 
The domain of expression of all insect 
Lipocalins analyzed so far commonly includes, 
although is not restricted to, ectodermal 
derivatives, with nervous system and epidermal 
tissues been recurrent sites of expression [reviewed 
by 13]. Lepidopteran Lipocalins like Bilin binding 
protein from Pieris brasssicae and Samia cynthia 
or Insecticyanin from Manduca sexta are expressed 
in epidermis, and some of them have been 
demonstrated to play roles in cuticle coloration 
[17-19] and prevention of oxidative damage [20]. 
Brain Lipocalins have been identified both in 
Diptera and Lepidoptera. The lepidopteran protein 
Hyphantrin from Hyphantria cunea is up-regulated 
in the brain in response to injury [21]. Also, 
Bombyrin and Gallerin were isolated from pupal 
brain extracts of Bombyx mori and Galleria 
mellonella [22,23], but their function remains 
unknown.  
In Drosophila melanogaster, two Lipocalins 
expressed in the nervous system are the Lazarillo 
homologs Neural-Lazarillo (NLaz) and Glial-
Lazarillo (GLaz) [9,14,24]. NLaz and GLaz have a 
key role in the regulation of longevity and defense 
against oxidative stress [25-27], and over-
expressing NLaz or GLaz increases lifespan and 
survival against different forms of oxidative stress 
[26,28].  
The function of ApoD, the closest chordate Laz 
homolog, has also been studied extensively in 
diverse model organisms as well as in humans. Its 
expression in the brain is the most consistently up-
regulated upon aging in different mammalian 
species [29,30], and it is also up-regulated in many 
human neurodegenerative diseases [reviewed by 
31]. Moreover, ApoD have demonstrated 
L 
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protective effects in the mouse brain upon 
oxidative stress [32-34]. That this protective 
function of ApoD is a conserved trait is supported 
by the results with transgenic flies expressing 
human ApoD. Like NLaz and GLaz, over-
expressing human ApoD increases fly longevity 
and resistance against different stresses [35].  
So far the Lazarillo GPI-anchor is a unique 
feature within metazoan Lipocalins, which are 
mainly secreted proteins. Lipocalins linked to 
membranes through other mechanisms have been 
reported in bacteria and plants [36,37], and indirect 
interactions of Lipocalins with membranes have 
been described for α1-acid-glicoprotein [38], β-
Lactoglobulin [39] and Tear Lipocalin [40]. These 
data point to the existence of membrane receptors 
for Lipocalins, some of which have been already 
characterized, mostly for vertebrate Lipocalins [41-
43], but also for Insecticyanin in Manduca sexta 
[44]. 
In this work we test the protective potential of 
grasshopper Lazarillo in a cell culture system using 
the MT promoter system, and in adult fruit flies 
expressing grasshopper Laz with the UAS/GAL4 
system. We test whether the GPI-linked Lazarillo, 
locally acting within and outside the nervous 
system, is able to promote survival upon different 
stress forms and extend the lifespan and healthspan 
of flies. Fat storage and hydrocarbon profiles are 
also explored as variables potentially controlled by 
the Lazarillo-related Lipocalins and contributing to 
their mechanism of regulating stress resistance and 
longevity. We also test whether the membrane-
anchored Lazarillo is able to functionally restore 
the loss of NLaz by exploring stress resistance, 
biomarkers of aging-related damage, and 
behavioral phenotypes. Our purpose is to assay 
whether the protective capacity of NLaz, GLaz and 
ApoD is evolutionarily conserved in the 
grasshopper Lazarillo protein, and if this role can 
be exerted linked to the plasma membrane by a 
GPI-tail in a cell-autonomous manner. Finally, we 
found two new Lipocalins with predicted GPI-
anchors in mosquitoes that point to the functional 
advantages of GPI-linkage as being commonly 
exploited by Lipocalins in the arthropodan lineage. 
 
 
2. Material and Methods 
 
2.1. Cell culture. 
Drosophila S2 cells were maintained as semi-
adherent cultures at 27ºC in Express-Five medium 
(Gibco) supplemented with 10% L-Glutamine, 50 
U/ml Penicillin, and 50 μg/ml Streptomycin. The 
culture medium was replaced twice a week. 
 
2.2. Cloning and Purification of the Lazarillo 
Protein. 
A fragment of the Lazarillo cDNA, translating into 
residues 1-192 of the precursor (Uniprot reference 
P49291), and thus missing the GPI signal peptide, 
was subcloned using the EcoRI and NotI sites into 
the pRmHa3 vector [16,45]. This system expresses 
the cloned sequence under the control of the 
inducible Drosophila metallothionein promoter, 
and the presence of a C-terminal His-tag sequence 
allows for protein purification from the culture 
medium. 
The Laz-pRmHa3 plasmid was co-transfected 
with the selection vector pCoBlast (conferring 
blasticidin resistance) into Drosophila S2 cells 
using FuGENE6 (Roche) at 3:1 ratio according to 
the manufacturer instructions. Transfected cells 
were selected with 25 μg/ml blasticidin-S for 3 
weeks (Invitrogen). 
The recombinant protein was expressed in 
spinner flasks with blasticidin free medium, upon 
induction with 1mM CuSO4 for 5-7 days. The 
secreted Lazarillo protein was purified from the 
cell medium by immobilized metal affinity 
chromatography using Ni-NTA resin (5-Prime). 
The Laz protein was further purified by size 
exclusion chromatography (Superdex prep grade 
75, Amersham Biosciences) in PNEA buffer (25 
mM PIPES, 150 Mm NaCl, 1mM EDTA, 0.02% 
NaN3). The purified protein was deglycosylated by 
treatment with peptide-N-glycosidase F (PNGase-
F) from Flavobacterium meningosepticum (New 
England Biolabs) after denaturation following the 
protocol supplied by the manufacturer. 
Bacterial recombinant Lazarillo was purified 
from the periplasmic space of Escherichia. coli as 
previously described [16]. 
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2.3. Fly Generation and Handling. 
Flies were grown in a temperature-controlled 
environmental incubator at 25 ºC under a 12h 
light-dark cycle. The stocks were routinely 
maintained in tubes containing our standard 
medium [yeast 84 g/l, sugar 84 g/l, NaCl 3.3 g/l, 
agar 10 g/l, wheat flour 42 g/l, apple juice 167 
ml/l, propionic acid 5 ml/l; [25]], or a 
yeast/cornmeal/agar medium [maize flour 83 g/l, 
agar 11 g/l, yeast 8.3 g/l, nipagine 5 g/l; [46]] in 
the case of hydrocarbon and triglyceride 
measurements. NLaz loss-of-function mutant 
(NLaz-KO) was generated in a w1118 background 
[47] and crossed with a w1118-CS wild type line to 
generate the NW5 line used in this study [26]. 
 
2.3.1. Generation of Lazarillo transformed 
Drosophila fly lines 
P-element mediated transformation of w1118 
flies was used to generate a pUASt-Laz fly line 
using standard procedures (BestGene Inc. USA). 
An EcoRI/XhoI fragment containing the full length 
Lazarillo cDNA [1] was subcloned into the 
pUAST vector (FlyBase annotation 
FBmc0000383) to generate the UAS-Lazarillo 
transgene, with Upstream Activating Sequences 
(UAS) upstream of Lazarillo cDNA. Two different 
independent insertion lines of pUASt-Laz were 
used in our experiments, producing identical 
results. pUASt-Laz-8F has the insertion on X-
chromosome, whereas pUASt-Laz-7F has the 
insertion on the third chromosome. 
 
2.3.2. Expression of grasshopper Lazarillo under 
the control of GAL4 drivers 
To drive the expression of the Laz transgene a 
set of GAL4 lines, expressing the yeast 
transcription factor GAL4 in different 
spatiotemporal patterns, were crossed with pUASt-
Laz. To generate driver-only controls with minimal 
background differences we crossed each GAL4 
line with wild-type flies (the strain w1118 in which 
the Laz transgenic lines were generated). For the 
hydrocarbon and triglycerides measures drivers on 
the third chromosome were used with the TM3 
balancer. The Laz expression was achieved by 
crossing GAL4/TM3 flies with UAS-Laz flies. The 
resulting progeny bears the same genotype, 
excepting the third chromosome; UAS-Laz; TM3 
was used as control and UAS-Laz; GAL4 was used 
as overexpressing Laz.  
The following GAL4 drivers were used 
according to their main domain of expression: da-
GAL4 (ubiquitous expression); GAL4109(2)80 
(expression in brain and muscle);  BL7415 Repo-
GAL4 and  M1B-GAL4 lines (for glial 
expression), BL7009 Ddc-GAL4 (expression in 
dopaminergic and serotonergic neurons in the CNS 
and epidermis), BL 8699 He-GAL4 (expression in 
hemocytes), BL5820 31-1-GAL4 (expression in 
embryonic neuroblasts and neurons in the CNS and 
PNS), BL8816 D42-GAL4 (expression in 
motoneurons) and ppl-GAL4 (expression in fat 
body). 
 
2.4. Wolbachia Test. 
The absence of infection by Wolbachia pipiens in 
fly strains was tested by PCR of genomic DNA 
extracts. The following primers against the rRNA-
16S gene of Wolbachia were used: 5′-
GAAGATAATGACGGTACTCAC-3′, 5′-
GTCAGATTTGAACCAGATAGA-3′ and . The 
PCR conditions were: 2 min 94°C; (30 s 94°C; 30 
s 60°C; 45 s 72 °C)×30; 7 min 72°C. DNA from 
Wolbachia-infected Dirofilaria immitis worm was 
used as a positive control. Primer sequences and a 
positive control DNA were kindly provided by Dr. 
F. Simon (Univ. Salamanca).  
 
2.5. Quantitative RT-PCR. 
Procedures, primers, PCR parameters, and other 
reagents were previously described [27]. Briefly, 
total RNA was extracted from 3 days old flies 
(n=25/sample) using TRIzol (Invitrogen), and 
reverse transcription was performed with 
PrimeScript™ RT reagent Kit (Takara) according 
to the manufacturer instructions. PCR reactions 
were performed in quintuplicate for each RNA 
sample using the SYBR® Premix Ex Taq™ 
(Takara).  Expression of RPL18 was use to 
normalized the experimental samples. 
Transcriptional levels were calculated following 
the ΔΔCT method [48,49]. 
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2.6. Drosophila Lifespan Analysis. 
Flies were collected within 24 h of eclosion and 
allowed to mate for 2-3 days. They were then 
separated by sex under brief CO2 anesthesia and 
housed in groups of 25. Every three days, flies 
were transferred to fresh media without anesthesia 
and scored for viability. Over 140 individuals were 
analyzed per sex, genotype and condition. The 
viability tests were carried out at 25ºC. 
 
2.7. Oxidative Stress, Toxicity and Desiccation 
Stress Assays. 
 
2.7.1. Assays in flies 
Flies were collected and separated by sex as 
described for the longevity analysis. All tests were 
carried out at 25ºC. Over 60 individuals were 
analyzed per sex, genotype and condition. The 
following treatments were used: 
2.7.1.1. Starvation-desiccation Stress Assay 
Starting at 3 days of age, flies were transferred 
to empty plastic vials. Dead flies were scored 
every 2–7 hours. 
2.7.1.2. Hyperoxia Stress Assay 
Adult flies (3 days old) were placed in plastic 
vials (20–25 flies per vial) containing our standard 
food and maintained in a plastic box enclosure at 
room temperature (25ºC) in a humidified 99.5% O2 
atmosphere. Dead flies were scored every 12 
hours. 
2.7.1.3.Iron Toxicity Assay 
Flies were kept on regular food until the 
experiment started (3 days of age), starved 3 h at 
25ºC and transferred to vials with filter papers 
soaked in 1% glucose-15 mM FeSO4 solution in 
water. Flies were moved everyday to new vials 
with fresh iron-glucose solution. Dead flies were 
scored every 2–7 hours. 
 
2.7.2. Assays in cell cultures 
2.7.2.1. Oxidative Stress Assay 
S2 cells were seeded at a density of 2x106/ml in 
24-well plates, and 20 mM hydrogen peroxide 
(H2O2) was used as oxidant. When Lazarillo was 
generated by S2 cells, its expression was induced 
with 1mM CuSO4 24 h. In other experiments, 50 
nM of pure Lazarillo protein was added to the 
culture medium 30 min before H2O2 treatment. As 
a control protein, Trypsin Inhibitor (TI) from 
soybean (Sigma) was added at the same 
concentration. Laz and TI concentrations were 
determined with the Micro-BCATM protein assay 
(Pierce). Two hours after treatment, cells were 
stained with Trypan Blue (Invitrogen) and counted 
in a hemocytometer. Cell viability was determined 
as the percentage of live cells. Each condition was 
assayed in triplicate, and three measurements were 
made in each culture well. 
 
2.8. Climbing Assay. 
The flies climbing ability was tested after 48 (for 
males), 72 and 96 hours (for females) of iron 
treatment. Flies were placed in empty vials, and 
after a resting period of 10 min the animals were 
tapped to the bottom of the tube and the number of 
individuals able to climb 5 cm in 6 sec was 
recorded. The assay was repeated three times at 1 
min intervals. 
 
2.9. Courtship behavior. 
Courtship and mating tests were performed during 
60 min using virgin male–female pairs of 4–5 day-
old flies under a Petri cover dish (40 mm diameter) 
used as an observation chamber. The courtship 
index (C.I.) represents the proportion of time a 
male spends actively courting the female for the 
first 10 min. Copulation features such as mating 
time, mating latency and mating performance (%) 
were scored for 60 min. The test was performed in 
the first 1-3 h of the fly daylight period. 
 
2.10. Immunohistochemistry. 
Flies were fixed either with 5% glacial acetic acid, 
4% formaldehyde, 85% ethanol, or 4% 
paraformaldehyde, and embedded in paraffin 
following standard procedures. Sections (5 µm) 
were performed with a rotary microtome 
(Microm), mounted in series on PolysineTM slides 
(Menzel-Gläser), and dried. Sections were 
dewaxed with xylene, and rehydrated through an 
ethanol series into phosphate buffered saline 
(PBS). Sections were then permeabilized and 
blocked with Tween20 (0.2% in PBS), 1% BSA 
and 1% normal goat serum. 
The monoclonal antibody 10E6 against 
Lazarillo was used as primary antibody. Cy3 or 
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HRP-conjugated goat anti-mouse IgG (Abcam) 
were employed as secondary antibodies. HRP 
development was performed with DAB (0.03%) 
and H2O2 (0.002% in 50 mM Tris, pH 8.0). For 
fluorescence immunohistochemistry, sections were 
mounted with Vectashield-DAPI (Vector Labs). 
HRP immunohistochemistry sections were 
visualized with an Eclipse 90i (Nikon) microscope 
equipped with a DS-Ri1 (Nikon) digital camera. 
Images were acquired and processed with the 
NISElements BR 3.0 software (Nikon). Images 
from fluorescence immunohistochemistry 
preparations were obtained in a DMI 6000B 
microscope with a TCS SP5 X confocal system 
and a WLL laser (Leica) controlled by LAS AF 
software (Leica). 
 
2.11. Immunoblots. 
Flies were homogenized in RIPA lysis buffer [1% 
NP-40, 0.1% SDS, 0.5% Na-DOC and 10% 
complete protease inhibitors (Roche) in PBS]. 
Protein extracts were separated on 12% SDS-
PAGE and electrotransferred to nitrocellulose 
membranes. Membranes were washed (50 mM 
Tris, pH 7.6, 150 mM NaCl, 0.1% NaN3) and 
blocked for 2 hours with 0.2% gelatin, 2.5% BSA 
and 2.5% dry non-fat milk in the previous buffer 
[1]. Membranes were then incubated with primary 
antibody 10E6 (1:200 in blocking solution) for 2 
hours, washed again, and incubated with HRP-
conjugated goat anti-mouse (1:10000) (Dako) for 
1h at RT. Blots were developed with ECL 
(ImmobilonTM Western, Millipore), and the signal 
visualized with a digital camera (VersaDoc, 
BioRad). 
 
2.12. AGE assay. 
Fluorescent AGEs (advanced glycation end 
products) were measured according to [50] with 
minor modifications. Flies were homogenized in 1 
ml of PBS containing 10 mM EDTA. Cuticle and 
other debris were removed by centrifugation for 5 
min at 11.000 g. Supernatants were digested by 
addition of 10 mg/ml trypsin (Sigma). Following 
incubation for 24 h at 37ºC the digested 
homogenates were centrifuged and filtered through 
a 0.22 μm sterile filter. Filtrates were diluted up to 
an absorbance range of 0.02-0.05 units at 365 nm. 
Fluorescence (excitation and emission wavelengths 
of 365 and 440 nm, respectively) was measured in 
three aliquots of each filtrate with a Shimadzu RF-
5301PC spectrofluorophotometer at 25ºC. 
 
2.13. Hydrocarbon profile and triglyceride 
content assays. 
Flies were separated by sex just after emergence 
and kept in groups of ten flies for 5 days at 25°C. 
Each single fly was extracted with 100 μl heptane 
and 500 ng n-C26 (internal standard) for 5 min. 
Samples were injected into a Perichrom Pr200 gas 
chromatograph, as previously described [46]. 
Hydrocarbon profiles and total amount of 
hydrocarbons (between 23 and 29 carbons) was 
calculated. 
The total triglyceride content of 10 flies/sample 
was analyzed using the Triglyceride Liquicolor kit 
(Stanbio Laboratory) as described [51]. Two to 
four independent measures were performed for 
each genotype (with flies coming from 
independent crosses). 
 
2.14. Statistical Analysis. 
Statistical analyses were carried out with Statistica 
(v 5.5) software. Survival curves were analyzed 
using the Log-Rank Test. In maximal survival and 
quantitative PCR experiments the nonparametric 
Mann-Whitney U test was performed. Student’s t-
Test was used for the analysis of the climbing 
assays, cell survival, triglycerides and AGEs 
assays. One-way ANOVA followed by Tukey’s 
multiple comparison post-hoc test was used for 
hydrocarbon profile comparisons. Kruskal-Wallis 
one-way ANOVA on Ranks followed by Dunn’s 
multiple comparison post-hoc test was applied to 
analyze courtship experiments. Differences were 
considered statistically significant at p<0.05 (*) 
p<0.005 (**), and p<0.0005 (***). 
 
2.15. Sequence alignment and prediction of 
GPI-anchoring signal peptides. 
Multiple sequence alignments were performed 
with CLUSTAL-X2 [52]. Potential GPI cleavage 
sites were predicted by the big-PI Predictor [53]. 
Hydrophobicity profiles were determined by Kyte 
and Doolittle’s method [54] using a window of 9 
residues.
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3. Results and Discussion 
 
3.1. Grasshopper Lazarillo promotes survival in 
S2 cells upon oxidative stress. 
To test whether the ability of NLaz, GLaz and 
ApoD to protect organisms under oxidative stress 
is an evolutionarily conserved function in 
grasshopper Laz, we used two different 
recombinant forms of Laz to assay their effects on 
S2 cell survival (Figure 1). A secreted form of Laz 
was generated in E. coli and purified from the 
bacterial periplasmic space. A glycosylated and 
soluble form of Laz (Figure S1), lacking the GPI 
tail in order to make it a secreted form, was 
expressed by Drosophila S2 cells with an inducible 
expression system. 
We first tested the effect of expressing Laz on 
the survival of S2 cells exposed to oxidative stress.  
After 24 h of induction, S2 cells expressing soluble 
grasshopper Laz are more resistant to H2O2 (58.1% 
survival, Figure 1A) than control non-transfected 
S2 cells (35.9% survival). The exogenous addition 
of purified recombinant Laz protein also promotes 
cell survival (Figure 1B). Non-transfected control 
S2 cells show 51.4% and 51.6% survival upon 
H2O2 treatment when either no addition was 
performed or an unrelated protein was added to the 
culture. Survival increases to 71% and 69.7% 
respectively when Laz, either purified from S2 
cells (glycosylated) or from bacteria (non-
glycosylated), is added to the culture medium. A 
similar protective effect has been demonstrated for 
the mammalian Lazarillo homolog, ApoD, on 
primary astrocytes [33], where it contributes to 
lower the levels of lipid peroxides and to modify 
the transcriptional response of cells to oxidative 
stress. 
 
3.2. Expression of GPI-linked grasshopper 
Lazarillo in Drosophila docks the protein to the 
cell membrane and does not alter native 
Drosophila Lipocalins expression. 
We generated a full-length cDNA construct 
downstream of UAS promoter sequences in order 
to use the GAL4/UAS system to express the GPI-
linked grasshopper Laz in Drosophila with 
different expression patterns according to the 
GAL4 driver used. Two independent single-
insertion transgenic lines carrying the pUASt-Laz 
transgene were chosen for the study (lines 7F and 
8F, mapped to the 3rd and X chromosome 
respectively). These transgenic lines as well as 
other lines used in this study were tested for the 
presence of Wolbachia, an endosymbiont of 
arthropods known to alter longevity related traits 
[55]. No infection was detected (Figure S2 A). 
 
 
Figure 1. Grasshopper Lazarillo promotes survival 
in S2 cells upon exposure to hydrogen peroxide.  
(A) S2 cells over-expressing Laz without its GPI tail, 
therefore secreted to the medium, are more resistant 
than wild-type cells to the oxidative stress generated by 
20 mM H2O2. Expression is induced upon exposure to 1 
mM CuSO4. (B) Non-transfected S2 cells also improve 
their survival under oxidative stress upon addition of 
exogenous Lazarillo (50 nM) purified from either S2 
cells culture medium or bacterial periplasm. Addition of 
Trypsin Inhibitor (TI, 50 nM) as a control unrelated 
protein does not influence cell survival. (*** Student’s 
t-Test, p<0.0005). 
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Laz expression was tested by immunoblot 
(Figure 2A). The protein shows the characteristic 
smear due to its glycosylation and an 
electrophoretic mobility (40 kDa) similar to the 
native grasshopper protein. Both transgenic lines 
have similar Laz expression levels. The bacterially 
produced non-glycosylated Laz protein is shown 
for comparison. Immunohistochemistry 
experiments (Figure 2B-C) show the protein 
present in the expected cell type (glial cells in the 
particular case shown), and localized at the cell 
surface (arrows in Figure 2C). Negative controls 
performed to ascertain that the monoclonal 
antibody 10E6 against grasshopper Laz is not 
cross-reacting with any Drosophila epitope are 
shown in Figure S2 B. These experiments 
confirmed that all the post-translational 
modifications that take place in the native
grasshopper Laz, including anchoring to the cell 
membrane, were correctly reproduced in the 
transgenic flies.  
Since we intended to assay the effects of 
overexpressing Laz in wild type flies, we 
quantified the expression of the native homologous 
Drosophila genes (GLaz and NLaz) under these 
circumstances. NLaz gene expression was 
unaltered (Figure 2D), while GLaz gene was 
slightly (1.6-fold) up-regulated in flies 
overexpressing Laz ubiquitously. Increases of 7-10 
fold in GLaz ubiquitous expression have been 
reported to produce mild longevity extensions [28]. 
Therefore, though we cannot discard a contribution 
of the mildly altered expression of GLaz upon 
transgenic Laz over-expression, other results 
presented and discussed below cast doubt about the 
functional significance of these minor changes.  
 
Figure 2. Expression of grasshopper Lazarillo in transgenic flies. Influence on the expression of the Drosophila 
homologs NLaz and GLaz. 
(A) Immunoblot against Lazarillo with MAb 10E6 confirms its expression in flies at the protein level. Two lines 
representing independent insertions of the Laz gene in the Drosophila genome were tested (mapped to the 3rd and X 
chromosome). The level of expression is subject to the known temperature sensitivity of the GAL4/UAS expression 
system in Drosophila. Bacterially produced non-glycosylated Laz (Laz-Strep) was used as positive control and shows 
the difference in electrophoretic mobility with the protein produced in Drosophila. (B-C) MAb 10E6 also recognizes 
grasshopper Laz expressed under the control of a glial driver (Repo-GAL4). Membrane localization of the labeling is 
evident in confocal sections (C). (D) Quantitative PCR of NLaz and GLaz in transgenic flies over-expressing Laz 
compared to their driver-only controls. NLaz expression is not altered, while GLaz is slightly up-regulated when 
Lazarillo is present (Mann-Whitney U test, p<0.0005). 
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3.3. Membrane bound grasshopper Lazarillo 
increases lifespan with both ubiquitous and 
nervous system-enriched expression. 
Laz overexpression produces a significant increase 
in fly longevity. Median survival increases in 
female flies by 28%, 43.5% and 31.4% when Laz 
is expressed either ubiquitously (da-GAL4 driver, 
Figure 3A), in the nervous and muscular system 
(GAL4109(2)80 driver, Figure 3B), or in the 
dopaminergic-serotonergic neurons and epidermis 
(Ddc-GAL4 driver, Figure 3C). Effects in male 
flies (Table 1) are less prominent when Laz is 
expressed ubiquitously (8.5%), but very similar 
when expressed under the control of GAL4109(2)80 
or Ddc-GAL4 drivers (32.7% and 30% 
respectively). Similar results were obtained with 
both Laz transgenic lines. The survival curves 
shown in Figure 3 are the average of data obtained 
independently in cohorts from both lines. Survival 
curves obtained independently for each UAS:Laz 
line are shown in Figure S3. Table 1 summarizes 
the results of all tests performed with male and 
female flies.  
The magnitude of the effects obtained with Laz 
overexpression contrasts lifespan extension 
obtained in transgenic male flies producing GLaz 
with similar expression patterns: 0-21% in 
ubiquitous patterns (actin or Hsp70 drivers), 23-
29% when driven by GAL4109(2)80, and no effect 
when expressed panneuronally (elav driver) or in 
motor neurons (D42 driver) [28]. Thus, 
grasshopper Laz is able to extend lifespan of flies 
more efficiently than the native GLaz, especially 
when the expression domain included neurons 
(GAL4109(2)80 and Ddc-GAL4 drivers). So far, no 
analysis of NLaz effects on longevity have been 
performed with neuronally enriched patterns. On 
the other hand, ubiquitous overexpression of NLaz 
with the da-GAL4 driver produces a 42-50% 
increase in median longevity of male flies [26], a 
larger effect than that obtained with Laz.  
The Ddc-GAL4 line used drives the expression 
of UAS-transgenes with the dopa decarboxylase 
promoter, the enzyme controlling the synthesis of 
dopamine (DA).  DA is not only a neurotransmitter 
in insect CNS, but has also a role in the 
sclerotization of pigmented cuticle. The Ddc gene 
is expressed in late embryogenesis, when cuticle 
hardening is taking place [56], and in the epidermis 
of third instar larvae [57]. Also, DA levels peak 
within the first hours after pupa eclosion [58]. DA 
contributes to adult cuticle hardening in this 
period, but also regulates cuticular sex-specific 
hydrocarbon biosynthesis in female flies [59,60]. 
Curiously, the later effect is dependent on DA 
production in the brain, and not on local 
production of DA by Ddc activity in the epidermis. 
In addition, Ddc expression can be induced in the 
larval and adult epidermis upon local infection, as 
part of the immune response [61]. Ddc basal 
expression in adult epidermis is small compared to 
the expression in the CNS domain [61]. In view of 
these data the large extension of lifespan caused by 
Laz expressed under the control of the Ddc driver 
(Figure 3C) has probably an important contribution 
of the neuronal domain of expression 
(dopaminergic and serotonergic neurons in the 
CNS), where Ddc is expressed throughout life. 
However, below we describe sex-dependent effects 
of Laz on stress resistance when expressed under 
the control of Ddc-GAL4. The putative 
contribution of Laz epidermal expression will be 
discussed. 
 
3.4. Lazarillo protects flies against different 
forms of stress in a cell-type dependent manner 
within the nervous system. 
Laz increases survival of flies upon starvation-
desiccation stress when expressed with ubiquitous 
or wide range patterns (23.1-30% median survival 
increase, Figure 4A and Table 1). Protective 
effects are obtained when Laz is expressed by 
dopaminergic-serotonergic neurons and epidermis 
(Ddc-GAL4 driver, Figure 4B), or by a subset of 
embryonic neuroblasts and neurons in the CNS and 
PNS (31-1-GAL4 enhancer trap insertion; Figure 
S4). However, no protection is obtained when Laz 
is driven to motoneurons by D42-GAL4 (Figure 
4B). These effects are, moreover, sex-dependent 
(see below). In contrast, glial cell expression of 
grasshopper Laz consistently protects both male 
and female flies from starvation-desiccation stress 
with survival extensions ranging 10.4-38.3% 
(Figure 4C and Table 1). 
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Figure 3. The overexpression of grasshopper 
Lazarillo extends lifespan.  
(A) Drosophila lifespan increases when Laz is 
expressed using the ubiquitous da-GAL4 driver (da-
GAL4>Laz) compared to da-GAL4> + control flies. 
Median survival time is increased by 28.3% in the 
Lazarillo expressing flies (Long-rank test: p<0.0005). 
(B) Median lifespan is also increased by 43.5% when 
GAL4109(2)80 drives the expression of Laz in muscles and 
brain (Log-rank test: p<0.0005). (C) When Laz is 
expressed in dopaminergic and serotonergic neurons 
and epidermis, fly survival increases by 31.4% (Log-
rank test: p<0.0005). Female data is shown in all panels. 
The complete data for both sexes is shown in Table 1. 
 
 
 
Figure 4. Lazarillo protects flies against starvation-
desiccation stress.  
(A) Resistance against starvation-desiccation increases 
when Lazarillo is expressed in flies using da-GAL4 or 
GAL4109(2)80 drivers. Median survival increases by 25.8 
and 30% respectively (Log-rank test: p<0.0005 in both 
cases). (B) Median survival is increased by 37.9% (Log-
rank test: p<0.0005) when Lazarillo expression is driven 
by Ddc-GAL4. However, using a motoneuron driver 
(D42-GAL4) no changes in median-survival upon 
starvation-desiccation are observed. (C) Expression in 
glial cells (Repo-GAL4 or M1B-GAL4 drivers) also 
promotes survival upon starvation-desiccation (survival 
increases 24% and 38.3% respectively; Log-rank test: 
p<0.0005 in both cases). Female data is shown in all 
panels. The complete data for both sexes is shown in 
Table 1. 
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When flies are subjected to oxidative stress 
(exposure to 15 mM FeSO4, Figure 5), Laz is able 
to extend their survival when expressed with the 
glial driver M1B (Figure 5C), the Ddc driver 
(Figure 5B), the nervous and muscular systems 
driver (GAL4109(2)80, Figure 5A) or the ubiquitous 
driver (da-GAL4). These protective effects are 
therefore also cell type-dependent and could be 
sensitive to variations in timing or magnitude of 
overexpression. 
We also assayed whether Laz expression either 
ubiquitously or in neuron-enriched patterns would 
modify the locomotor performance of Fe2+-
intoxicated flies. Generic overexpression of Laz 
(da-GAL4 driver) improves climbing performance 
after 72 h of iron treatment (Figure 5D and Table 
1) and the protecting effect is maintained up to 93 
h of treatment (Table 1). However, expression of 
Laz with D42 or Ddc drivers shows no significant 
effect (Figure 5D and Table 1). Thus, the 
ubiquitously-expressed grasshopper Laz is not only 
able to extend the flies’ lifespan under normal or 
stress conditions, but also to improve their 
healthspan. 
Finally, when oxidative stress is provoked by 
hyperoxia, neuronal or glial enriched expression of 
Laz is beneficial for flies (Figure 6 and Table 1) 
with significant effects ranging from a mild 6.8% 
to a substantial 23.7% increase in survival. 
However, no statistically significant survival 
extension was obtained with a wide expression of 
Laz (Figure 6A). 
 
3.5. Local effects of GPI-linked Lazarillo 
outside the nervous system promote survival 
under starvation and oxidative stress. 
The expression domains of Drosophila GLaz and 
NLaz and grasshopper Laz include cells outside 
the nervous system. GLaz is expressed in 
mesodermal cells, gut epithelium, and salivary 
glands primordia during embryogenesis [24], and 
in adult hemocytes [25]. NLaz is expressed in 
developing mesodermal cells and sessile cells in 
the gut lumen [24], and in the developing and adult 
fat body [24,26]. Finally grasshopper Laz is 
expressed in cells at the tip of the Malpighian 
tubules, nephrocytes of the subesophageal body, 
and in a group of mesodermal cells that might be 
the precursors of sessile hemocytes, nephrocytes, 
or fat body cells [2]. Thus, systemic effects of 
Lipocalins might be part of their longevity-
regulation and stress-protection functions. 
Interestingly, when expressed in hemocytes, 
grasshopper Laz has no effect in starvation-
desiccation resistance (Figure S4 B). However, 
flies expressing Laz in the fat body increase their 
resistance to both starvation-desiccation and 
hyperoxia stress (Figure S5 A-B and Table 1). Iron 
exposure appears to be deleterious for flies 
overexpressing Laz in fat-body (Figure S5 C). 
Expression of NLaz in the fat body is triggered 
by the JNK signaling pathway and promotes 
resistance to starvation and oxidative stress [26]. 
Since native NLaz is a secreted protein, we have 
proposed NLaz as an important component of the 
systemic control of metabolism necessary under 
stress conditions. In support of that idea, 
expression of NLaz in pericardial cells or 
hemocytes also protect against a starvation-
desiccation stress [26]. On the other hand, GLaz is 
not expressed by fat body cells, but controls fat 
storage in these cells [25], probably acting at a 
distance once secreted to the hemolymph by 
hemocytes. Our results show that the GPI-linked 
grasshopper Laz protects against stress when 
expressed in fat body cells (Figure S5 and Table 
1), but not in hemocytes (Figure S4 B and Table 
1), suggesting that not only systemic effects, but 
also local effects of these Lipocalins in the fat 
body tissue are important for stress resistance. 
 
3.6. Lazarillo protects flies against different 
forms of stress in a sex dependent manner. 
Using loss-of-function mutants we have previously 
shown that (i) lifespan extension by GLaz is sex 
dependent, (ii) NLaz and GLaz expression change 
in opposite directions (only in females) upon 
aging, and (iii) the relative contribution of head 
and body in Lipocalin expression also varies with 
sex [27]. A multivariate analysis uncovered that 
differences in metabolic parameters, particularly 
protein and relative water content, account for the 
observed sex-specific patterns of longevity. 
Upon different types of stress, grasshopper Laz 
also shows sex-dependent effects. When expressed 
by the Ddc driver, resistance to starvation-
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desiccation stress is promoted only in females 
(Figure S6 A), resistance to hyperoxia is promoted 
in both sexes (Figure S6 B), and resistance to iron 
exposure is slightly enhanced in females and 
decreased in males (Figure S6 C). Some of these 
differences could be explained by functional 
differences of Laz in the Ddc cuticular domain of 
expression. Since epidermal DA production is 
triggered in stress situations [58,62] and Ddc 
functions downstream of the stress-responsive JNK 
signaling cascade upon a septic cuticle injury [61], 
a contribution to epidermal Laz expression might 
not be negligible under the stress situations used in 
our experiments. DA production is particularly 
important in females, where it controls the last 
biochemical steps toward the production of female-
specific long-chain hydrocarbons with
 pheromonal functions [60]. Although a 
quantitative profile of Ddc expression in the 
epidermis has not been reported yet, our data are 
compatible with a significant expression of 
membrane-bound Laz expression in female 
epidermis (driven by the Ddc promoter) as a 
putative cause for the sex-specific effects in 
starvation-desiccation resistance. 
Similarly, females expressing Laz in the 
nervous system and muscles (109-GAL4 driver) 
show a larger resistance to starvation-desiccation 
than males, but neuronal Laz (31-1 or D42 drivers) 
shows larger protective effects in males than in 
females (Table 1). 
Interestingly, overexpression of grasshopper 
Laz extends lifespan in both males and females 
(Figure 3 and Table 1). 
 
 
Figure 5. Expression of Lazarillo improves survival and locomotor behavior of flies exposed to iron. 
(A) Wide range expression of Lazarillo (da-GAL4>Laz or GAL4109(2)80>Laz) increase median survival upon FeSO4 
treatment by 17 and 24.1% (Log-rank test p<0.0005). (B) A small increase in median lifespan (5.3%; Log-rank test: 
p<0.05) is observed when Lazarillo is expressed by dopaminergic and serotonergic neurons and the epidermis of flies 
exposed to FeSO4. In contrast, D42-GAL4>Laz flies show no change in median survival. (C) Expression in glial cells 
with the repo-GAL4 driver does not modify fly resistance to iron intoxication. However, M1B-GAL4>Laz flies 
significantly increase their survival 42.3% (Log-rank test: p<0.0005).  (D) Climbing ability was assayed after 72h of 
iron exposure in ubiquitous and motoneuron overexpressor flies. Only ubiquitous expression of grasshopper Laz 
improves fly climbing ability after iron exposure (Student’s T-test: p<0.0005). Female data is shown in all panels. The 
complete data for both sexes is shown in Table 1. 
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Figure 6. Grasshopper Laz protects against 
hyperoxia in a cell-type dependent manner. 
(A) Wide range expression of Lazarillo (da-GAL4>Laz 
or GAL4109(2)80>Laz) does not modify median survival 
upon hyperoxia. (B) The expression of Laz in 
dopaminergic and serotonergic neurons and epidermis 
(Ddc-GAL4>Laz) or in motoneurons (D42-GAL4>Laz) 
increases slightly their median survival: 7.1 and 6.8% 
(Log-rank test: p<0.0005 and p<0.005 respectively). (C) 
When Lazarillo is expressed in glial cells using M1B-
GAL4 driver, it produces a significant survival 
expansion in female flies exposed to hyperoxia: 22% 
increase in median survival (Log-rank test: p<0.0005). 
Conversely, repo-GAL4>Laz flies show a milder 
increase (9.3%) in median-survival (Log-rank test: 
p<0.05). Female data is shown in all panels. The 
complete data for both sexes is shown in Table 1. 
3.7. Grasshopper Lazarillo rescues stress-
sensitivity and premature AGEs accumulation 
in NLaz null mutant flies. 
At least two arthropodan Lipocalins are predicted 
to be the minimal ancestral set of Lipocalins [63]. 
However, awaiting full genome sequencing, no 
other grasshopper Lipocalins have been reported so 
far. Among the Drosophila Lipocalins, NLaz and 
grasshopper Laz show many shared properties, in 
addition to their neuronal expression domain. They 
both have higher % similarity in protein sequence 
[9] and intron-exon structure similarity index [14] 
than the Laz-GLaz pair. Also NLaz, but not GLaz, 
bears an extended C-terminal segment similar in 
size to the GPI-anchoring signal of Laz [13] that 
could represent a vestigial NLaz tail (Figure 9). 
We therefore set to examine whether the 
ancient Laz is able to rescue the phenotypes caused 
by the loss of NLaz. The NLaz loss-of-function 
mutation is known to reduce longevity, and to 
increase the flies sensitivity to oxidative and 
starvation-desiccation stress [26,27]. Ubiquitous 
expression of the GPI-linked grasshopper Laz (da-
GAL4 driver) is in fact able to restore stress 
resistance to or above control levels, both under 
starvation-desiccation stress and iron induced 
oxidative stress (Figure 7A-B). Median survival 
increases by 71.7% and 83.2% respectively with 
respect to control flies. 
A slight increase in GLaz mRNA expression 
(1.6 fold increase) is observed when NLaz is 
absent (Figure 7C). As it has been described for the 
vertebrate homologue ApoD in the mouse [32-
34,64], without additional stress the absence of 
NLaz might cause an imbalance in tissue 
homeostasis, generating a basal level of stress. 
This in turn might cause the observed slight GLaz 
up-regulation. Since both proteins are secreted 
within and outside the nervous system, though 
from different cell types, they might be 
functionally compensating for each other. 
However, GLaz expression is equivalent to control 
levels when membrane-linked grasshopper Laz is 
expressed with the da-GAL4 driver. Therefore, the 
rescue of NLaz null mutation by grasshopper Laz 
cannot be ascribed to functional compensation by 
GLaz. These GLaz expression changes, together 
with those observed when grasshopper Laz is 
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expressed in wild type flies (Figure 2D), are 
indicative of the existence of stochastic small 
variations in the expression levels for GLaz. 
Whether they represent biologically relevant 
variations would need further study. 
During normal aging, reducing sugars react 
nonenzymatically with proteins or nucleic acids 
forming advanced glycation end-products (AGEs) 
that accumulate within cells. A 40% increase in 
AGEs has been reported in Drosophila between 10 
and 75 days of age [50]. Fluorescent AGEs are 
reliable biomarkers of aging-related damage. They 
track the effects of factors that condition mortality 
rates (e.g., temperature in the case of ectothermic
 animals like Drosophila), but are irreversible and 
thus not affected by other potentially reversing 
factors like dietary restriction [65]. If the lack of 
NLaz does impose a basal stress in the tissues, we 
should expect an accelerated aging occurring in the 
null mutant flies. This hypothesis is confirmed, 
since young 3-5 day old NLaz mutant flies exhibit 
31.6% more fluorescent AGEs than control flies 
(Fig. 7D). Interestingly, the ubiquitous expression 
of grasshopper Laz fully rescues the acceleration 
of aging in mutant NLaz flies (Fig. 7D). The 
beneficial action of grasshopper Laz therefore must 
prevent age-related damage to occur. 
 
 
 
 
Figure 7. Grasshopper Lazarillo expression rescues NLaz null mutant flies from stress-sensitivity and 
accelerated-aging phenotypes. 
(A, B) Homozygous NLazNW5 flies are more sensitive to starvation-desiccation and iron exposure than control flies. 
Ubiquitous expression of grasshopper Laz returns NLaz null mutant flies to or above control levels. Median survival 
increases by 71.7% (NLaz NW5; da-GAL4>+ versus NLaz NW5; da-GAL4>Laz) in the starvation-desiccation test and 
83.2% in the iron toxicity assay (Log-rank test: p<0.0005 in both cases). Female data is shown. The complete data for 
both sexes is shown in Table 1. (C) GLaz transcript levels slightly increase in homozygous NLazNW5 flies (da-GAL4>+ 
versus NLaz NW5; da-GAL4>+). Overexpression of grasshopper Laz returns GLaz expression back to control levels 
(NLaz NW5;da-GAL4>+ versus NLazNW5;da-GAL4>Laz  flies). (D) Advanced glycation end products (AGEs), which 
normally accumulate upon aging, are basally increased in NLaz null mutant young female flies reflecting an accelerated 
aging process. Grasshopper Laz expression rescues this phenotype completely (Student’s t-Test, p<0.0005 in both 
cases). 
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Table 1. Summary of the survival parameters and behavioral scores obtained with different experimental paradigms in 
flies of different sex and genotypes 
 
 
 
Background 
Driver 
(main site of 
expression)  
N  Sex Experiment  
Median Survival or 
Climbing Success Maximal Survival 
 Sig. % Change  Sig. % Change 
WT 
Da 
(Ubiquitous) 
266-418 ♀ Longevity *** 28.302 *** 21.413 
WT 239-294  ♂ Longevity *** 8.475 ** 9.962 
WT 93-123 ♀ Desiccation *** 25.806 *** 24.184 
WT  105-144 ♂ Desiccation *** 23.112 *** 10.677 
WT 38-69 ♀ Hyperoxia ns -3.736 * 15.926 
WT 45-63 ♂ Hyperoxia ns 0.000 ns -0.925 
WT  105-116 ♀ Iron *** 17.056 *** 21.210 
WT  99-100 ♂ Iron *** 28.205 * 5.370 
WT 42-77 ♀ Climbing (72h) *** 67.532   
WT 15-40 ♀ Climbing (96h) * 275.00   
WT  24-61 ♂ Climbing (48h) * 16.065   
NLazNW5 87-118 ♀ Desiccation *** 71.678 *** 17.098 
NLazNW5 85-119 ♂ Desiccation *** 45.038 *** 23.149 
NLazNW5 68-110 ♀ Iron *** 83.167 *** 23.811 
NLazNW5 62-112 ♂ Iron *** 94.130 ***  31.214  
WT 
109 
(CNS / Muscle) 
171-286 ♀ Longevity *** 43.548 *** 40.937 
WT 136-294  ♂ Longevity *** 32.727 *** 32.455 
WT  89-140 ♀ Desiccation *** 30.055 *** 20.732 
WT  79-138 ♂ Desiccation ns 3.333 ns 4.409 
WT 43-55 ♀ Hyperoxia ns 0.000 ns 3.577 
WT 27-42 ♂ Hyperoxia *** -12.859 ns -9.266 
WT 90-105 ♀ Iron *** 24.113 ** 12.789 
WT  80-97 ♂ Iron * 0.000 ** 7.230 
WT 24-73 ♀ Climbing (72h) ns -7.347     
WT 24-43 ♂ Climbing (48h) ns -17.395     
WT 31-1 
(Neurons) 
68-95 ♀ Desiccation * 5.849 *** 35.647 
WT 61-79  ♂ Desiccation * 14.815 *** 20.192 
WT 
Ddc 
(Dopaminergic 
and 
Serotonergic 
Neurons) 
117-119 ♀ Longevity *** 31.479 *** 13.410 
WT 118-121 ♂ Longevity *** 30.000 *** 11.753 
WT  233-289 ♀ Desiccation *** 37.903 *** 21.689 
WT 262-312 ♂ Desiccation ns 2.105 ns 6.748 
WT 82-94 ♀ Hyperoxia *** 7.154 * 6.412 
WT 86-98 ♂ Hyperoxia *** 23.680 *** 24.910 
WT  97-102 ♀ Iron * 5.282 * 7.091 
WT  94-101 ♂ Iron *** -14.450 * -3.725 
WT 40-54 ♀ Climbing (72h) ns -1.234     
WT 23-59 ♂ Climbing (48h) * -45.735     
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Background 
Driver 
(main site of 
expression)  
N  Sex Experiment  
Median Survival or 
Climbing Success 
   Sig.        % Change 
Maximal Survival 
 
   Sig.      % Change 
WT 
D42 
(Motoneurons) 
93-100 ♀ Desiccation * -1.990 *** -20.659 
WT 80-95 ♂ Desiccation ** 4.444 ** 20.815 
WT  69-86 ♀ Hyperoxia ** 6.772 ns 2.785 
WT 87-96 ♂ Hyperoxia ns 7.155 ** -1.509 
WT 81-93 ♀ Iron ns -14.571 * 5.864 
WT  72-85 ♂ Iron ns 0.000 *** -23.170 
WT  59-61 ♀ Climbing (72h) ns 47.766     
WT 8-31 ♂ Climbing (48h) ns -55.288     
WT 
Repo 
(Glial cells) 
87-109 ♀ Desiccation *** 23.980 *** 21.809 
WT 62-74 ♂ Desiccation ** 10.484 ** 41.286 
WT 67-81 ♀ Hyperoxia * 9.282 * 7.018 
WT 57-88 ♂ Hyperoxia *** -23.077 ** -9.964 
WT 29-34 ♀ Iron ns -1.29 ns 11.745 
WT 13-57 ♂ Iron ns 0.000 ns 7.831 
WT 
M1B 
(Glial cells) 
84-91 ♀ Desiccation *** 38.298 *** 28.791 
WT  83 ♂ Desiccation ** 23.256 ** 7.483 
WT 81-90 ♀ Hyperoxia *** 22.049 *** 12.899 
WT 83-91 ♂ Hyperoxia *** 7.618 ** 7.028 
WT 73-93 ♀ Iron *** 42.324 *** 28.193 
WT 48-51 ♂ Iron ns 0.000 ns 4.141 
WT He 
(Hemocytes) 
82-112 ♀ Desiccation ns -3.468 ns 1.692 
WT 81-87 ♂ Desiccation ns 0.000 * 2.688 
WT 
ppl 
(Fat body) 
77-89 ♀ Desiccation *** 21.212 *** 22.865 
WT 81-83 ♂ Desiccation *** 18.868 *** 20.139 
WT 81-99 ♀ Hyperoxia *** 13.117 ** 12.258 
WT 79-94 ♂ Hyperoxia *** 7.877 *** 25.376 
WT 81-93 ♀ Iron *** -8.450 ns -1.679 
WT 82-94 ♂ Iron *** -25.535 * -8.242 
 
Values in bold indicate changes in median or maximal survival larger than 20%. Survival curves differences tested with 
Log-rank test. Climbing success differences tested with Student's T-test. p < 0.05 (*); p < 0.005 (**); p < 0.0005 (***). 
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3.8. Courtship behavior and cuticular sex 
pheromones are not altered by Lazarillo 
expression. 
NLaz not only modulates longevity and regulates 
the metabolic response to stress [26,27], but also 
participates in fly mating behavior [27]. Loss of 
NLaz leads to deficiencies in courtship that are 
dependent on functional alterations in both sexes, 
since both wild type males paired with mutant 
females and mutant males paired with wild type 
females are less involved in courting. The 
courtship index decreases to even lower levels 
when both flies are NLaz null mutants [27]. Here 
we show that a ubiquitous overexpression of Laz is 
not able to rescue the courtship defects produced 
by the lack of NLaz (Figure 8A), indicating that 
Lazarillo is not able to substitute NLaz in all of its 
functions. 
We have proposed that courtship defects in 
NLaz mutants might be due to its role as a 
transporter of pheromones either at the emission or 
reception level. As mentioned above, the main sex-
pheromones in insects are cuticular long-chain 
unsaturated hydrocarbons (HC) synthesized from 
fatty acid precursors in epidermal cells. They, 
together with visual and acoustic cues, play an 
important role in male courtship behavior [46]. 
Interestingly, HC are also important factors 
modulating survival upon desiccation. A causal 
association between HC composition, their 
resulting global melting point and desiccation 
survival has been well documented [66,67]. 
We assayed the profile of HC in Laz 
overexpressing flies, comparing global expression 
(da-GAL4 driver) with nervous system enriched 
expression (Ddc-GAL4 driver). In no case the 
expression of Laz produced major changes in the 
profile of HC in males or females (Tables S1 and 
S2). The total amount of HC (between 23 and 29 
carbons), calculated for da, and Ddc-driven 
expression of Laz, also showed no significant 
differences (Figure 8B and Table 2). 
 
3.9. Neutral fat stores are promoted by 
Lazarillo. 
Since Laz does not change the profiles or total 
amounts of HC, they cannot account for its ability 
to increase starvation-desiccation resistance in 
flies. We therefore tested whether greater 
metabolic stores, particularly fat stores, could be 
the mechanism by which flies can better resist the 
lack of nutrients and water in our starvation-
desiccation test.  
A significant increase in total triglycerides 
content is actually observed when grasshopper Laz 
is expressed ubiquitously (da-GAL4 driver) or in 
dopaminergic cells (Ddc-GAL4 driver) both in 
males and females (Figure 8C and Table 2). 
However, the effect is not attained when Laz is 
expressed in hemocytes (He-GAL4 driver). 
Opposite to Laz overexpression, NLaz and 
GLaz null mutant adults exhibit reduced 
triglycerides stores and are sensitive to diverse 
forms of starvation [25,26]. Also, the fat body 
tissue is markedly reduced in GLaz mutants [25]. 
Our results support a model in which the control of 
fat storage by Lipocalins is a conserved ancestral 
function, promoting both starvation and 
desiccation resistance. 
 
3.10. Tissue specificity and range of action of 
Lazarillo related Lipocalins: Contributions to 
the control of the aging process. 
 
The ubiquitous expression of grasshopper Laz, 
anchored to cell membranes, is able to accomplish 
many functions. In wild type background it 
promotes lifespan extension, decreases starvation-
desiccation sensitivity, and improves survival and 
locomotor activity upon iron treatment. In addition 
it decreases AGEs formation in the accelerated-
aging NLaz mutant background, and rescues its 
sensitivity to starvation-desiccation and oxidative 
stress. 
Some of these functions are also possible when 
grasshopper Laz is expressed by subsets of cells, 
within or outside the nervous system. We have 
reasoned above that the sex-independent longevity 
extension obtained with the Ddc-GAL4 driver 
could be mostly dependent on the neuronal 
expression, while the female-specific resistance to 
starvation-desiccation stress is better explained by 
the epidermal expression of Laz. On the other 
hand, the results obtained with restricted patterns 
of expression (e.g. hemocytes or fat body) clearly 
show that Laz can perform its protection against  
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Figure 8. Ubiquitous expression of Lazarillo 
promotes fat storage, but does not alter phenotypes 
related to pheromonal signaling. 
(A) Homozygous NLazNW5 flies show a decreased 
courtship index and expression of Lazarillo under the 
control of da-GAL4 does not rescue this phenotype. (B) 
Total amounts of cuticular hydrocarbons are not altered 
by Laz expression neither ubiquitously nor when 
expressed in a nervous system enriched pattern (Ddc-
GAL4>Laz). (C) Triglyceride contents increase in flies 
overexpressing Laz with da-GAL4  or Ddc-GAL4 
drivers. Laz has no effect on fat storage when expressed 
only in hemocytes (He-GAL4>Laz). (* Student’s T-test: 
p<0.05). Female data is shown in all panels. The 
complete data for both sexes is shown in Table 2. 
starvation-desiccation when locally expressed in 
the fat body and not in hemocytes, which contrasts 
with the long-range actions of the secreted GLaz or 
NLaz homologs [25,26]. We have shown that 
secreted forms of grasshopper Laz are also able to 
protect insect S2 cells in culture when exposed to 
oxidative stress, both in an autocrine and a 
paracrine manner. Thus, Lazarillo has the potential 
of acting both, from the extracellular space or 
linked to the cell membrane. Interactions of the 
secreted GLaz and NLaz with cell membranes 
upon which they exert their protective functions 
are predicted as a result. 
The restricted neuronal expression of the 31-1-
GAL4 driver (similar to the embryonic expression 
pattern of grasshopper Laz) consistently, though 
moderately, improves survival upon starvation-
desiccation in a sex-independent manner. Glial 
restricted expression of Laz does cause large 
survival increases upon different forms of stress, 
reflecting the wider range of protective functions 
exerted by glial cells. As we have shown for mouse 
ApoD [33], protecting glial cells might represent a 
beneficial strategy to maintain the nervous system 
homeostasis and ultimately improve the whole 
organism survival. Our results with grasshopper 
Laz are in agreement with the protecting effects of 
glial-derived ApoD on oxidation-challenged 
dopaminergic neurons in the mouse [33], as well as 
global effects on survival upon systemic oxidative 
stress [32].  
 
3.11. Ancestral vs. derived functions of the 
Lazarillo-related Lipocalins.  Is the GPI-linked 
grasshopper Lazarillo an evolutionary rarity? 
 
We have shown that grasshopper Laz is able to 
perform protective functions when expressed in a 
variety of patterns. Moreover, a ubiquitous 
expression of Laz rescues NLaz null mutants from 
stress sensitivity and accelerated aging phenotypes. 
However, functional equivalence between 
grasshopper Laz and Drosophila NLaz is not all-
inclusive since deficient courtship phenotypes of 
NLaz null mutants are not rescued. A divergent 
evolution of hydrophobic ligand binding 
specificities could account for the differences 
between grasshopper Laz and NLaz. 
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Table 2. Total hydrocarbon and triglyceride content in Laz over-expressing vs. control flies. 
 
  Control males Laz males Control females Laz females 
Hydrocarbons (ng/fly)         
da-GAL4 x UAS-Laz 1474 ± 203 1207 ± 71 1471 ± 90 1704 ± 104 
Ddc-GAL4 x UAS-Laz 1289 ± 66 1186 ± 65 1499 ± 60 1207 ± 73 
Triglycerides (μg/fly)         
da-GAL4 x UAS-Laz 7.04 ± 0.25 10.77 ± 0.3a 9.48 ± 0.8b 14.9 ± 0.3a 
Ddc-GAL4 x UAS-Laz 7.03 ± 0.23 8.06 ± 0.49 a 9.41 ± 0.44 b 14.91 ± 1.09 a 
He-GAL4 x UAS-Laz 7.04 ± 0.20 6.62 ± 0.25 10.12 ± 0.70 9.00 ± 0.13 
Average ± SEM is represented. Values in bold and shaded in gray indicate significant differences assayed by 
Student's T-test.  
a Difference between Laz overexpression and driver-only control (p < 0.05). 
b Difference between females and males of the same genotype (p < 0.05). 
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Dmel.NLaz 1 QVPFPGKCPDVKLLDTFDAEAYMGVWYEYAAYPFA-FEIGKKCIYANYSLIDN-STVSVV 58
Same.Laz 57 NSMKDNTTHEVNTTTGWAEFASELHTDGKLSVHFPNSPSVG---NYWILSTDYDNYSIVW 113
Aaeg.Lip 59 NTMKKLPDQKPSVARGRAVLAHPTSGEAKLLVRFESTPEAAPSSIYWVLKTDYQKYAVVW 118
Cqui.Lip 59 NRMRVIADDATVEARGTAVTDPDYPGQGVLRVRFEETPPEVPASYYRILGVVYDRYAVVW 118
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Aaeg.Lip 174 APAAKIS----CVLLILFVLLICKKS- 195
Cqui.Lip 174 AAALTTS----IVVFILSVFVMLQSNN 196
Dmel.NLaz 173 GTGLAGEDGLDVDDFVSTTVPNAIEKA 199
*
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Figure 9. GPI-linkage is a shared character in Orthoptera and Diptera Lipocalins. 
(A) Multiple sequence alignment of Lazarillo (Same.Laz), NLaz (Dmel.NLaz) and the two predicted GPI-linked 
Lipocalins from the mosquitoes Aedes aegypsi (Aaeg.Lip) and Culex quinquefasciatus (Cqui.Lip). Sequences were 
aligned with CLUSTAL-X2. Black and gray boxes show residue identities and similarities respectively. Potential GPI 
cleavage sites for Aaeg.Lip and Cqui.Lip were predicted by the big-PI Predictor software and are highlighted with an 
asterisk. They align with the experimentally demonstrated GPI-signal peptide cleavage site of Same.Laz. (B) 
Hydrophobicity plot of the Lipocalin protein sequences determined by Kyte and Doolittle’s method using a window of 
9 residues. The hydrophobic domains of the GPI-anchoring signal are indicated by arrows. 
 
These results strongly support the hypothesis 
that some functions (e.g., lipid storage control, 
protection against oxidative stress, and oxidative 
age-related damage), all of them impacting on 
lifespan regulation, represent the ancestral suite of 
functions for this group of Lipocalins. The 
Lazarillo-related Lipocalins include ApoD, which 
also extends lifespan and protects against oxidative 
stress in the fly [35]. Other functions, such as the 
specific signaling required for proper courtship, 
might be part of the autapomorphic characters 
evolved independently in different lineages, like 
the NLaz-dependent courtship behavior in 
Drosophila, or the axillary odorant binding by 
human ApoD [68]. 
The features currently present in the extant 
Drosophila Lipocalins might be the result of a gene 
duplication occurring before the divergence of 
Orthoptera and Diptera. As mentioned above this 
would predict the existence of a GLaz-like gene in 
grasshoppers, but it also predicts that more 
Lipocalins derived from a GPI-linked ancestor 
might exist in insects. Thanks to the genome 
sequencing of diverse insect species, we were able 
to identify two Laz-like mosquito Lipocalins with 
an extended C-terminal segment that is not only 
similar in size to the GPI-anchoring signal of Laz, 
but also has the characteristic hydrophobicity 
profile and predicted cleavage site (Figure 9). This 
finding strongly supports the hypothesis of an 
ancestral GPI-signal peptide as the origin of the 
vestigial NLaz C-terminal tail, and that insects 
have exploited the functional possibilities provided 
by GPI-linked Lipocalins in more lineages than 
previously thought. 
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Figure S1. Expression and purification of 
grasshopper Lazarillo from S2 cells. 
(A) Size-exclusion chromatography elution profile of 
Laz enriched extracts obtained after metal affinity 
chromatography of culture medium harvested from 
stably transfected S2 cells. The main peak eluting at 70 
ml correspond to Laz protein (98% pure) secreted by the 
cells. (B) SDS-PAGE analysis of purified Laz protein. 
The redox state of the protein affects only slightly its 
electrophoretic mobility while a large shift in relative 
mobility is observed in Lazarillo after deglycosylation. 
Lane 1: No reducing agent added. Lane 2: The 
electrophoresis sample buffer contains DTT. Lane 3: 
Proteins treated with PNGase-F. 
 
 
 
 
 
 
 
Figure S2.  
(A) Fly lines used in this 
study are free of Wolbachia 
infection. PCR of genomic 
DNA extracts from drivers, 
responders and mutant fly 
lines used in this work. 
Primers against the rRNA-
16S gene of Wolbachia 
endosymbiont were used. 
DNA from Dirofilaria 
immitis worms infected with 
Wolbachia is used as 
positive control. (B) Controls 
of MAb 10E6 specificity 
against grasshopper Laz. No 
labeling is detected in 
control flies not expressing 
Laz and the secondary 
antibody used does not yield 
any detectable signal either. 
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Figure S3. Overexpressing grasshopper Lazarillo 
using different transgenic lines extends lifespan. 
(A-B) Two lines with independent insertions of the Laz 
gene in the Drosophila genome were tested (mapped to 
the 2nd and X chromosome). Drosophila lifespan 
increases when Laz is expressed from both transgenes 
using the ubiquitous da-GAL4 driver or the muscles and 
brain driver GAL4109(2)80. Median survival time is 
increased by 25.65%  and 17.17% in da-GAL4>Laz 
(7F) and da-GAL4>Laz (8F) respectively, compared to 
da-GAL4> + control flies, and 49.56%  and 32.30% in 
GAL4109(2)80>Laz (7F) and GAL4109(2)80>Laz (8F) 
compared with the GAL4109(2)80>+  control flies (Log-
rank test: p<0.0005 for all comparisons). 
 
 
 
Figure S4. Expression of Lazarillo in restricted patterns within or outside the nervous system has different 
consequences on starvation-desiccation resistance. 
(A,B) Pan-neuronal expression of grasshopper Laz under the control of 31-1-GAL4 produces a 5.8% extension of 
median survival in females and 14.8% in males (Log-rank test p<0.0005 in both cases). (C,D) In contrast, when 
Lazarillo expression is targeted only outside the nervous system with He-GAL4 driver (expression by hemocytes) no 
significant changes were found in median or maximal survival in either sex. 
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Figure S5. Local expression of the membrane-
linked grasshopper Lazarillo in the fat body 
increases survival upon starvation-desiccation and 
hyperoxia stress but not upon iron treatment. 
(A) Median survival upon starvation-desiccation stress 
increases by 21.2% in flies expressing Laz in the fat 
body (ppl-GAL4>Laz; log-rank test: p<0.0005). (B) Fat 
body expressed Lazarillo increases resistance against 
oxidative stress provoked by hyperoxia (13.1% median 
survival increase; log-rank test: p<0.0005). (C) Survival 
under iron treatment does not change significantly by 
expressing Laz in the fat body. Female data is shown in 
all panels. The complete data for both sexes is shown in 
Table-1.
 
 
 
 
Figure S6. Beneficial effects of Grasshopper 
Lazarillo are stress and sex-specific. 
(A) Expression of Lazarillo in dopaminergic and 
serotonergic neurons and in the epidermis increases 
resistance to starvation-desiccation in female but not in 
male flies (Log-rank test:p<0.0005 in females). (B) In 
contrast, both Ddc-GAL4>Laz females and males flies 
resist more under hyperoxia than control flies (Ddc-
GAL4> +): 7.2% and 23.7% median increase 
respectively (Log-rank test: p<0.0005). (C) Ddc-
GAL4>Laz female flies increase their resistance to iron 
exposure (Log-rank test: p<0.05), but males expressing 
Laz in the same pattern show a decrease of 14.5% in 
their median-survival (Log-rank test: p<0.0005). 
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General Discussion and Future Perspectives 
 
In this thesis I have explored the physiological roles of Laz and Laz-related 
Lipocalins and their molecular mechanisms. 
 
This work has confirmed and even broadened the functions in which Laz and Laz-
related Lipocalins are involved. Among these functions, I would like to highlight their 
role in the process of aging. 
Aging is defined as a gradual impairment of biological functions. Thus, it is a 
universal, deleterious and progressive process [1]. Aging is a complex and multi-
factorial process that can be influenced by both, external and genetic factors. The 
expression levels of Laz and Laz-related Lipocalins is one of the critical genetic factors 
that determine not only lifespan, but also the quality of life upon aging, measured as 
behavioral outputs. 
The contribution of GLaz, NLaz and ApoD to the aging process and to the 
protection against external stress has been extensively studied [2-8]. However, the 
results obtained in Chapter 4 have added grasshopper Laz to the aging-related group of 
Lipocalins. Especially interesting is the fact that Laz is able to increase fly lifespan and 
stress resistance as a protein attached to the membrane, reinforcing the idea that the role 
of ApoD, NLaz or GLaz could be associated with the plasma membrane. A 
tridimensional model of ApoD associated with the cell membrane is available at the 
OPM database  [9]. Another interesting connection is that Laz expression in 
dopaminergic cells is enough to extent Drosophila lifespan, and dopaminergic cells are 
one of the most affected systems in ApoD-KO mice under oxidative stress [2]. These 
data suggest what can be considered a more general principle: that protecting 
dopaminergic cells is critical to slow down aging. 
Surprisingly, in the absence of external stress, lifespan is not reduced in GLaz-KO 
female flies (Chapter1), but in the presence of metabolic or oxidative stress, their 
survival decreases dramatically. Thus, the lifespan of GLaz-KO flies might be also 
reduced in the absence of ideal living conditions, that is, in a real setting. 
Moreover, the results presented in Chapter 3 make it possible to go one step further: 
A functional ligand-binding protein is required to achieve a proper response to oxidative 
or metabolic stress. The newly developed fly and cell lines expressing NLaz point-
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mutants are useful tools for future research on NLaz biological functions and its 
molecular mechanisms. Likewise, solving the structures of NLaz (as apoprotein and as 
holoprotein in complex with different ligands) and of the NLazL130R mutant would be 
critical to fully understand the ligand-binding interactions. 
ApoD is the gene most up-regulated among those with conserved expression 
responses upon brain aging in mammals [10,11]. Additionally, ApoD transcription and 
protein levels are increased in the stroma of prostate during aging in mice [12]. It would 
be really interesting to analyze which tissues might require ApoD to slow down the 
aging process and to study what they have in common. 
In the works presented in this thesis, control of the aging process and defense 
against oxidative stress have emerged as shared functions of Laz and Laz-related 
Lipocalins and these functions are probably part of the ancestral abilities of this protein 
family. 
 
The protective properties of Laz and Laz-related Lipocalins have also been tested in 
cell-culture models upon oxidative stress (Chapters 3 and 4, and [2]). A protective 
mechanism has been reported for hApoD that involves binding of the oxidized lipid 
molecule and a detoxification reaction through Met93 [13,14]. This mechanism could 
be combined with the conventional hypothesis of binding and protecting easily oxidable 
compounds. Alternatively, binding to products of lipid peroxidation would stop 
peroxidative chain reactions. A mechanism relying on the binding of toxic products has 
been already described for other Lipocalins: OBP and TL bind 4-HNE [15,16] and 
ApoM binds oxidized phospholipids [17]. 
The ApoD residue Met93 is absent in the insect proteins Laz, NLaz and GLaz. 
Therefore, a catalytic mechanism is not expected. A non-enzymatic alternative 
mechanism may explain the anti-oxidative and pro-survival properties of the Laz-related 
insect Lipocalins. 
Therefore, the group of mammalian Lipocalins with enzymatic activity (L-PGDS, 
α-1m and TL [18-20]) now includes ApoD. Enzymatic activity could be influenced by 
the presence of a second ligand. Indeed, in the chicken Lipocalin ExFABP the binding 
cavity is subdivided, with lysophosphatidic acid bound to the lower part, and 
siderophore-iron complexes bound to the upper part [21]. Given that the Met93 residue 
is located close to the rim of the binding pocket in ApoD, the situation described for L-
PGDS can potentially have resemblances with that of ApoD. The lower part of L-PGDS 
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cavity is highly hydrophobic and can fit several different ligands, whereas the residue 
Cys65 catalyzes the isomerization of PD-H2 in PD-D2 in the upper part of the cavity 
[19]. 
 
The analysis of the binding properties of Laz, NLaz and hApoD (Chapter2) has 
opened a door to discover novel functions, and has also helped to explain phenotypes 
characterized in the null-mutants of mice and fly. 
For instance, the selective binding of the pheromone 7-T by NLaz can explain the 
deficit in courtship behavior that NLaz-KO flies exhibit. 7-T increases Drosophila 
female sexual receptivity, making female flies to mate faster and more often with males 
with higher levels of 7-T, while low levels of 7-T in males reduce their courtship 
success [22]. NLaz can be acting as a soluble receptor transporting 7-T to sensory 
organs (Chapter 1 and 3). This proposal can also explain why grasshopper Laz, 
anchored to the plasma membrane, cannot rescue the courtship behavior deficits in 
NLaz null-mutants (Chapter 4). 
The discovery of AEA binding to ApoD may implicate Lipocalins in the 
endocannabinoid system, suggesting new functions in the central nervous system. AEA 
binding to ApoD invites to think of other N-acylethanolamines (NAE) as potential 
ApoD ligands. OEA and PEA (oleoylethanolamine and palmitoylethanolamine) are 
known to regulate food intake and lipid metabolism, either by acting in the brain or in 
signaling from the gastrointestinal tract or the pancreas [23]. Moreover, low levels of 
NAE occur under dietary restriction, a condition that leads to lifespan extension [24]. 
The inhibitory action over the IIS pathway, known for NLaz and proposed for ApoD 
[5,25-27], could be acting synergically with a putative sequestration of NAE. This 
situation would create a ‘state of dietary restriction’ and, consequently, an extension of 
lifespan. 
NLaz inhibits the IIS pathway at the PI3K level [5], but no one knows how. PI3K 
carries out the phosphorylation of PIP2 to PIP3 at the plasma membrane. Thus, 
modifications in the plasma membrane composition might lead to a different IIS/PI3K 
activity [28,29]. The ability of Laz and Laz-related Lipocalins to bind FA and SM 
(Chapter 2 and [30-32]), together with the reported capacity of hApoD to influence AA 
signaling [33], strongly suggest that NLaz inhibition of PI3K activity could be achieved 
through modifications of plasma membrane lipid composition. Additionally, it has been 
described that there is a progressive enhancement of neutral sphingomyelinase (SMase) 
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in the hippocampus of aged mice. SMase hydrolyses SM in phosphocholine and 
ceramide, being ceramide a pro-apoptotic molecule. This mechanism underlies neuronal 
death in the substantia nigra in Parkinson’s disease [34], a tissue where Laz/ApoD 
protection is fundamental (Chapter 4 and [2]). Another connection between ApoD and 
SM is that, hApoD lipoparticles are enriched in SM [35]. Thus, Laz/ApoD may be 
binding SM and keeping it at the right level to control cell-death in age-sensitive neural 
circuits. 
 
Therefore, Laz and Laz-related Lipocalins can control the IIS pathway and the 
process of aging, and can deal with oxidative stress through the management of a set of 
different hydrophobic ligands.  
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Conclusions 
This thesis demonstrates that: 
1. GLaz and NLaz have both common and specialized functions that influence lifespan 
in a sex-dependent way. 
2. ApoD, NLaz and Laz bind selectively to a different but overlapping set of lipid 
ligands. This multispecificity can explain the multiple functions they possess.   
3. NLaz requires an intact ligand-binding cavity to carry out most of its biological 
functions. Further molecular interactions prove to be also essential for NLaz actions in 
vivo. 
4. Grasshopper Laz, GPI-linked to the plasma membrane, increases lifespan and 
functionally replaces NLaz of its protective functions. 
5. Ligands, and their management, are critical to understand Laz and Laz-related 
Lipocalins functions. 
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Resumen 
Lazarillo (Laz) de saltamontes, Lazarillo Glial (GLaz) y Lazarillo Neural (NLaz) 
de Drosophila, y Apolipoproteina D (ApoD) de vertebrados, son proteínas homólogas 
pertenecientes a la familia de las Lipocalinas. Funcionalmente se han asociado con un 
papel protector frente al estrés oxidativo y al envejecimiento [1-6]. Además tienen un 
papel activo en la regulación del metabolismo [4,5,7-9]. 
 La familia de las Lipocalinas está presente en todos los reinos. Sus miembros 
tienen entre 160 y 230 aminoácidos y son secretados al espacio extracelular. Los 
integrantes de la familia típicamente presentan una baja identidad de secuencia, pero sin 
embargo una alta conservación en su estructura terciaria. El plegamiento de las 
Lipocalinas se caracteriza por un barril-β que forma una cavidad o bolsillo donde se van 
a unir pequeños compuestos o ligandos, que serán habitualmente de carácter 
hidrofóbico.  El ligando (o ligandos) es un elemento clave en las Lipocalinas y 
habitualmente define sus funciones biológicas. Es frecuente encontrar que muchos 
miembros de la familia presentan un amplio espectro de ligandos y por tanto están 
implicados en múltiples procesos biológicos [10]. 
El estudio de la filogenia de las Lipocalinas integra a Laz y a las Lipocalinas 
relacionadas (GLaz, NLaz y ApoD) en el clado I del árbol filogenético de proteínas. El 
clado I por tanto se convierte en punto de unión de las Lipocalinas de invertebrados y 
vertebrados [11-13]. 
En esta tesis he estudiado a la Lipocalina Lazarillo y a sus homólogos como 
grupo. La identificación de sus ligandos y su influencia en las funciones que llevan a 
cabo es el objetivo global de esta tesis. Para alcanzar este objetivo global se 
desarrollaron cuatro objetivos concretos que han sido resumidos anteriormente junto a 
los resultados, estos últimos organizados según los capítulos en que se organiza esta 
tesis. 
 Para la consecución del objetivo global he empleado distintos niveles de 
aproximación experimental: 1) Ensayos in vitro: expresión génica, medidas de 
peroxidación lipídica, medidas de triglicéridos y glucosa, ensayos de unión ligando-
proteína, etc. 2) Cultivos celulares: neuroblastomas humanos y líneas celulares de 
Drosophila. 3) Ensayos in vivo utilizando Drosophila melanogaster como organismo 
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modelo. Entre los ensayos in vivo se incluyen estudios de longevidad, resistencia a 
estrés, análisis del comportamiento, etc. 
El primer objetivo específico (objetivo 1) consistió en la caracterización de las 
funciones biológicas en que están implicadas las Lipocalinas de Drosophila GLaz y 
NLaz. Para ello se utilizaron mutantes nulos de GLaz o NLaz y se estudió qué fenotipos 
están alterados, prestando especial atención a su relación con el envejecimiento y a los 
dimorfismos sexuales. La ausencia de NLaz reduce la supervivencia en machos y en 
hembras. Sin embargo, la falta de GLaz reduce la longevidad en machos, pero no en 
hembras. El análisis de los mutantes revela que los cambios en la homeostasis de 
proteínas son los responsables de las diferencias observadas en longevidad. Tanto GLaz 
como NLaz están implicadas en la respuesta a estrés y el control de lípidos peroxidados, 
sin embargo, los ensayos de comportamiento y el almacenaje de grasas a los largo del 
tiempo diferencian a los mutantes de GLaz y NLaz. Por tanto se observa una división 
parcial de trabajos entre GLaz y NLaz. 
 Dado que el ligando es el responsable de muchas de las funciones que llevan a 
cabo las Lipocalinas, en el objetivo 2 estudié las capacidad de unión de Laz, NLaz y 
ApoD. Para ello, cloné estas Lipocalinas en un sistema de expresión en células S2 de 
Drosophila, las purifiqué, y las enfrenté a una batería de posibles ligandos. La capacidad 
de unión fue monitorizada mediante fluorimetría. Laz, NLaz y ApoD son capaces de 
unir ligandos hidrofóbicos dentro un gran rango de estructuras y tamaños, pero a su vez 
muestran una alta especificidad. Por ejemplo, ApoD une selectivamente el cannabinoide 
anandamida y NLaz une específicamente la feromona 7-T. Por otra parte, ApoD, NLaz 
y Laz presentan ligandos en común, como es el caso del ácido retinoico o la 
esfingomielina. 
 En el objetivo 3 estudié in vivo la relevancia de la unión de los ligandos. Para 
ello diseñé una serie de mutaciones puntuales en la secuencia de NLaz que podrían 
alterar la capacidad de unión a ligandos. En concreto, la mutación L130R elimina la 
unión in vitro del ergosterol y la feromona 7-T a NLaz. El estudio in vivo de los 
mutantes puntuales L130R mostró que, en muchos fenotipos, se asemejan más a 
individuos mutantes nulos para NLaz que a individuos silvestres. Los fenotipos en los 
que se observó este patrón incluyen la regulación de la longevidad, la respuesta a estrés, 
las habilidades comportamentales (test de escalada y de cortejo) y, por último, el 
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almacenaje de triglicéridos. Sin embargo, la homeostasis de la glucosa no se vio 
alterada por la pérdida de la capacidad de unión a ligandos de NLazL130R. 
 En el último objetivo específico (objetivo 4), me planteé si estas Lipocalinas 
pueden llevar a cabo sus funciones protectoras desde otra localización sub-celular. La 
Lipocalina escogida fue Laz, ya que Laz de saltamontes en su contexto natural presenta 
la exclusividad de aparecer unida a la membrana plasmática mediante una cola GPI. 
Mediante transgénesis obtuve moscas que expresan Laz anclado a la membrana 
plasmática. Estos individuos, mostraron una mayor resistencia a distintas formas de 
estrés y una longevidad incrementada. Por tanto, las funciones protectoras de este grupo 
de Lipocalinas pueden ser ejercidas desde la membrana. Sin embargo, la presencia de 
Laz en individuos deficientes en NLaz no fue capaz de restaurar el fenotipo silvestre en 
los ensayos de cortejo. En este último caso sí que es necesario la presencia de la 
proteína libre, probablemente debido a que es necesario el transporte del ligando. 
 
De todos estos resultados se concluye que Laz y las Lipocalinas relacionadas 
están implicadas en un gran número de procesos biológicos, jugando tanto su 
localización sub-celular como el ligando un papel fundamental en la correcta ejecución 
de sus funciones. 
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La apolipoproteína-D (ApoD) pertenece a la familia de las lipocalinas. En general, las apolipoproteínas se producen fundamentalmente en
el hígado; sin embargo, ApoD se encuentra ampliamente distribuida en el organismo y tiene un alto nivel de expresión en determinadas
situaciones fisiológicas y patológicas. El aumento de la expresión de ApoD con la edad es un fenómeno conservado en los mamíferos.
Sabemos que los homólogos de ApoD en Drosophila, Lazarillo Glial (GLaz) y Lazarillo Neural (NLaz), son capaces de modular la
longevidad y los niveles de oxidación tisular, y que el envejecimiento esta íntimamente relacionado con un incremento de la oxidación de
biomoléculas. Además, esta situación se exacerba en patologías asociadas a la edad.
En esta revisión analizamos los conocimientos actuales sobre ApoD-Lazarillo y el papel que juegan en el envejecimiento y en las
enfermedades neurodegenerativas, cardiovasculares y el cáncer, donde la edad es un importante factor de riesgo.
El envejecimiento es la pérdida gradual de las funciones
biológicas con el paso del tiempo. Esta pérdida aumenta
el riesgo de sufrir enfermedades y de morir. Es un
proceso deletéreo, progresivo, endógeno e irreversible.
El envejecimiento se asocia con un aumento de las
especies reactivas de oxígeno (ROS) y de nitrógeno
(RNS). Estas moléculas son capaces de reaccionar con
proteínas, lípidos y ácidos nucleicos provocando su
deterioro funcional (Oliveira y cols., 2010). Este estrés
oxidativo está íntimamente ligado a la inflamación, y
ambos lo están a patologías como la aterosclerosis, a la
resistencia a insulina y a la diabetes (Uranga y cols., 2010).
Pese al carácter irreversible del envejecimiento,
el ser humano siempre ha buscado la manera de evitarlo
o, al menos, retrasarlo lo máximo posible. Esto ha
convertido al envejecimiento en uno de los temas
centrales de la investigación. Se han identificado
recientemente distintas maneras de incrementar la
longevidad, muchas de ellas gracias a las herramientas
genéticas disponibles en organismos modelo. La
longevidad aumenta cuando: (1) se inhibe la actividad de
la vía de la insulina (IIS) (Berryman y cols., 2008; Clancy y
cols., 2001; Tatar y cols., 2001); 2) se disminuye la tasa de
respiración mitocondrial (Dillin y cols., 2002; Lee y cols.,
2003); y, por último, (3) cuando se realiza un patrón de
ingesta de alimentos restringida (DR), sin caer en la
malnutrición. Esta última manipulación permite ampliar
la esperanza de vida de un modo conservado desde
levaduras hasta mamíferos (Fontana y cols., 2010;
Skorupa y cols., 2008).
Analizando en conjunto el perfil de expresión
génica del cerebro de humanos, macacos y ratones
envejecidos, se han descrito los genes en común que
aumentan su expresión con el envejecimiento.
Apolipoproteína D (ApoD) es el gen que más aumenta su
expresión (Loerch y cols., 2008) en todas las especies
analizadas. Un resultado idéntico se obtuvo de un meta-
análisis de transcriptomas de distintos tejidos de ratón,
rata y humanos envejecidos (de Magalhaes y cols., 2009),
por lo que la elevación de ApoD con la edad es
generalizable a muchos tejidos. Esto convierte a ApoD
en un elemento clave en el estudio del envejecimiento y
sus mecanismos.
ApoD es una glicoproteína secretada que fue
inicialmente identificada en el plasma humano asociada a
las lipoproteínas de alta densidad (HDL) (McConathy y
Alaupovic, 1973). Se ha detectado su expresión en
numerosos tej idos. Al contrario que otras
apolipoproteínas, sus niveles de expresión en el hígado e
intestino no son altos. Destaca el sistema nervioso como
uno de los principales tejidos de expresión, siendo
producida principalmente por las células de la glia (Van
Dijk y cols., 2006). En su promotor se han identificado
elementos reguladores de respuesta a estrés,
estrógenos, progesterona y glucocorticoides de entre
otros muchos (Do Carmo y cols., 2002).
ApoD se sintetiza como un polipéptido de 189
aminoácidos, correspondiendo los 20 primeros al
péptido señal que será eliminado dando lugar a la
proteína madura, que se secreta al medio extracelular.
ApoD ha sido recientemente cristalizada y su estructura
resuelta con una resolución de 1,8Å (Eichinger y cols.,
2007). Como ya se había predicho por su estructura
primaria, ApoD pertenece a la familia de las lipocalinas,
Esta familia se caracteriza
áminas-
ípicamente delimitado por aminoácidos
apolares, lo que permite la unión de pequeños ligandos
hidrofóbicos (Flower, 1996, 2000).
Experimentos in vitro han descrito varios
ligandos potenciales de ApoD: progesterona (con la que
ha sido cristalizada) (Eichinger y cols., 2007), colesterol
(Patel y cols., 1997), retinol (Breustedt y cols., 2005) y
ácido araquidónico -por el que muestra la mayor
afinidad- (Morais Cabral y cols., 1995; Vogt y Skerra,
2001). Únicamente se conoce un ligando fisiológico: el
odorante ácido E-3-metil-2-hexanoico (E3M2H) de la
piel de la axila humana (Zeng y cols., 1996). Además,
ApoD presenta dos puntos de glicosilación: Asn45 y
Asn78 y presenta cadenas de azúcares cuya longitud
puede variar considerablemente en función del tejido
Biología molecular de ApoD
por su estructura terciaria
altamente conservada: un barril- formado por 8
l antiparalelas. El barril- forma una cavidad o
bolsillo, t
β
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conservación funcional es clara, ya que la propia ApoD
humana confiere un fenotipo de mayor resistencia al
estrés, aumento de la longevidad y disminución de los
lípidos peroxidados cuando se sobre-expresa en
Drosophila (Muffat y cols., 2008).
El papel de ApoD también ha sido estudiado en
mamíferos. Los ratones ApoD-KO poseen una menor
resistencia al PQ, un aumento de lípidos peroxidados en
el cerebro y un menor éxito en pruebas de locomoción y
memoria (Ganfornina y cols., 2008). Estos animales
ApoD-KO presentan alteraciones en la composición y
distribución de varios receptores de neurotransmisores
(Boer y cols., 2010; Rajput y cols., 2009).
Por otra parte, la ausencia de ApoD prolonga la
respuesta inflamatoria retrasando la regeneración en el
nervio periférico tras un daño (Ganfornina y cols., 2010).
En situaciones inflamatorias se ha visto un aumento de la
expresión de ApoD en células tratadas con
lipopolisacárido bacteriano (LPS) (Do Carmo y cols.,
2007). También se ha comprobado su capacidad de
reducir los niveles de ácido araquidónico en membranas
(Thomas y cols., 2003b), lo que disminuye la señalización
inflamatoria. Los ratones sobreexpresores de hApoD
son capaces de resistir la infección por el coronavirus
OC43 (Do Carmo y cols., 2008).
La sobre-expresión de hApoD en las neuronas
de ratón provoca intolerancia a la glucosa y resistencia a
la insulina (Do Carmo y cols., 2009). Se ha descrito
recientemente que la sobre-expresión de ApoD en el
hígado de ratones silvestres u obesos provoca una
disminución de los triglicéridos en plasma, ambos casos
mediados por el aumento de la actividad de la enzima
lipoproteína-lipasa (Perdomo y cols., 2010). El control
del metabolismo es un punto clave que determina la tasa
envejecimiento y la esperanza de vida. Todo apunta a que
ApoD-Lazarillo es un elemento esencial en este control.
Existe un gran número de patologías asociadas a la edad
que en los últimos cien años han cobrado gran relevancia,
ya que la esperanza de vida en los países industrializados
se ha incrementado considerablemente. Las más
relevantes pueden agruparse en tres categorías:
enfermedades del sistema nervioso, cardiovasculares y
cáncer.
Las enfermedades del sistema nervioso tienen un gran
impacto social, principalmente aquellas que cursan con
un déficit cognitivo.
La enfermedad de Alzheimer (AD) es una
demencia progresiva que lleva a la pérdida de funciones
cognitivas como son la memoria y el lenguaje. A nivel
ApoD y las patologías asociadas al envejecimiento
SistemaNervioso
(Zeng y cols., 1996). Esto hace que el peso final de la
proteína varíe entre 19 y 32kDa (Rassart y cols., 2000).
ApoD es la lipocalina de mamíferos más ancestral dentro
del árbol filogenético de la familia, siendo sus homólogos
más cercanos las proteínas Lazarillo de artrópodos
(Ganfornina y cols., 2000; Gutierrez y cols., 2000).
Lazarillo es un homólogo del saltamontes Schistocerca
americana que se encuentra anclado a la membrana
plasmática de las neuronas (Ganfornina y cols., 1995;
Sanchez y cols., 1995). Los estudios de unión a ligandos
han demostrado que, al igual que ApoD, tiene una gran
afinidad por ácidos grasos de cadena larga, entre ellos el
ácido araquidónico (Sanchez y cols., 2008). Se han
identificado dos homólogos de ApoD en la mosca del
vinagre Drosophila melanogaster: Lazarillo Glial (GLaz) y
Lazarillo Neural (NLaz), que reciben este nombre
debido a las células del sistema nervioso que los
expresan. Sin embargo, al igual que ApoD, también se
expresan ampliamente fuera del sistema nervioso
(Sanchez y cols., 2000).
Para un mejor estudio de ApoD y sus
homólogos, y su contribución en el envejecimiento, se
han generado mutantes de pérdida (KO) y ganancia de
función. La caracterización de las moscas GLaz-KO ha
revelado una importante disminución de la esperanza de
vida, una mayor sensibilidad al ayuno y a distintas formas
de estrés oxidativo: al agente generador de ROS,
paraquat (PQ) y al H O . Además los niveles de apoptosis
neuronal y de lípidos peroxidados aumentan en estos
mutantes (Sanchez y cols., 2006). Opuestamente, la
sobre-expresión de GLaz aumenta la longevidad y otorga
mayor resistencia frente a un potente estrés oxidativo
como es la hiperoxia (Walker y cols., 2006). También en
células S2 de Drosophila, la sobre-expresión de GLaz
aumenta la viabilidad cuando son expuestas a PQ o al
péptido A
Recientemente se ha descrito un papel
importante de NLaz en la regulación metabólica, ya que
es capaz de reprimir la actividad de la vía IIS a nivel de la
PI3K (fosfoinositol-3-cinasa) en larvas y moscas adultas.
Al igual que sucede en los mutantes GLaz-KO, los
individuos NLaz-KO tienen una menor esperanza de vida
y resistencia al estrés, mientras que la sobre-expresión
de NLaz incrementa su resistencia y su longevidad (Hull-
Thompson y cols., 2009).
Los genes Lazarillo tienen características
ancestrales, demostrando una función protectora en
otros organismos como en amphioxus (Branchiostoma
belcheri) (Zhang y cols., 2010) e incluso en plantas
(Arabidopsis thaliana) (Charron y cols., 2008). La
Papel de ApoD y sus homólogos en el
envejecimiento
2 2
β42 (Muffat y cols., 2008), ampliamente
utilizado para simular la enfermedad de Alzheimer en
modelos experimentales.
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tisular la AD se caracteriza por la degeneración de
neuronas hipocampales y corticales, observándose
ovillos neurofibrilares y placas de agregados del péptido
-amiloide (Parihar y Hemnani, 2004).
En pacientes con AD se detectan niveles
elevados de ApoD en el líquido cerebroespinal y en
diversas regiones cerebrales afectadas: el hipocampo
(Glockner y Ohm, 2003; Terrisse y cols., 1998), el córtex
temporal (Kalman y cols., 2000) y prefrontal (Thomas y
cols., 2003a). ApoD aumenta selectivamente en el
córtex entorrinal de pacientes con AD, pero la proteína
no se detecta en las neuronas con ovillos (Belloir y cols.,
2001). Esto sugiere que la expresión de ApoD se
incrementa en las neuronas que están sufriendo un estrés
pero antes de estar verdaderamente dañadas. En un
modelo de AD en ratón aumenta la expresión de ApoD
en mayor medida en los cerebros patológicos que en sus
controles silvestres envejecidos (Thomas y cols., 2001).
Navarro y cols. (2003) han detectado la presencia de
ApoD en los depósitos de
Existen correlaciones entre pacientes con AD y
determinados polimorfismos de ApoD en poblaciones
de Finlandia, afroamericanas y del norte de China (Chen
y cols., 2008; Desai y cols., 2003; Helisalmi y cols., 2004).
Varios trabajos que estudian ApoD y AD han intentado
encontrar alguna relación con apolipoproteina E (ApoE)
sin encontrar una clara relación entre ellas (Glockner y
Ohm, 2003; Kalman y cols., 2000; Terrisse y cols., 1999;
Thomas y cols., 2003c).
Otra enfermedad neurodegenerativa asociada a
la edad y de diferente origen es el Parkinson. Únicamente
existe una publicación donde se describe una mayor
cantidad de ApoD en la glia que rodea la sustancia negra
de estos pacientes (Ordonez y cols., 2006).
Los accidentes cerebro-vasculares son
frecuentes en edades avanzadas. Con la edad aumentan
las moléculas de adhesión en el endotelio provocando
inflamación endotelial, y en última instancia llevando a
sufrir ateroesclerosis e ictus (Uranga y cols., 2010). En un
modelo de ictus oclusivo en rata se observa como la glia y
principalmente los oligodendrocitos sobre-expresan
ApoD en el área peri-infartada. No se observa ApoD en
las neuronas piramidales hasta varios días tras la
reperfusión, lo que indica que las neuronas en
regeneración captan ApoD de la glia de la escara (Rickhag
y cols., 2008). Ya que la presencia de ApoD inicialmente
se sitúa en la sustancia blanca, se postula que tiene que
ver con la reparación de las sinapsis y el aporte de
colesterol y lípidos para la biogénesis de las membranas,
así como con la formación de la escara astrocitaria.
Como ya se ha comentado, ApoD aumenta en el
cerebro ante el envejecimiento normal y patológico,
pero es una reacción generalizada ante cualquier tipo de
daño o patología sin ser necesaria una vinculación con la
edad. Este incremento ocurre, por ejemplo, en
enfermedades genéticas como Niemann-Pick (Suresh y

β-amiloide de pacientes con
AD.
cols., 1998), enfermedades infecciosas como la
encefalopatía 'scrapie'(Dandoy-Dron y cols., 1998) o
idiopáticas como la esquizofrenia (Sutcliffe y Thomas,
2002; Thomas y Yao, 2007) y ante el daño por
excitotoxicidad con ácido kaínico (Ong y cols., 1997).
La edad es un factor de riesgo muy importante en la
aterosclerosis. Esta patología está habitualmente
asociada a otras como son la hipertensión, la
hipertrigliceridemia o hipercolesterolemia y la diabetes
tipo 2. Esta asociación se conoce con el nombre de
síndrome metabólico (Duvnjak y Duvnjak, 2009). La
desregulación del metabolismo lipídico o la obesidad son
uno de los principales factores de riesgo en la
aterosclerosis. ApoD como componente de las HDL ha
suscitado estudios sobre su relación con el colesterol y
los lípidos (Perdomo y Dong, 2009). Se han detectado
variantes alélicas del gen en la población afroamericana.
Dos de ellas elevan el riesgo de enfermedad
cardiovascular: Una de ellas reduce las cantidades de
HDL y la otra eleva los triglicéridos y ApoA-I en plasma
(Desai y cols., 2002).
Otros polimorfismos se asocian con los niveles
de insulina basal y la obesidad. Por todo ello, se propone a
ApoD como marcador de obesidad y hiperinsulinemia
(Vijayaraghavan y cols., 1994). Se ha propuesto que
ApoD interacciona con el receptor de leptina en el
hipotálamo, donde la expresión de ApoD se estimula con
dietas ricas en grasa y se correlaciona con la ganancia de
peso, con la cantidad de grasa corporal y con los niveles
de leptina circulantes (Liu y cols., 2001).
En el inicio de la aterogénesis los lípidos juegan
un papel importante, junto con la proliferación de las
células de músculo liso de la íntima de las arterias. Las
señales proliferativas son citocinas y factores de
crecimiento secretados por los leucocitos infiltrantes
activados por las lipoproteínas (sobre todo por LDL
oxidadas). Uno de los factores típicos es el factor de
crecimiento de origen plaquetario (PDGF). Se ha
demostrado que ApoD se encuentra en la placa de
ateroma y que si se sobre-expresa en células de músculo
liso, éstas no reaccionan al PDGF. El mecanismo de
acción de ApoD para inhibir la acción de PDGF y la
proliferación de las células se basa en bloquear la entrada
al núcleo de la cinasa ERK activa (Sarjeant y cols., 2003).
Sin embargo otro trabajo propone un efecto aditivo
entre PDGF y ApoD (Leung y cols., 2004). Un detalle
importante es el hecho de que una dieta rica en grasa
aumenta la proporción de ApoD en las LDL plasmáticas
(Perdomo y Dong, 2009), lo que podría concordar con
una mayor presencia de ApoD en la placa de ateroma.
Enfermedades cardiovasculares
· F
IS
IO
LO
G
íA
. B
ol
et
ín
 in
fo
rm
at
iv
o 
de
 la
 S
EC
F
7
· F
IS
IO
LO
G
íA
. B
ol
et
ín
 in
fo
rm
at
iv
o 
de
 la
 S
EC
F
8
cols., 2009).
Frecuentemente se ha sugerido la posibilidad de
utilizar ApoD como una diana terapéutica en patologías
asociadas a la edad de muy distinta índole, ya sea
modulando sus niveles o mediante las llamadas
“antical inas”. Las antical inas son lipocalinas
mutagenizadas con la intención de transportar un ligando
específico y ejercer un efecto terapéutico (Skerra, 2008;
Vogt y Skerra, 2004).
Sin embargo, permanecen muchos aspectos
desconocidos acerca de ApoD y sus homólogos. ¿Cómo
modulan un proceso tan multifactorial como la
longevidad? ¿Cuál es su papel exacto en las enfermedades
n e u r o d e g e n e r a t i v a s y e l c á n c e r ? … E l
futuro…¡Esperamos llegar a viejos para conocerlo!
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Conclusiones y perspectivas
Cáncer
La parada del crecimiento celular induce la expresión de
ApoD, lo cual la relaciona directamente con el cáncer
(Do Carmo y cols., 2007). Además, su expresión está
controlada por p73 y p63 (Sasaki y cols., 2009), proteínas
de la familia del supresor de tumores p53, ambas
implicadas en el control del desarrollo.
Muchos trabajos sobre distintos tipos de cáncer
coinciden en señalar a ApoD como un marcador de buen
pronóstico. Entre ellos se encuentran los de mama
(Diez-Itza y cols., 1994), ováricos (Vazquez y cols.,
2000), hepáticos (Utsunomiya y cols., 2005; Vizoso y
cols., 2007), colon (Ogawa y cols., 2005), astrocitomas
(Hunter y cols., 2002; Hunter y cols., 2005b) y
neurofibromas (Hunter y cols., 2005a). En otros tipos de
cáncer se ha usado como marcador diagnóstico
apareciendo en los dermofibrosarcomas protuberantes
(Linn y cols., 2003; West y cols., 2004) y encontrándose
ausente en los fibromixomas (Lisovsky y cols., 2008).
Existe controversia en cuanto a la aparición de ApoD en
el cáncer de próstata (Hall y cols., 2004).
Existe una clara relación entre ApoD, sus homólogos, el
envejecimiento y las patologías asociadas. El
envejecimiento es un proceso global del organismo en el
que la interrelación entre los distintos sistemas y tejidos
es fundamental (Murphy y Partridge, 2008). ApoD se
incrementa con la edad (Loerch y cols., 2008) y, además,
tiene un amplio patrón de distribución, permitiendo ser
una proteína muy pleiotrópica y desempeñar distintos
papeles en los diferentes tejidos (Rassart y cols., 2000).
Todo esto la convierte en una excelente candidata para el
estudio y comprensión del envejecimiento.
La gran conservación funcional de ApoD y los
Lazarillos ha permitido trabajar con modelos animales.
Todos los resultados indican un papel protector y de
mantenimiento de la homeostasis para este grupo de
proteínas. Merece destacarse (1) la capacidad para
reducir los lípidos peroxidados y modular la longevidad
(Ganfornina y cols., 2008; Muffat y cols., 2008; Sanchez y
cols., 2006; Walker y cols., 2006) y (2) la regulación de la
vía de la insulina por parte de NLaz (Hull-Thompson y
Figura 1. ApoD en el laberinto de la vida. Esquema representativo de ApoD a lo
largo del complejo entramado de la vida: del desarrollo a la vejez, destacando su
elevada expresión en el envejecimiento.
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